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Abstract
Measurement of lung function in preschool children (those aged two to five years) 
is notoriously difficult. The aims of this thesis were to determine whether multiple- 
breath inert gas washout (MBW) could be performed successfully in preschool 
children, and whether MBW indices were more sensitive for detecting cystic 
fibrosis (CF) lung disease in preschool children than spirometry indices.
First, quality control criteria for data collection and interpretation in children with 
and without CF were examined. 75% of preschool children successfully performed 
spirometry at first attempt, but adult criteria for start and end of test and 
reproducibility were inappropriate. Similarly, 79% of preschool children completed 
MBW at first attempt. The primary outcome measure from MBW (Lung Clearance 
Index [LCI]) was independent of subject characteristics in healthy preschool and 
school-age children. Analysis of the progression of the phase III slope through 
MBW allowed derivation of indices representing conducting zone ( S cond) and 
acinar zone (S a c in ) inhomogeneity. Volume correction of these indices facilitated 
comparison between groups.
MBW and spirometry results were compared in 55 school-age and 60 preschool 
children. Whilst group differences were seen for both tests, 11/22 (50%) of school- 
age children with CF had normal spirometry, whilst only one (5%) had normal LCI. 
26/30 (87%) of preschool children with CF had normal spirometry, whilst only 
eight (27%) had normal LCI. Virtually all children with CF had raised S cond, with no 
age relationship seen. Sacin was normal in most younger children with CF, and 
raised in most aged 10 years and older.
MBW detected lung disease in preschool children with CF more frequently than 
spirometry. Most young children with CF had evidence of conducting airway 
disease, whilst acinar zone involvement was predominantly seen in older school-age 
children. These findings support the hypothesis that MBW will have value as a 
clinical measure in this patient group.
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Chapter 1: Introduction
1.1 Lung function testing in preschool children with cystic fibrosis
1.1.1 Introduction
The preschool years, defined as the years between a child’s second and sixth 
birthdays, have been termed “the silent years” with regard to measurement of lung 
function. Measurement techniques commonly employed in older children and adults 
require levels of co-operation and co-ordination that are not possible from preschool 
subjects. Techniques employed in infants that require subjects to be sedated are 
similarly impractical in the preschool years. Since the 1980s a few reports have 
described modifications of lung function techniques for use in preschool children. 
The majority concluded that the effort required to obtain usable results could not be 
justified.
This consensus is now changing. The last decade has witnessed a number of studies 
describing measurement of lung function in preschool children, with some utilising 
lung function measures as outcomes to differentiate between groups, or to evaluate 
interventions. The commonest techniques reported have been measures of airway 
resistance, either measured by body plethysmography or by the interrupter 
technique, but there have also been recent reports of successful spirometric 
measurements in this age group. A variety of other techniques, including inert gas 
multiple-breath washout (MBW), and measures from forced oscillation, have also 
been reported.
This work is only beginning. Significant hurdles remain before preschool lung 
function measures can be reliably employed as research tools, and certainly before 
they can be employed in routine clinical practice. Specifically, it is now necessary 
to establish age-appropriate standards for data collection and interpretation; and to 
identify which techniques are of the most value in distinguishing health from 
disease.
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1.1.2 Clinical importance of measuring lung function in preschool children with 
CF
Cystic fibrosis (CF) is the commonest life-threatening inherited disorder in 
Caucasians, with an incidence of approximately 1 in 2500 live births. The disease is 
caused by mutations in a gene on chromosome seven, encoding cystic fibrosis 
transmembrane conductance regulator (CFTR), which is a polypeptide sited on the 
apical membrane of epithelial cells. The primary cause of death for people with CF 
is respiratory failure resulting from chronic suppurative lung disease. CF usually 
presents in the first two years of life with respiratory symptoms (cough, wheeze, or 
respiratory failure), failure to thrive, and steatorrhoea. Less common presentations 
are bowel obstruction (meconium ileus), rectal prolapse, or electrolyte disturbance. 
A minority of individuals present late, usually with mild disease, and an even 
smaller minority present with a borderline phenotype, where the diagnosis of CF is 
uncertain1.
The major cause of progressive lung damage is neutrophil-driven chronic 
bronchocentric inflammation, secondary to chronic bacterial infection. The most 
common infecting organisms are Haemophilus influenzae, Staphylococcus aureus, 
and Pseudomonas aeruginosa. Chronic infection with P aeruginosa is 
progressively more common as subjects get older, and is the primary infecting 
organism by the teenage years. It is now recognised that inflammation secondary to 
P aeruginosa infection is the main cause of CF lung disease2’3, but the reason for 
the association between abnormal CFTR function and chronic P aeruginosa 
infection is less clear. Although the CF lung is histologically normal at birth, and 
appears to remain so for the first few weeks after birth4'6, it is now clear that infants 
with CF have evidence of airway inflammation as early as 4 weeks after birth7. 
Recent studies7 9 suggest that young children with CF have a more intense 
inflammatory response to bacterial infection than non-CF subjects. It is still unclear 
whether this enhanced inflammatory response is present in the absence of bacterial 
infection. This inflammation can cause airway obstruction, either from intraluminal 
mucus, or as a result of airway wall thickening, increase in airway smooth muscle, 
or effects on airway-parenchymal tethering. Studies of pulmonary function in 
infants with CF have demonstrated abnormal airway function early in life, even in
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those infants with no history of respiratory symptoms 10' 15. These studies are 
addressed in more detail later in this chapter.
Eradication of early P aeruginosa infection has been shown to increase life 
expectancy in CF. Once chronic P aeruginosa infection is established, regular
control of infection load, and treatment of infective exacerbations improves
*>.*1
prognosis ’ . This is achieved by regular use of nebulised anti-pseudomonal 
antibiotics, and by courses of intravenous anti-pseudomonal antibiotics. The 
progress of CF lung disease can also be slowed by interventions that improve 
mucus clearance, such as chest physiotherapy, and inhaled DNase; and by 
interventions that reduce inflammation, such as oral corticosteroids, or oral 
ibuprofen. Oral azithromycin has been demonstrated to improve lung function in 
subjects with CF16’17, but its mode of action is unclear, and may be related to an 
anti-inflammatory effect rather than an antibiotic effect.
Regular measurement of lung function, usually by spirometry, is an essential 
component of clinical monitoring of adults and school-age children with CF. 
Specifically, the forced expired volume in one second (FEVi), or its rate of decline 
is commonly used to monitor disease progression in individuals, to predict 
prognosis in subjects with advanced lung disease18,19, and as an outcome measure in 
clinical trials16. Over the last two decades there has been a shift towards closer 
monitoring and more aggressive treatment of early CF lung disease20'22, and, as a 
consequence, two major disadvantages to the use of FEVi in children with CF have 
become apparent. First, many school-age children with CF now have FEVi within 
the normal range, even though they probably have lung disease . Second, reliable 
forced expiratory manoeuvres are difficult to obtain in children under the age of 5 
years, with testing in the infant and preschool age groups being largely confined to 
specialist laboratories 24;25. As interest in monitoring younger patients increases, so 
does the need for alternative, more sensitive measures of lung function that can be 
obtained in children of all ages.
One possible reason for the relative insensitivity of FEVi for detecting early lung 
disease in CF is that CF lung disease may commence in the peripheral airways, 
which contribute little to total airway resistance. For this reason, a variety of 
alternative lung function measures have been investigated, including measurement
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of the ratio of residual volume to total lung capacity, as a marker of hyperinflation;
1 ^maximal expiratory manoeuvres using gases of different density , the slope of the 
alveolar plateau from the single-breath inert gas washout , and a variety of indices 
derived from M BW 27'29.
1.1.3 Aim of thesis
The broad aim of this thesis is to investigate whether the efficiency o f gas mixing, 
measured by the inert gas multiple-breath washout technique, could be employed as 
a measure o f  lung function in preschool children with CF. Prior to considering this 
aim, it is necessary to ask a series of questions:
• What do we require of a lung function measure in this population, and how 
do we assess whether a test meets these criteria?
• Can school-age children perform MBW, and, in those with CF, does it 
provide more information than spirometry?
• What modifications to data collection and analysis are required for the 
preschool age group?
The remainder of this chapter discusses what is meant by a lung function test, and 
how such tests can be modified for the preschool age group. Spirometry and MBW 
are then described in detail. Finally, the above broad aim is refined into specific 
hypotheses, aims, and objectives, and the outline of the body of the thesis is 
presented. A basic description of respiratory physiology, and of the 
pathophysiology of CF lung disease is provided in the Appendix. Readers who are 
unfamiliar with these areas are encouraged to read this appendix before addressing 
the remainder of this chapter.
1.2 What is a lung function test, and what can it tell us?
1.2.1 What is the purpose of a lung function test?
An ideal lung function test should be easy to obtain, and involve no risk to the 
subject. In order to be of value, it should be able to help diagnosis, assist prognosis, 
monitor disease progress or measure the effect of therapeutic interventions30.
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For the researcher, a test should be able to identify differences in lung function 
between groups, describe longitudinal changes in health and disease, and identify 
group responses to interventions. For the clinician, it is important to know whether 
lung function testing is helpful in distinguishing health from disease and is capable 
of monitoring disease progress in individuals. Ideally, a clinical test should be able 
to identify an exacerbation of lung disease, and identify whether a therapy has been 
of benefit. The requirements for clinically useful tests are therefore more stringent 
than those for research tests, and a test that can identify group differences may be of 
little value in individual subjects.
1.2.2 Precision and repeatability
To properly interpret any measurement of lung function, the precision of the
measurement should be known in health and in disease. This is usually described by
 ^1
the coefficient of variation (CoV) . When several measurements are made in 
succession, the within-subject CoV is calculated as
CoV(%) = 100 • standard deviation (SD) / mean
To evaluate change following an intervention, the repeatability of the test should be 
known over the time course of the intervention. If this time period is short enough 
to encompass a single testing session (e.g. following bronchodilator inhalation) then 
this is described as the within-occasion repeatability. If the time period 
encompasses more than one test session, then this is described as the between- 
occasion repeatability. Both within-occasion and between-occasion repeatability 
are assessed by calculation of the limits of agreement (LA) of two measurements, 
where
LA = mean +/- 2 • SD of the differences between measurements 
If a difference between two lung function measurements lies between these limits 
then it cannot be said with 95% certainty that there has been a change in lung 
function.
For lung function testing, it is assumed that both the CoV and the within-occasion 
repeatability measure the stability of the apparatus: and, for tests that require 
technical expertise on the part of the subject or the operator, the short-term 
consistency of this expertise. Between-occasion repeatability also measures
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biological variability. In subjects where airway lability is part of the clinical 
condition and where manoeuvres involving rapid changes in lung volume can 
themselves change airway properties, biological factors can also contribute to 
instability between measurements on the same occasion.
The between-subject variability is a measure of differences between individuals 
within a group. It can be expressed as the group SD.
For the researcher studying group differences, knowledge of the precision of a 
measurement, as well as the between-subject variability, is important for calculating 
power of study, and for avoiding type 2 error. For the clinician, knowledge of the 
between-occasion repeatability is essential for interpreting changes over time in the 
individual.
1.3 Special considerations for lung function testing in the preschool 
age group
1.3.1 Co-operation or passivity, incentive or distraction?
The majority of lung function tests employed in adults and school-age children 
(those aged six to 16 years) require a large measure of active co-operation, and a 
degree of co-ordination. Neither are readily available when studying younger 
children. In infants and in very young children up to the age of two years this 
problem can be overcome by performing measurements when the child is asleep. It 
is then possible to take measurements of tidal breathing, measurements of lung 
volumes by body plethysmography, or even measures of forced expiration. In 
preschool children daytime sleep is uncommon, particularly in a laboratory 
environment, and may be difficult to obtain even with sedation.
There are two main methods by which lung function measurements can be obtained 
in the preschool age group. For measurements that can be obtained during tidal 
breathing, it may be sufficient to distract the child, for example with music or an 
entertainment video. In this situation the child is passive whilst the investigator 
obtains measurements. For measurements that require a degree of co-operation, 
such as spirometry, some form of incentive is required. In essence the investigator
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encourages the child to perform the appropriate manoeuvres by incorporating them 
into play.
1.3.2 Lung function measurement techniques available for use in preschool 
children
There is value in classifying the lung function measurement techniques available for 
use in preschool children into two groups: those either commonly or rarely used in 
older children and adults.
A. Techniques commonly used in older children and adults:
• Spirometry
• Body plethysmography
Techniques in this group have a detailed literature arising from studies of older 
children and adults. This allows development of standardised methodology for 
obtaining measurements in older age groups; development of commercially 
manufactured laboratory equipment, which aids standardisation between centres; 
and calculation of reference ranges for normal (older) populations. The standardised 
methodology and commercially available equipment may be modified for use in 
this younger age group. Reference data from normal older children and adults 
cannot be extrapolated to normal preschool children, and this issue will also be 
addressed in this thesis.
The other important feature of these techniques is familiarity, which is particularly 
important for clinicians who are not specialists in respiratory physiology.
B. Techniques rarely used in older children and adults:
• Inert gas washout
• Impulse oscillation technique (IOT), also known as forced oscillation 
technique (FOT)
• Interrupter technique (Rint)
• Tidal breathing analysis
• Transcutaneous oximetry
• Objective measurement of breath sounds
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None of these techniques have well established reference ranges for normal 
populations of adults and older children.
The investigations reported in this thesis employ spirometry and multiple-breath 
inert gas washout. Spirometry is chosen because this is the main tool for monitoring 
lung function of older children and adults with CF, both in the clinic and in clinical 
research studies. MBW is selected because there is reason to believe that it may be 
a more sensitive measure of mild CF lung disease than spirometry. These two 
techniques are discussed in detail below, whilst the other techniques listed are 
described more briefly.
1.4 Spirometry
1.4.1 Principles of spirometry
Spirometry is the term applied to the analysis of the volume versus time (volume­
time) and flow versus volume (flow-volume) curves produced when a subject 
exhales with maximum effort from total lung capacity. The principles of spirometry 
are described in the Appendix for readers who are unfamiliar with the technique. 
The reproducibility of spirometry is a result of the physiological phenomenon of 
flow limitation, first demonstrated by Hyatt and Fry in 195832. By placing 
oesophageal catheters in adult volunteers these researchers were able to plot the 
relationship between intra-thoracic pressure and expiratory flow at different lung 
volumes. They demonstrated that at all lung volumes expiratory flow became effort 
independent above a certain minimum intra-thoracic pressure. This maximal flow 
varied with lung volume, being greater at higher lung volumes, and less at lower 
lung volumes (Figure 1.1). By plotting the maximal flow against lung volume, it is 
possible to obtain a normal flow-volume plot, where at the beginning of expiration 
flow rapidly increases to a peak, but then steadily falls as intra-thoracic volume 
falls, or expired volume increases. As long as the mechanical properties of the lungs 
are unchanged, the starting volume of the expiration is unchanged, and the subject 
generates enough positive intra-thoracic pressure to achieve flow limitation, then 
the flow-volume and volume-time curves should be identical on repeated 
measurement.
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Figure 1.1 Relationship between driving pressure and expiratory flow
High Intra-thoracic 
Lung Volume
Mid Intra-thoracic 
Lung Volume
Low Intra-thoracic 
Lung Volume
Driving Pressure
Legend: With increased driving pressure, flow only increases up to a certain point, 
and thereafter becomes independent o f  driving pressure. This maximal flow is 
greater at high lung volumes, and less at lower lung volumes. After Hyatt32
' X ' XAn explanation for flow limitation has been provided by wave-speed theory . This 
“tube-law” states that mean flow through a flexible tube cannot exceed the speed at 
which the pressure driving that flow can be propagated along that tube. The velocity 
of pressure propagation is described as the tube wave-speed. During flow limitation 
the speed of gas molecules flowing in the tube at the site of flow limitation (this site 
is termed the choke point) equals the wave speed. Therefore, bulk flow is the 
product of the wave-speed and the cross-sectional area at the choke point. Forced 
expiratory flows limited by this mechanism are inversely proportional to gas 
density, and directly proportional to airway wall elastance and cross-sectional area 
at the choke point,
Bulk flow at wave speed = (A'SPtnvbA' 1) 172 • (p_1) 1/2 A3/2
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Where A is the cross-sectional area, p is the gas density, and dPtnvSA' 1 is a measure 
of the tube wall elastance. Ptm is determined by the extrinsic properties of the lung:
Ptm = (Palv -  Ppl) -  (Palv -  Pib)
Where Palv is the alveolar pressure, Ppl is pleural pressure, and Pib is the 
intrabronchial pressure at the choke point. (Palv -  Ppl) represents the elastic recoil 
pressure of the lungs. (Palv -  Pib) represents the gas pressure difference from the 
alveolus to the choke point. This second term is zero under static conditions, 
meaning that Ptm is determined by elastic recoil only. During expiration Palv is 
greater than Pib, Ptm decreases, and thus wave-speed decreases. The opposite is the 
case during inspiration. This explains why flow is more likely to be limited during 
expiration than inspiration, and also demonstrates that as expiratory flow develops 
the wave speed decreases until at some point (the initial choke point) the wave 
speed will begin to limit the real flow. The initial choke point is in the proximal 
airways (where Ptm is lower, and the total cross-sectional area smaller, than at the 
alveoli), and as forced expiration continues, moves peripherally as the wave-speeds 
in these airways diminish. Flow measured at the mouth represents the integrated 
output of all airways. Further exploration of this theory is beyond the scope of this 
chapter.
A number of technical factors can impact upon reliable measurement of FVC, FEV,, 
and maximal expiratory flows. The most important are: ensuring the subject takes a 
rapid full inspiration prior to expiration; ensuring that flow limitation is achieved; 
and ensuring that the expiration continues down to residual volume. In addition, it is 
essential that the measuring equipment is standardised and correctly calibrated.
Both the European Respiratory Society and the American Thoracic Society have 
published standards for the collection and analysis of spirometry manoeuvres34’35.
1.4.2 Spirometry and lung disease
Characteristic changes to the volume-time and flow-volume curves are produced by 
intra- and extra-thoracic airway obstruction, as well as by restrictive lung disease 
and by respiratory muscle weakness.
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With mild intra-thoracic airway obstruction, the earliest change seen is development 
of curvilinearity of the maximal expiratory flow-volume curve, convex to the 
volume axis. This is seen as a result of reduced expiratory flow, particularly at 
lower lung volumes, which is also recorded as reduction in maximal expiratory 
flows. In normal subjects, PEF reflects the characteristics of the largest intra- 
thoracic airways, while MEF50 and MEF25 are more influenced by the smaller 
airways. When airway resistance is increased by disease, PEF, MEF50, and MEF25 
are all reduced. With moderate or severe intra-thoracic airway obstruction, the 
reduction in expiratory flow reduces the volume that can be exhaled during any 
time t, so that FEV, is reduced. FVC is relatively preserved, so the ratio FEV,/FVC 
is also reduced. In the healthy adult, approximately 70% of FVC is exhaled during 
the first second of a maximal forced expiration, so that FEVi/FVC in a healthy adult 
is approximately 70%. In adult clinical practice, FEVi has been accepted as the 
primary outcome measure from spirometry, as it is both reproducible and sensitive 
to moderate airway obstruction.
FEVi is also used as the primary lung function measure in the clinical care of 
school-age children with CF, and as the primary outcome measure in intervention 
studies investigating possible treatments for CF lung disease.
Detailed description of the effects of extra-thoracic airway obstruction, restrictive 
lung disease, and respiratory muscle weakness are beyond the scope of this chapter.
1.4.3 How sensitive is spirometry to mild airway disease?
The rationale for this thesis is that spirometry is insensitive to early CF airway 
disease in preschool children. The basis for this argument is that airway disease in 
CF is known to be non-uniformly distributed. First, if flow measured during forced 
expiration is the integrated output of all airways (see above), then it is possible that 
minor alterations of airway calibre in some lung regions may be masked by normal 
function in other regions. Second, airway obstruction in CF is partly due to 
intraluminal mucus, and this may be dislodged by a forced expiratory manoeuvre. 
Third, spirometry is insensitive to changes in the peripheral airways, as the large 
total cross-sectional area in the lung periphery prevents flow limitation in this
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region, even in the presence of extensive disease. This concept will be discussed 
further below. The rationale for this thesis is presented schematically in Figure 1.2.
Figure 1.2 How sensitive is spirometry?
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Legend: Traditionally, the severity o f CF lung disease has been defined by 
spirometry results, i.e. subjects with slightly abnormal spirometry are defined as 
having mild lung disease, subjects with poorer spirometry results defined as having 
moderate disease etc. This approach may have been practical, but it is not logical, 
as there is no reason to assume that children with normal spirometry results must 
have normal airways. What i f  some o f  these children with normal spirometry results 
have early or mild disease that would benefit from intervention? These children 
(shaded area) are completely excludedfrom the spirometry dose-response curve.
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1.5 Spirometric measurement in preschool children
1.5.1 Assessing flow limitation
Spirometry requires the child to inhale deeply, and then exhale, at maximum effort, 
down to residual volume. The precision of forced expiratory manoeuvres is a result 
of flow limitation. Achieving flow limitation requires a degree of co-ordinated 
effort from the child, which may be difficult for preschool children.
Comparison of FVC and FEVi results between different expiratory manoeuvres and 
calculation of variability gives some idea of whether flow limitation has been 
achieved. Alternatively, for assessment of a single manoeuvre, the transpulmonary 
pressure during a forced expiration can be measured using an oesophageal catheter. 
This is an invasive measurement, which is poorly tolerated in children. Another 
method is to apply a short pulse of negative expiratory pressure (NEP) at the airway 
opening during a forced expiration. If this increases flow, then flow limitation was 
not present during the manoeuvre. If this technique is applied to all forced 
expirations the results obtained from each expiration can then be assessed 
retrospectively. If flow limitation is not achieved for any expiration, then the results 
from that expiration can be disregarded. This technique has been applied to a small 
group of three to five year old children and is reported to be well tolerated, although 
it is not yet widely employed.
1.5.2 Previous studies in preschool children
There have been a number of publications in the last two decades describing 
spirometry in the preschool age group24’36'42. Kanengiser described a retrospective 
review of all forced expiratory manoeuvres performed by 3 to 5 year old children in 
one paediatric lung function laboratory between January 1992 and August 199338. 
98 children had attempted spirometry during this period. Of these, 88  were able to 
produce six expiratory manoeuvres that were recorded. However, only 71% of 3 
year olds, 48% of 4 year olds, and 62% of 5 year olds were able to produce FVC 
measurements that met ATS reproducibility criteria, namely that the largest FVC 
and the second largest FVC varied by 5% or less. Very few of the children could 
produce reproducible FEVi measurements (none of the 3 year olds, 38% of the 4
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year olds, and 36% of the 5 year olds). The poor success rate for FEVi 
measurement may indicate that this measure is of limited value in very young 
children, many of whom have completed a forced expiration in less than 1 second. 
This explanation is supported by the authors’ observation that none of the 3 year 
olds, 14% of the 4 year olds, and 27% of the 5 year olds were able to exhale for at 
least 1 second on all 6  of the recorded expiratory manoeuvres.
Crennesse described a retrospective review of 473 children, aged 3 to 5 years, who 
attempted spirometry for the first time between September 1993 and December 
1997 . Of these, 267 (56%) were able to produce 2 or more technically acceptable 
curves. Only 26 of these children were aged less than 4 years. The forced expiratory 
time (FET) was equal to or less than 1 second in 21% of all tested children. 
Zapletal42 described a population of 173 healthy children aged 3 to 6  years, and 
reported that 62% were able to produce technically acceptable curves.
Two recent studies have described results of spirometry in large populations of 
healthy young children. Eigen tested 259 healthy children aged 3 to 6  years (mean 
age 5.0 years) in the community24. Of these, 214 (83%), were able to produce 
satisfactory curves with FET greater than 1 second. From these data, the authors 
were able to report regression equations for peak flow (PEFR), FVC, FEVi,
MMEF, FEVj/FVC, and MMEF/FVC. Nystad tested 652 children aged 3-6 years, 
in the community, of whom 603 (92%) were able to produce technically acceptable 
curves40. Regression equations for PEFR, FVC, FEVi, and FEV0.5 were calculated 
from these data.
1.5.3 Use of incentive software
Success in achieving maximal forced expiration in preschool children may be 
increased by the use of incentive spirometry computer programs. These programs 
display interactive cartoon games in which the task of the game is achieved if the 
subject produces a forced expiration. Animations can be designed to encourage 
deep inspiration, rapid expiration, and prolongation of expiration. Manufacturers 
recommend first teaching the child how to use a mouthpiece, then using an 
incentive that encourages rapid expiration, then using an incentive that encourages 
prolonged expiration. These programs do not measure whether flow limitation has
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been achieved: this must still be estimated from repeatability of expirations. Nystad 
used two Jaeger Masterscreen incentive programs to encourage expiration40. These 
were the candles program, in which a high peak flow results in candles being blown 
out, and the balloon program in which a prolonged expiration causes a balloon to be 
blown up. Vilozni compared the Jaeger candle incentive alone with a home 
designed “Spirogame” program41. The Spirogame is a complex animation that 
encourages tidal inspiratory and expiratory breathing, deep inspiration, rapid 
expiration, and prolonged expiration. The study population was a group of 79 
healthy children aged 3 to 6  years, of whom the majority were aged 5 years and 
older. Success in producing PEFR and FEV0.5 was similar with both incentive 
programs (84% and 87% respectively), although success in producing FVC was 
higher for the Spirogame than for the candle blowing game. This may be because 
the candle blowing game is designed to encourage rapid expiration rather than 
prolonged expiration, and would not be expected to promote a full forced expiration 
when used alone. Interestingly, PEFR and FEV0.5 results were significantly higher 
with the candle incentive than with the Spirogame. Gracchi compared spirometry 
results with and without use of incentive programs in 88  children aged 4 to 8 
years43, and reported that children produced more reproducible FEVi and FVC 
results without incentives. The PEFR results obtained with incentives were 
significantly higher than those obtained without incentives. However, in the 
majority of subjects the Jaeger candle program alone was used as an incentive, 
possibly explaining these results.
1.5.4 Quality control
Many school-age children are unable to meet the quality control criteria published 
by the European Respiratory Society and the American Thoracic Society34’44, and 
they are likely to be inappropriate for preschool children also. This issue has never 
been studied.
1.5.5 Spirometric measurements in this thesis
Spirometry is the gold standard for quantifying lung disease in older children and 
adults with cystic fibrosis, and spirometric measurements will therefore be 
employed in this thesis.
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However:
a) It will first be necessary to examine whether spirometry can be performed 
reliably by preschool children, and whether modifications to published 
quality control criteria are necessary for this age group
b) It is assumed that spirometry is a poor measure of mild CF lung disease, and 
other lung function techniques may be better. Ideally, spirometry should be 
compared with numerous other measures of lung function. In practice it is 
unlikely that preschool children will tolerate a lengthy protocol, and some 
selection is required. The rationale for selecting MBW as the most 
promising alternative technique is now presented.
1.6 Measurement of gas mixing by inert gas washout
1.6.1 The phase III slope
The uniformity of ventilation distribution can be assessed by analysis of exhaled N2 
following inhalation of a single breath of 100% O2 (Figure 1.3). When exhaled N2 
concentration is plotted against exhaled volume, the resulting curve has three 
distinct phases. The first two phases represent mixing of inhaled O2 with resident 
N2 in the conducting airways. Phase III represents mixing of inhaled O2 with 
resident N2 in the respiratory zone of the lung. If gas mixing within this zone is 
homogenous, phase III will have a slope of zero. In human subjects, phase III has a 
positive slope, indicating inhomogeneity of ventilation distribution.
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Figure 1.3 The single-breath nitrogen washout curve
Phase ill
Phase II
Phase I
Expired volume
Legend: The plot shows three phases. Phases I  and II represent incomplete mixing 
o f expired gas with resident gas in the conducting airways. In a perfectly mixing 
lung, Phase III represents mixing o f inspired gas and resident gas in the lung 
periphery. In human subjects, mixing o f  gas in this zone is inhomogeneous, even in 
health, and the Phase III slope also reflects some gas mixing in conducting airways.
One possible explanation for this positive slope is presented in Figure 1.4.
The observation that phase III slopes obtained from human subjects are always 
positive has a direct implication: whatever the anatomical origin of these units, the 
best ventilated ones (left unit in Figure 1.4, where N2 concentration is lower) 
necessarily empty more (with respect to the less well ventilated units) at the 
beginning of the expiration.
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Figure 1.4 Two compartment model of ventilation inhomogeneity
100% o .
Legend: This schematic diagram provides one possible explanation for the positive 
slope o f phase III during a single breath nitrogen washout. The two balloons 
represent lung units with differing time-constants for filling and emptying. Prior to 
the inspiration, both have equal volumes, and equal N2 concentration. During 
inspiration, the unit on the left expands more quickly, and hence finishes inspiration 
with a lower N2 concentration than the unit on the right. During expiration the unit 
on the left empties more rapidly, and hence contributes more to the early part o f the 
phase III slope than the slowly emptying unit on the right. The exhaled N2 
concentration therefore continues to slowly rise through the expiration.
It is also possible to perform a single-breath inert gas washout using an inhaled, 
poorly soluble, inert gas, such as helium, argon, or sulphur hexafluoride. In this 
case, the shape of the washout curve will be inverted, and the phase III will have a 
negative slope (Figure 1.5).
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Figure 1.5 Single-breath SF6 washout
Phase I
Phase II
Phase III
Expired volume
Legend: SF6 concentration plotted against expired volume following a single 
inhalation o f a gas mixture containing SF& At the beginning o f the expiration the 
SF6 concentration in the expired gas is the same as that in the inhaled gas. This 
falls rapidly as the SF6 that was inhaled into the periphery o f  the lung has been 
diluted with the resident gas. The slope o f phase III is negative.
1.6.2 The multiple-breath washout curve
The inert gas multiple-breath washout (MBW) describes the analysis of changes in 
gas concentration over a series of expirations. Again, this can be performed using 
resident N2 as the marker gas, or alternatively an inhaled marker gas can be 
employed. In the former case, washout is performed with 100% oxygen, which can 
be provided via a bias flow or demand valve45. In the latter case it is first necessary 
to “wash-in” a tracer gas46. Washout can then be performed with air. The most 
straightforward method for analysing a multiple-breath washout is to study the
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progression of the end-tidal marker gas concentration, plotted either against time; 
breath number; or against an index of cumulative expired volume. This plot is 
displayed in Figure 1.6.
Figure 1.6 Plot of end-tidal N2 concentration against cumulative 
expired volume (expressed as lung volume turnovers) for a multiple- 
breath nitrogen washout
£
TO (CEV / FRQ
Legend: CetN2 = end-tidal N2 concentration as % o f starting concentration.
TO = number o f lung volume turnovers, calculated by dividing the cumulative 
expired volume (CEV) by the functional residual capacity (FRC).
For a perfectly mixing compartment the plot shows exponential decay, and if  
logCetN2 is plotted against TO, a linear relationship is seen.
The washout curve in Figure 1.6  is derived from a N2 MBW performed with 100% 
O2. The curve obtained is identical to that obtained if an inert marker gas is first 
washed in, and washout is then performed with air. A number of indices to describe 
this curve have been proposed (all of which are essentially measuring similar 
aspects of airway function)47,48:
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The Lung Clearance Index (LCI) is the number of lung volume turnovers required 
to reduce end tidal gas concentration to 1740th of starting value, so that 
LCI = CEV/FRC
CEV = cumulative expired volume, FRC = functional residual capacity
The Mixing Ratio (MR) is the ratio between the observed and the predicted number 
of breaths required to reduce the end tidal tracer concentration to 1740th of starting 
value, where the predicted number of breaths is that which would be needed to 
complete the washout in ideal mixing conditions
The Becklake Index is the number of TO required to wash 90% of FRC free from 
tracer gas, divided by 0.9
The Multiple Breath Alveolar Mixing Inefficiency (MBAMI) is given by the 
formula
1 0 0  ’ (1  — T O jdeal /  T O actual) 
where: TO jdeal = ideal number of T O  required to wash 90% of FRC
free of tracer gas
and: TOactual= actual number of TO required to wash 90% of FRC
free of tracer gas
Moment ratios represent the ratio between the first and zeroth moment of the 
washout (Mi / Mo) or the ratio between the second and zeroth moment of the 
washout (M2 / Mo)
Where
i) Mo is the area under the [gas] versus TO plot
ii) Mi is the area under the [gas] • TO versus TO plot
iii) M2 is the area under the [gas] • TO versus TO plot.
Pulmonary clearance delay (PCD) is given by the formula
100  • (actual average time a tracer gas molecule remains in the lung -  the ideal
time) 7 the ideal time
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There have been few studies comparing these indices directly to determine which 
gives the most information. From the limited published data available, Lung 
Clearance Index, Mixing Ratio, and moment ratios appear to have similar ability to 
discriminate between health and disease states.
1.6.3 The progression of the phase III slope during MBW
In the traditional analysis of MBW, only end or mean expired N2 concentrations are 
used. When plotted as a function of breath number or lung turnover they are 
referred to as the expired N2 washout curve. However, diverse alterations in 
anatomy or lung function can lead to similar alterations of the N2 washout curve. In 
particular, washout curves do not provide information about the mechanisms 
involved in the production of ventilation inhomogeneity, or the magnitude of lung 
units involved. However, it has been suggested49’50 that the identification of specific 
mechanisms could be obtained from the MBW if the phase III slope is also 
computed for each breath.
The simplest model allowing a quantitative description of transport in parallel units 
is represented in Figure 1.4, and consists of two compartments. A MBW simulated 
with the two-compartment model is shown in Figure 1.7.
Change in N2 concentration through the washout can be calculated for each of the 
two compartments of this model. The washout curve for each unit follows an 
exponential decay (dashed lines), and the expired N2 washout curve resulting from 
the two units combined (solid line) therefore shows a bi-exponential N2 decay. If 
the logarithm of the N2 concentration is plotted against TO, a linear relationship 
will be seen.
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Figure 1.7 Washout curve from simulated MBW based on two 
compartment model
TO
Legend: This plot is mathematically derived from two compartment model 
presented in Figure 1.4. The dashed lines represent the exponential decay o f gas 
concentration in each compartment. The solid line is the bi-exponential decay 
obtained by combining them.
LnN2 = natural logarithm o f end-tidal N2 concentration
TO = lung volume turnover
The projected phase III slopes derived from this model are dependent upon the 
expiratory flow profile of each unit upon emptying. In this respect, the phase III 
slope not only gives information on spatial, but also on temporal ventilation 
inhomogeneities. If the two units empty synchronously, the phase III slope is flat, 
whatever the concentration difference between them.
Figure 1.8 displays simulated phase III slopes as a function of TO for this parallel 
unit model. The slopes have been corrected for mean mid-phase III gas 
concentration, to produce normalised phase III slopes (SnIII).
Increase of SnIII through the washout can be understood from Figure 1.4. The 
calculation of the SnIII compares the concentration differences between units to 
their mean value. As the concentrations decrease exponentially, the relative 
concentration difference increases progressively. It is maximal when the best- 
ventilated unit is empty (N2 concentration equal to zero in that unit).
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The model described in Figure 1.4 assumes that ventilation inhomogeneity is 
generated by differing gas flows to and from parallel units, as a result of differences 
in time constants. This model predicts that SnIII will increase linearly through the 
course of an MBW.
Figure 1.8 Simulated SnIII versus turnover for the two compartment 
model
TO
Legend: TO -Lung volume turnover
SnIII = phase III slope divided by mean gas concentration over phase III slope
1.6.4 The Paiva-Engel model
An alternative model for the generation of ventilation inhomogeneity has been 
proposed by a series of theoretical and experimental studies reported by Paiva, 
Engel, and colleagues4950'57. This model, based upon morphometric data reported by
co
Weibel , consists of two asymmetric ‘trumpets’. The trumpets meet at a branch 
point, and above this share a common airway (Figure 1.9). Each trumpet increases 
in cross-sectional area with increasing distance from the branch point, with this 
cross-sectional area representing both conducting airways and alveoli58"60. 
Convection and diffusion take place simultaneously in each trumpet.
During a multiple-breath washout of this asymmetrical two-trumpet model, the 
concentration of inspired gas is higher (and therefore the concentration of resident, 
tracer gas lower) in the terminal alveoli of the smaller trumpet, as the inspired gas is
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able to reach the terminal alveoli of the smaller unit more rapidly by diffusion. The 
smaller unit is thus ‘better ventilated’ despite the inspiratory flow (per unit volume) 
to the two units being equal.
Figure 1.9 The two-trumpet model
V d
Legend: Vo = resting lung volume (FRC); Vr = tidal volume;
Vd = airway dead-space 
The model is based upon two units o f  differing size, but equal time-constants. 
Initially, diffusion results in the concentration o f tracer gas falling more rapidly in 
the smaller unit than in the larger unit. As the MBW progresses, the tracer gas 
concentration at the mouth o f the larger unit during expiration (S2)  is higher than 
the concentration within the smaller unit (Si). Tracer gas molecules therefore 
diffuse from the larger unit into the smaller unit, and the difference in gas 
concentration between the units no longer rises.
SnIII can be related to the end expiratory N2 concentration difference between the 
two trumpet units. As the washout progresses this difference initially increases, but 
then remains constant as the concentration gradient between inspired gas and the 
resident gas in the two units falls (Figure 1.9). The mechanism for this is a form of
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pendelluft54. During expiration, tracer gas (e.g. N2) concentration at the mouth of 
the larger unit will be higher than tracer gas concentration within the smaller unit. 
Tracer gas molecules will therefore diffuse into the smaller unit, reducing the 
difference in gas concentration between the two units. The prediction from this 
model is that the slope of the phase III will initially rise, but reach asymptote after 
4-5 breaths, or 1.5 lung volume turnovers52.
This diffusion-convection interaction in an asymmetric acinus results in 
inhomogeneity of gas concentrations, and a sloping plateau, even when the 
simulated acinar expansion is uniform52. Inequality of airway cross-sectional 
diameter within the lung periphery also results in intra-acinar inhomogeneity and a 
sloping plateau61. Paiva and Engel proposed that both convection and diffusion- 
convection interaction generate ventilation inhomogeneity. A washout curve from a 
MBW simulated with the diffusion-convection interaction model is shown in Figure 
1. 10.
Figure 1.10 Simulated washout curve based on the two-trumpet model
TO
Legend: LnN2 = natural logarithm o f end-tidal N2 concentration 
TO = lung volume turnover. As for a single compartment model (Figure 1.7), there 
is exponential decay o f the end tidal N2 concentration. In other words, analysis o f  
the washout curve does not differentiate between inhomogeneity created by the two- 
compartment model presented in Figure 1.4, and the diffusion-convection 
interaction model presented in Figure 1.9.
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Figure 1.11 displays simulated SnIII as a function of TO for the two-trumpet model.
Figure 1.11 Simulated SnIII versus TO plot based on the two-trumpet 
model
TO
Legend: TO =Lung volume turnover
SnIII = phase III slope divided by mean gas concentration over phase III slope 
SnIII increases over the first 1.5 TO, then reaches asymptote
In summary, the model described by Paiva and Engel describes two mechanisms by 
which ventilation inhomogeneity is generated during an MBW. Convection 
dependent inhomogeneity (CDI) is generated by temporal and spatial differences in 
filling and emptying between parallel units. The transport mechanism bringing 
inspired O2 to these lung units is convection, and this mandates that these units 
should not be too small, otherwise the concentration would equilibrate by molecular 
diffusion. In adult man, under normal breathing conditions, CDI is thought to take 
place between lung units at least as big as acini, i.e. the set of units subtended by a 
terminal bronchiole.
The diffusion-convection front arises because of the dramatic increase in total 
cross-sectional area with increasing airway generation (Figure 1.12). During 
inspiration, air is initially transported peripherally by convection. As the cross- 
sectional area increases, so the forward velocity of the gas falls. Eventually,
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diffusion takes over as the dominant mechanism of gas transport. The region in 
which diffusion and convection both play major roles in gas transport is termed the 
diffusion-convection front. Proximal to this front, convection is the dominant 
mechanism of gas transport. Distal to this front, diffusion is the dominant 
mechanism of gas transport.
Figure 1.12 The diffusion-convection front
DifTmioa dominated
Convection dominated
MfMMKMvectiN front
Airway generation ----------------------------- ►
Legend: With increasing airway generation, the total cross-sectional area o f the 
bronchial tree increases. As the cross-sectional area increases convection plays a 
lesser role in gas mixing, until a point where diffusion plays as large a role in 
transport o f  gas molecules as convection. This region is termed the diffusion- 
convection front.
49
Diffusion-convection dependent inhomogeneity (DCDI) arises as a consequence of 
interactions between diffusion and convection in the region of the diffusion- 
convection front. This inhomogeneity is generated by size differences in units 
subtended at branch points within the diffusion-convection front, and by differences 
in airway calibre at these branch points. Any inhomogeneous gas distribution distal 
to the diffusion-convection front is rapidly eliminated by diffusion.
Crawford et al suggested that DCDI only increases for the first 5 breaths, or 1.5 TO 
of an MBW49. Therefore, after the fifth breath the increase in SnIII is diffusion 
independent and represents a measure of CDI. Subtraction of this component from 
the overall slope leaves DCDI. (Figure 1.13).
The phase III slope of the first breath is almost entirely due to DCDI 
inhomogeneities. The DCDI component of the phase III slope obtained from breath 
1 (which has been labelled Sacin as an indicator that it represents inhomogeneity 
generated in or at the entrance to the acinus), is computed by subtracting the CDI 
contribution. This CDI contribution is computed from the linear portion of the SnIII 
versus TO relationship.
The advantage of using TO instead of breath number is mainly for MBW 
comparisons with different lung and/or tidal volumes. Sacin is therefore an index of 
diffusion-convection dependent ventilation inhomogeneity, generated in the region 
of the diffusion-convection front. The CDI contribution to the SnIII versus TO plot, 
calculated as the normalised slope difference per TO determined by linear 
regression between TO=1.5 and TO=6 , can be used as an index of convection 
dependent inhomogeneity. This index has been labelled S COnd> as an indicator that it 
represents inhomogeneity generated in the conducting airways. S COnd is therefore an 
index of convection dependent ventilation inhomogeneity, generated proximal to 
the diffusion-convection front. The derivation of these indices is illustrated in 
Figure 1.13.
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Figure 1.13 The contribution of CDI and DCDI to overall ventilation 
inhomogeneity
Sn = Sn + SnIH(toUI) lll(cdl) lll(dcdi)
total
cdl
dcdl
TO
Legend: According to the Paiva-Engel model, CDI has a linear relationship with 
expired volume (whether expressed as breath number or TO). DCDI rises for the 
first 5 breaths, or 1.5 turnovers, and then is unchanged. These characteristics allow 
separation o f the SnIII versus breath number (or SnIII versus TO plot) into the two 
components. The Scond index is calculated as the slope o f  the SnIII versus turnover 
CDI relationship. Sacin is the DCDI component o f  the first breath SnIII, calculated 
by subtracting the CDI component (see inset equation).
1.6.5 Evidence to support the Paiva-Engel model 
When N2 multiple breath washouts were performed in healthy subjects, the 
observed results matched the diffusion-convection model more closely than they 
matched the sequential emptying model53. Further evidence comes from studies that 
attempted to reduce or eliminate the contribution of convection dependent 
inhomogeneity. Crawford et al performed MBW with two tracer gases: sulphur
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hexafluoride (SFe) and helium (He). Whilst convection of SF6 and He is similar, the 
lower molecular weight of He allows it to diffuse more readily then SF6. Any 
difference in inhomogeneity recorded during simultaneous SF6 and He washouts 
can be attributed to differences in diffusion-convection interaction, and the impact 
of this diffusion-convection interaction component on overall inhomogeneity. 
Crawford demonstrated that the difference between the SnIII for SF6 and He 
increased for the first five breaths, and then remained constant for the rest of the 
washout49.
Animal studies, performed in rats56’62, and steers63, produced SnIII versus TO 
relationships different from those seen in man. In rats, SnIII increased for the first 3 
breaths of the washout and then remained constant, suggesting that CDI plays an 
insignificant role in the generation of ventilation inhomogeneity in this animal. The 
anatomy of the rat lung has been described64, and this information was used for 
modelling studies generating predicted SnIII versus TO plots, based on the Paiva- 
Engel model57. As in humans, there was close concordance between results 
predicted by the model and those obtained experimentally. A recently published 
study measured the effect of oleic acid infusion into the right atrium of ventilated 
dogs upon CDI and DCDI during MBW of He. Total ventilation inhomogeneity 
increased, largely due to increasing DCDI, an observation consistent with the 
pulmonary oedema that oleic acid infusion induces65.
When single-breath washout (SBW) or MBW is performed in healthy adults, the 
SnIII increases with increasing pre-inspiratory lung volume, but decreases with 
breathholding, suggesting that diffusion plays some role in the production of 
ventilation inhomogeneity54’66,67. MBW studies suggest that increasing tidal volume 
reduces the inhomogeneity due to DCDI, but increases the inhomogeneity due to 
CDI68.
As the majority of convection dependent inhomogeneity is generated by the effect 
of gravity, with (in adults) dependent regions being better ventilated, further studies 
were performed in microgravity. Multiple-breath washout experiments performed in 
healthy adults during sustained microgravity (during the Spacelab flight Spacelab 
Life Sciences-2) showed that the plot of SnIII against lung turnover was not
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significantly different from that obtained in 1G, suggesting that the mechanical 
characteristics of the compartments are not gravity dependent69.
1.6.6 Effect of lung disease upon gas washout indices
Any process that increases resistance of airways or reduces the compliance of the 
lung will increase the time taken for inhaled gas to equilibrate with the resident gas 
of the lung. Any process that has uneven effects upon airway resistance or lung 
compliance (i.e. affecting some areas of the lung more than others) will increase 
inhomogeneity of ventilation distribution. In both cases, but particularly the latter, 
the predicted effect is a prolongation of the washout curve. This will result in an 
increase in the number of lung volume turnovers required to clear resident gas, and 
an increase in LCI, MR, and moment ratios47’48. Increased inhomogeneity of 
ventilation distribution will also result in an increase in the phase III slope52. The 
Paiva-Engel model has been applied to study the effects of histamine challenge in 
asymptomatic non-smoking adults45 (Figure 1.14) and ventilation inhomogeneity in 
adults with well controlled asthma, before and after bronchodilator70. These studies 
suggest that asymptomatic individuals who will respond to histamine challenge 
have abnormal baseline Sacin, but that histamine challenge predominantly affects 
Scond- Stable asthmatic patients have abnormal S cond and Sacin, and both these indices 
improve with bronchodilator. Factor analysis of Sacin and S cond alongside a variety of 
more established lung function measurements in patients with chronic obstructive 
pulmonary disease (COPD) suggests that S cond is linked to specific airway 
conductance (sGaw) and forced expiratory flows, whereas Sacin is linked to diffusion 
capacity measurements71.
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Figure 1 .14  Effect of histamine challenge on S aCin and S COnd
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Legend: Closed markers represent SnIII prior to histamine challenge, open circles 
represent SnIII post challenge. There is little change in SaCm (total SnIII fo r breath 1 
does not change) but marked increase in Scond• From Verbanck et al51.
1.7 Measurement of gas mixing by multiple-breath inert gas washout in 
preschool children
1.7.1 MBW studies in preschool children
The use of this technique in children is largely confined to the measurement of 
indices from MBW rather than SBW. There have been three previous studies of 
MBW involving preschool children. In 1985, Couriel reported MBW in 58 healthy 
children and 24 children with CF aged 3.9 to 6 .8  years72. The test was performed
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using a mouthpiece and nose-clip apparatus, and the authors reported great 
difficulty in collecting adequate measurements in this age group72. Acceptable 
results were obtained in only 40 children (49%) of whom only 10 were aged less 
than 5 years (29% of the 34 children in this age group who attempted the test). 
Moment ratios obtained in children with CF were significantly higher than those 
obtained in controls, and moment ratios obtained in children with CF who had 
evidence of severe lung disease were significantly higher than those obtained in 
children with fewer symptoms. In the same year, Wall reported measurements in 36 
healthy children and 10 children with CF aged 3-6 years. Again, a mouthpiece and 
nose-clip apparatus was employed, but in this study the children were distracted by 
means of a portable music system and headphones. Success rates from this study 
were not presented. Children with CF had significantly higher moment ratios than 
healthy children, and there was a negative relationship (r = 0.49) between M j/M o 
and Shwachman score in the children with CF. In the discussion of these results, the 
author speculated that use of a facemask system, sealed with putty, would allow 
MBW measurement in even younger children. Recently Gustafsson has reported 
MBW and spirometry in 43 children with CF and 28 healthy children27. Eight of 
these children were aged 6  years or less, and used a facemask apparatus rather than 
the mouthpiece and nose-clip used by the older children. Main outcome measures 
were MR and LCI from MBW, and FEVi and MEF25 from spirometry. The 
majority of children with CF had normal spirometry results, but many of these had 
abnormal LCI or MR.
There are no data on SnIII analysis from MBW in children.
1.7.2 MBW studies in older children with CF
In addition to the above, several previous studies, mostly performed during the 
1980s and early 1990s, have investigated ventilation distribution in school-age and 
adult CF subjects using this or related methods. These studies have already shown 
that indices of ventilation inhomogeneity are raised in CF subjects compared with 
healthy subjects ’ ’ ’ ' , that ventilation inhomogeneity is correlated to airway 
resistance28 and FEVj75 in CF subjects. MBW has also been performed in healthy 
pre-term infants, and in infants with lung disease15’76.
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1.7.3 SBWstudies in children
Three studies of SBW analysis in school-age children have been reported. These 
studies were performed in healthy children77, children with asthma78, and children 
with CF26. In this last study, younger children with CF were noted to have reversal 
of the normal SF6-He phase III slope relationship {i.e. the slope of phase III was 
steeper for He than for SF6) indicating that airways in the region of the He diffusion 
convection front were involved in the pathological process.
1.8 Other methods for measurement of lung function in preschool 
children
1.8.1 Body plethysmography
The mechanical properties of the lung can be described by the resistance (R), and 
the compliance (C). The reciprocal of the resistance is the conductance (G). A 
suffix is added to describe which component of the respiratory system is measured 
(aw for airway, l for lung, and rs for respiratory system). Airway resistance (R a w ) and 
thoracic gas volume (TGV) may be calculated from the relationship between airway 
flow and plethysmographic volume. The subject is required to sit inside a body 
plethysmograph, whilst breathing heated and humidified air. The airflow at the 
mouth is measured by a pneumotachograph, whilst the change in volume and 
pressure inside the plethysmograph is measured. The principle behind the 
measurement is that movement of gas from lungs to box results in no change in 
total volume (provided there is no change in temperature), and so the change in box 
pressure during breathing is related to volume change of the lungs. The total gas 
volume can be calculated via a Pfueger manoeuvre, where the airway is temporarily 
occluded with a shutter and variations in mouth pressure and in thoracic volume are 
recorded. The thoracic volume can be derived from Boyle’s Law:
P1 x V1 = P2 x V2 
where PI and VI denote the pressure and volume respectively of the gas at 
condition 1, and P2 and V2 denote the pressure and volume respectively of the gas 
at condition 2. If the volume of thoracic gas is known, the observed change in box
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pressure can be used to calculate the change in alveolar pressure. Dividing change 
in alveolar pressure by change in flow at the mouth gives Raw- Measurements at 
different lung volumes in a body plethysmograph have demonstrated that RaW has a 
curvilinear negative relationship with lung volume, increasing greatly as RV is 
approached. If the result of the measurement is specific to the lung volume at which 
it is measured, then the term ‘specific’ is added to the description, and the prefix ‘s’ 
added to the abbreviation. Thus specific airway resistance is denoted sRaW. 
Calculation of TGV and Raw can be difficult in young children, who may have 
difficulty with breathing against the airway occlusion. More than 20 years ago Dab
70* snand Alexander ’ proposed a simplified method for calculating specific airway 
resistance ( s R a W)  which does not require the measurement of T G V ,  and which can 
be measured during tidal breathing through a mouthpiece: 
sR a w  =  A Pbox /  A V ’ X (Pbar ~  Ph2o) 
where A P box and A V ’ represent changes in plethysmographic pressure and volume 
flow respectively; and Pbar -  Ph20 is barometric pressure minus water vapour 
pressure in the lung. Many modem plethysmographs allow electronic compensation 
for temperature, pressure, and humidity, and this has been proposed as an 
alternative to using heated humidified air or to asking the subject to pant.
A number of reports have employed measurement of sRaw as an outcome measure 
in short term intervention studies in preschool children81'83, sometimes in 
combination with other lung function tests (below).
1.8.2 Impulse oscillation technique (IOT)
This technique is also known as the forced oscillation technique (FOT). The 
technique is based upon the observation that the mechanical characteristics of a 
system may be calculated by relating the stress applied to the system to the resultant 
deformation. The mechanical characteristics of the lung can therefore be calculated 
by applying a stress to the lung (in the form of a pressure signal) and measuring the 
deformation (the change in size and shape) that results. This deformation can be 
measured as a flow signal at the mouth. The technique is analogous to listening for 
an echo, except that as the lung is a compliant rather than a rigid structure, the echo 
is in the form of a flow signal rather than a pressure signal.
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During breathing, pressure is being generated by the respiratory muscles to produce 
deformation of the lung, and flow at the airway. Rather than interrupt breathing to 
obtain IOT measurements, the applied transpulmonary pressure can be varied in a 
frequency domain different from that of respiratory muscle activity. This allows the 
flow signals arising from the respiratory muscle activity and the applied pressure to 
be separated, and the mechanics related to the applied transpulmonary pressure to 
be studied.
In practice, the frequency employed for IOT measurements is 6Hz or greater. This 
signal is generated by computer and delivered through one or more loudspeakers 
placed at the mouth or at the chest, or alternatively is delivered through a headbox. 
The angular velocity and frequency of applied pressure and resultant flow are 
measured. These measurements allow calculation of the respiratory resistance (RrS) 
and the respiratory reactance. The latter measure is related to the respiratory 
impedance and reflects the apparent elasticity of the respiratory system.
A number of methodological issues with this technique have yet to be resolved., and 
as yet the methodology and equipment for performing the IOT have not been 
standardised. There are no reference data for normal children. However, a number 
of centres have compared IOT with plethysmography and other techniques in young 
children following methacholine challenge81’84, cold air challenge85 or 
administration of bronchodilator86. Data from adults in which IOT measurements 
(and Rint measurements) were compared with the presumed gold standards of total 
airway resistance (Raw) measured during panting manoeuvres in a body 
plethysmograph, and total lung resistance measured with an oesophageal catheter, 
suggest that both Rrs and Rint (described below) are less sensitive at detecting 
induced airways narrowing than the more established methods87.
1.8.3 Interrupter technique (Rint)
This technique is based upon the assumption that change in transpulmonary 
pressure observed immediately after sudden occlusion of the airway is entirely 
explained by cessation of flow. Resistance of the respiratory system can then be 
calculated from change in pressure during the interruption and flow immediately 
preceding the interruption. If this technique is to provide an accurate measure of
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airways resistance it is assumed that pressure measured at the mouth represents 
pressure throughout the airways, i.e. that pressure at the mouth equilibrates with 
pressure at the alveoli within the time that the shutter is closed. As the duration of 
the occlusion (in most studies) is 100ms, this assumption is probably invalid, 
particularly in the presence of airway obstruction. However, as with other 
techniques described here, the true value of the technique to the clinician is whether 
it can distinguish between health and disease, not whether a single factor of 
respiratory physiology is accurately represented.
Early studies of this technique were performed in animals, and in awake and 
anaesthetised human adults87'89. However, the technique has never been widely 
used in adults, and it was only with the realisation that it may be of value in 
performing measurements in infants90 and young children91 that research interest 
increased. Early studies in children suggested that Rint correlates with RaW and 
FEVi in children with asthma and cystic fibrosis91 and that the technique was well 
tolerated even in 3 year old children . Rint appears able to discriminate between 
asthmatic children, children with chronic cough, and control children both at 
baseline and following bronchodilator administration , and is able to detect 
response to exercise challenge in children with asthma94. Reference data for Rint in 
preschool children have been published95, and data on between-occasion
Q O
repeatability are also available .
Studies comparing Rint with alternative measures of lung function during 
methacholine challenge have produced conflicting results87’96’97. There is currently 
great interest in this technique, largely due to the recent introduction of a portable, 
commercially available interrupter device. However, the potential clinical 
applications of the technique have not yet been fully determined.
1.8.4 Analysis o f  tidal breathing
This technique is based upon the observation that a characteristic pattern of 
expiratory flow is seen in airways obstruction, even during tidal breathing. The first 
detailed analysis of this technique was reported in 198198, though the technique had 
been described earlier. The technique has been extensively studied in sleeping 
infants99' 101. In preschool children, the technique is reported to be well tolerated,
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and the ratio of time needed to reach maximal tidal expiratory flow to the total 
expiratory time (Tm e/T e) is able to distinguish between normal children and 
children with CF or asthma102. Further data are awaited.
1.8.5 Transcutaneous measurement of oxygen tension
The transcutaneous measurement of partial pressure of oxygen in the capillaries 
(tcPCh) is easy to perform and well tolerated in young children. The measure is a 
sensitive and repeatable means of detecting changes following methacholine 
challenge in young asthmatic children92,96,103. The technique does not simply 
measure changes in airway resistance during bronchoconstriction, and correlates 
poorly with other measures of lung function92;104. It is likely that a fall in tcPC>2 
represents an increase in ventilation perfusion inequality (VQ mismatch) following 
bronchodilator challenge.
1.8.6 Objective measurement of breath sounds
Breath sounds have long been used by clinicians to detect changes in airway calibre 
during acute exacerbations of asthma, or during bronchodilator challenge105;106. 
Objective analysis of breath sounds involves recording sounds at the chest wall and 
analysing frequency and power spectra. Data thus far have been mixed, but some 
reports suggest that changes in vesicular breath sounds are of value in detecting 
changes in airway calibre during methacholine challenge in children with asthma107.
1.8.7 Lung function studies in preschool children with CF
Spirometry and MBW studies of preschool children with CF have been described in 
Sections 1.5.2, and 1.7.1. In addition, there have been a small number of studies 
utilising other lung function techniques.
In 2002, Beydon 108 described measurement of FRC (by He dilution) and Rint in 40 
preschool children with CF, and 79 healthy controls. Thirty-nine children were able 
to complete the measurements. Children with CF had significantly higher Rint, and 
significantly lower interrupter conductance (Gint), but FRC results were identical 
for the CF and control groups. Children with CF who had a history of respiratory 
symptoms (n=31) had significantly lower Gint, and significantly higher FRC 
standard deviation score (z-score), than those children with CF who had no history
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of respiratory symptoms (n=8). When individual data were analysed, 9 of the 39 
children with CF (23%) had a Rint z-score greater than +2. sRaw has been utilised as 
an outcome measure in one longitudinal study of young children with CF, published 
by Nielsen in 2004 109. In this latter study, 30 children with CF - of whom 13 were 
aged 6.0 years or less at the start of the study - were repeatedly tested over a four- 
year period. Seventeen of the 30 children (57%) in Nielsen’s study had raised sRaw 
at commencement, whereas none had raised Rint, only one had raised respiratory 
reactance, and only two had raised respiratory resistance (both latter measured by 
the impulse oscillation technique). Group mean sRaw was persistently abnormal 
over the four-year period, whereas the other measures tested were not consistently 
abnormal.
97*90* 7Q-79Comparison of these studies with those described earlier ’ ’ ’ is complicated by 
differences in the lung function tests employed, and by differences in the study 
populations. The care of children with CF has changed in the last two decades, and 
populations measured in the early 1990s cannot be compared with populations 
studied in the last few years. In addition, the term preschool, though widely used, 
does not have a universally accepted definition. Although PubMed defines a 
preschool child as one aged between two to five years, in the studies quoted above 3 
groups studied children aged three to six years but did not define them as
7 9 -9Q -70preschool ’ ’ , one group studied children aged three to eight years and described 
them as preschool108; whilst one studied children aged two to eight years, but did 
not describe them as preschool109.
1.9 MBW as an outcome measure in young children with CF
There are a number of alternative measures of lung function that could have been 
examined in this thesis. MBW was chosen as the main outcome measure because:
a) CF is a heterogeneous disease. Whilst most lung function measures listed 
above will not detect inhomogeneous changes in lung function (indeed, 
abnormalities in some regions can be masked by normal function in other 
regions), MBW is predicted to be a sensitive marker of heterogeneous 
change.
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b) Whilst most of the measures described above are determined by large, 
central airway function, CF lung disease is also known to affect the small, 
peripheral airways. MBW is predicted to detect heterogeneous change in the 
lung periphery, as distal as the location of the diffusion-convection front.
c) MBW is measured during tidal breathing, which should not dislodge 
intraluminal mucus. In CF the presence of mucus is of clinical importance, 
as it is the cycle of infection and inflammatory response to infection that 
leads to bronchiectasis.
1.10 Rationale for study, aims and hypotheses
1.10.1 Starting aim of study
In Section 1 of this chapter, the starting aim for this study was presented as: “to 
investigate whether the efficiency o f gas mixing, measured by the inert gas multiple- 
breath washout technique, could be employed as a measure o f  lung function in 
preschool children with CF." This general aim must now be distilled into an 
answerable study question, informed by the review of data presented in this chapter.
1.10.2 Choice of outcome measures, and quality control
The FEVj, obtained from spirometry, is by far the most commonly used lung 
function measure in children and adults with CF. Recent reports have suggested that 
spirometry is possible in preschool children. It is therefore necessary that MBW in 
preschool children be measured against spirometry.
Although a small number of studies have been published, the application of 
spirometry in the preschool age group has not been studied critically. In particular, 
published standards for spirometry data collection and analysis are specific to 
adults, and have already been demonstrated to be unsuitable for school-age children 
44. A detailed analysis of quality control criteria for spirometry in preschool children 
has never been undertaken.
Similarly, almost all previous MBW studies have been performed in school-age 
children or adults. The Paiva-Engels analysis has never been tested in the preschool 
age group.
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Specific outcome measures from spirometry will be selected after quality control 
analysis is completed, as one of the hypotheses (below) is that FEVi may not be a 
suitable outcome measure in this age group. For MBW, the Lung Clearance Index 
(LCI) is selected as the basic outcome measure from washout curve analysis 
(Section 1.6.2). LCI is selected because it is easier to comprehend than the other 
indices described, and because in a preliminary analysis, presented in the Appendix, 
it was as sensitive in discriminating between school-age children with CF and 
healthy school-age children as the Mixing Ratio or Moment Ratios. It is also 
proposed that Sacin and Scond be calculated in preschool children, but it will first be 
necessary to investigate whether some of the assumptions of this analysis are 
applicable to the preschool age group.
1.10.3 Study design, and method of comparison
To fully answer the general aim of this study, it is necessary to determine that 
preschool children can perform MBW; and that indices from MBW are more 
sensitive than spirometry indices for detecting early CF lung disease. Although the 
first question is relatively straightforward, the second is complicated by the lack of 
a “gold standard” for defining CF lung disease. If the presence or absence of lung 
disease cannot be confirmed, then it is not possible to determine whether MBW is 
able to detect disease more reliably than spirometry. The best means of answering 
this question is by a series of studies, investigating:
• Whether indices derived from MBW are more commonly abnormal in 
children with CF than spirometry indices
• The relationship between MBW indices and spirometry indices
• The relationships between these lung function indices and clinical 
information {i.e. symptoms, clinical examination, radiology findings)
• The relationship between lung function indices and measures of 
inflammation or infection
• The effect of CF treatment upon MBW indices
• The change in MBW indices over time
Given that these studies must be preceded by pilot studies to establish methodology, 
and by quality control analyses, it is clear that this series of studies is beyond the
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scope of a single research thesis. It is therefore proposed that this thesis will first 
address methodology and quality control, and then establish the relationship 
between spirometry and MBW. Studies will be performed first in school-age 
children, to establish the technique, and then in preschool children. Relationships 
between lung function measures and clinical status will be performed as a 
secondary analysis. The possible design of future longitudinal and intervention 
studies will be discussed at the end of the thesis.
1.10.4 Study hypotheses, aims, and objectives 
Primary hypotheses:
• More children with CF will have abnormal washout results than will have 
abnormal spirometry results.
• Children with CF with abnormal washout curve results will also have 
abnormal phase III slope results. These children will have evidence of 
inhomogeneity arising both from convective flow (i.e. Scond), and from the 
interaction between diffusion and convection (i.e. Sacin). Both measures of 
inhomogeneity will be greater in older children.
Prior to undertaking these investigations, it is necessary to undertake a series of 
quality control analyses for both spirometry and MBW:
Preliminary hypotheses:
• Children aged two to five years are unable to meet some of the quality 
control criteria for spirometry, but alternative criteria may be feasible.
• In healthy subjects, the LCI is independent of subject age, age group (i.e. 
preschool or school-age), sex, and body size. In all subjects, the LCI is 
independent of variations in respiratory rate, tidal volume, and functional 
residual capacity seen during spontaneous tidal breathing.
• In healthy subjects, the phase III slope is negatively related to tidal volume, 
but otherwise independent of subject age, age group, sex, and body size. In 
all subjects, the phase III slope is negatively related to tidal volume, but is
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independent of variations in respiratory rate and functional residual capacity 
seen during spontaneous tidal breathing.
Aims:
• To determine whether preschool children can perform spirometry, and how 
best to analyse the data
• To determine in preschool children the precision of LCI and the phase III 
slope, and to determine any modifications to the Scond and Sacin analysis 
necessary in this age-group
• To compare the sensitivity of MBW and spirometry for detecting abnormal 
lung function in preschool children with CF
• To determine whether the predominant mechanism for ventilation 
inhomogeneity in preschool children with CF is that related to convection 
{i.e. CDI, or Scond), or to the interaction between diffusion and convection 
{i.e. DCDI, or Sacin), or whether both mechanisms are equally involved
Objectives:
• To analyse results from spirometry performed by preschool children against 
quality control criteria recommended for such measures in adults; and to 
identify possible modifications, which could be applicable in preschool 
children
• To examine, in school-age and preschool children, the precision of the Lung 
Clearance Index and the first breath phase III slope, over three repeated 
measures; and to investigate whether subject age, age group, sex, body size, 
and spontaneous variations in breathing pattern influence these indices
• To determine which, if any, modifications to the Scond and Sacin MBW 
analysis are necessary to calculate these indices in spontaneously breathing 
children
• To determine whether the Lung Clearance Index is more frequently 
abnormal in preschool children with CF than indices derived from 
spirometry
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• To calculate S cond and Sacin for both school-age and preschool children, and 
determine which mechanism predominates in which age-group
1.10.5 Structure of thesis
This thesis is presented in seven chapters. Equipment and data processing are 
described in Chapter 2. The next four chapters describe the following studies:
• Analysis of quality control for spirometry in preschool children
• Analysis of effect of subject characteristics and breathing pattern upon 
MBW indices
• Comparison of LCI and spirometry results in school-age and preschool 
children
• Comparison of S cond and Sacin results in school-age and preschool children 
Other than the description of equipment and data processing, each results chapter is 
self-contained, with a detailed description of aims and hypotheses (including 
secondary aims and hypotheses), a description of the study population and 
statistical methods, results, and an interpretation of these results.
The thesis concludes with a discussion of the implications of the thesis findings and 
suggestions for further investigation.
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Chapter 2: Methods
2.1 Summary of study design
This methods chapter describes the equipment and data processing methods 
employed in these investigations. The study structure for preschool children is 
summarised in Figures 2.1 and 2.2. Children with CF were primarily recruited from 
the CF clinic at Great Ormond Street Hospital for Children, though a minority were 
recruited from other CF centres in London. Healthy children were recruited from 
the community. If preschool children were able to complete the study protocol on 
the first laboratory visit, they were discharged. Preschool children who were unable 
to complete the protocol were asked to return for another attempt approximately six 
months later. No school-age children were recalled for repeat attempts.
Figure 2.1 Summary of study pathway for preschool children
No
Laboratory visit
Preschool 
children with CF
Protocol
com pleted?
Healthy P reschool 
children
Y es
67
Figure 2.2 Preschool subjects included in main study
30 subjects in final 
population
4 complete protocol on 
retesting
37 Healthy Preschool 
Subjects recruited
6 non-white subjects 
excluded, leaving 25
31 subjects
27 complete full 
protocol on first visit
10 unable to complete 
full protocol on first 
visit
7 complete protocol on 
retesting
30 subjects in final 
population
40 Preschool Subjects 
with CF recruited
17 unable to complete 
full protocol on first 
visit
23 complete full 
protocol on first visit
Further 5 white 
children recruited and 
complete protocol 
complete protocol on 
retesting
Legend: The two panels describe recruitment o f  preschool children with CF, and 
healthy preschool children. In addition, two preschool children attempted 
spirometry at the beginning o f  the study period, before the MBW system was set up. 
Their results are included in Chapter 3 only.
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Recruitment of children to the preschool study is summarised in Figure 2.2. The 
aim was to obtain lung function results in 30 children with CF, and 30 healthy 
control children who were matched for age, sex, and ethnicity. On original 
recruitment the populations were not matched by ethnicity. The original control 
population was therefore used to calculate success rates for the lung function tests, 
but a further five healthy white children were also tested and included in the control 
population for comparison of lung function results. The last 6 non-white subjects 
were excluded from this population. Further details on hypotheses, study design, 
and subject recruitment are presented in the four results chapters (Chapters 3 to 6).
2.2 Test Procedure
On arrival at the laboratory the procedures were explained to the parents and to the 
children. The parents were then asked to complete and sign a study consent form 
approved by the Research Ethics Committee of Great Ormond Street Hospital and 
The Institute of Child Health (Appendix). School-age children signed an assent 
form (Appendix). They had already read information leaflets sent by post 
(Appendix). Prior to testing the parent was asked to complete a symptom 
questionnaire for the child, with questions being administered by the author. The 
questionnaires differed for school-age and preschool children, and are presented in 
the Appendix. The primary outcome measures from these questionnaires are 
detailed in Chapter 5.
Height without shoes was measured in cm to 1 decimal place by a calibrated wall- 
mounted Harpenden stadiometer (Holtain, Crymych, UK). Weight was measured in 
kg to 1 decimal place with calibrated electronic scales (Tanita HD-305, Tanita 
Corporation, Tokyo, Japan), with the child wearing minimal clothing. Weight 
measurements were performed in duplicate, and only accepted if results were 
identical.
Physical examination of the child was performed by the author, and whether 
wheeze or crackles were heard was noted. Measurement of transcutaneous oxygen 
saturation was performed using an Ohmeda Biox pulse oximeter (Model 3740, 
Ohmeda, Louisville, USA).
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School-age children then performed MBW, followed by spirometry. Preschool 
children performed MBW, followed by body plethysmography, followed by 
spirometry. Details of equipment and data collection for spirometry and MBW are 
presented below. Body plethysmography results are not presented in this thesis. 
Children with CF were isolated according to the hospital infection control policy.
2.3 Spirometry
2.3.1 Spirometry equipment and calibration
Spirometry was performed with a Jaeger MasterScope spirometer (VIASYS 
Healthcare GmbH, Hochberg, Germany). Calibration was performed once daily, 
according to manufacturers’ instructions, using a 1L calibration syringe.
The Jaeger Masterscope system consists of a PC based system incorporating a 
heated screen pneumotachometer. Manufacturers’ specifications give a flow 
accuracy of +/- 2% over a flow range of 0.2 to 12 L-sec'1, and a frequency response 
of 100Hz, which is filtered to 60Hz to reduce noise.
Following each testing session the spirometer was cleaned according to a set 
protocol (Appendix). Collection of spirometry data is described below.
2.3.2 Spirometry data collection, inspection and reporting in school-age children 
All measurements were performed with the child wearing a nose-clip and in the 
seated position. The child was encouraged to sit upright, not slumped. Spirometry 
was performed with the child blowing through a mouthpiece and filter. In all cases 
expiration was encouraged using a Jaeger incentive program that promoted 
prolonged expiration. During each expiration, the flow-volume curve was 
monitored on the screen so the investigator could interpret the effort. Between three 
and five expirations were recorded for each subject. Recording was stopped when 
the investigator assessed that maximal results had been obtained, or if the child was 
showing signs of fatigue or restlessness.
Recordings were accepted for further analysis if they met the following criteria on 
visual inspection: the flow-volume trace showed a rapid rise to peak flow, and a 
smooth descending limb, with no evidence of cough or glottic closure; and the
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volume-time trace “went around the comer”, i.e. the trace was approaching a 
horizontal plateau. All other traces were excluded. Children were required to 
produce two repeatable FVC and two repeatable FEVj results, with the lower result 
being within 5% of the higher. If only one technically acceptable curve was 
obtained the results were not reported. Data were automatically stored on the Jaeger 
Masterscope system. The highest values for FVC, FEVi, and MEF25 were 
transferred manually to a SPSS data file (Statistical Program for Social Sciences, 
SPSS Inc, Chicago, USA). Following all data entry, data were verified by selecting 
a sample of 10 cases and cross-checking values entered on the SPSS file against 
those stored on the Jaeger Masterscope system.
2.3.3 Spirometry data collection and recording in preschool children 
Prior to performing spirometry, children were instructed in what was expected by 
means of descriptions and a story. They were asked to demonstrate that they had 
understood the instructions by blowing into a mouthpiece. Spirometry was then 
performed (Figure 2.3). The first expirations were encouraged using the Jaeger 
‘Candles’ incentive program, which encourages a rapid expiration. When the child 
had mastered rapid expiration the program was changed to display an incentive that 
encourages prolonged expiration. In most cases this was the Jaeger ‘Bowling’ 
program, though some children responded better to other incentives (Figures 2.4 
and 2.5)
The difficulty (i.e. the flow or volume target required to successfully complete the 
game) of the incentive program was altered between expirations. The aim of this 
adjustment was to allow the child to score highly enough to remain motivated, but 
not to achieve the maximum score or to complete the task, as either achievement 
would result in the child ceasing their effort prematurely. At the end of the test 
session the difficulty level was adjusted again so that the child was allowed to 
achieve the maximum score or to complete the task.
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Figure 2.3 Four-year old child performing spirometry
Legend: Note that the nose-clip and mouthpiece are well tolerated. The 
pneumotachometer is connected to the mouthpiece via a bacterial filter to prevent 
cross-infection. The child is watching a computer-generated animation on a 
monitor (off left o f  picture), which promotes rapid or prolonged expiration.
During each expiration the flow-volume curve was monitored on the screen so the 
investigator could interpret the effort. The Jaeger Masterscope program allows only 
5 manoeuvres to be recorded per test file. Additional test files were therefore 
created as necessary, and a maximum of 25 expiratory manoeuvres were recorded. 
Recording was stopped when the investigator assessed that maximal results had 
been obtained, or if the child was showing signs of fatigue or restlessness.
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Figure 2.4 Spirometry incentive animations from the Jaeger 
Masterscope system for initial training, or for school-age children
Legend: The animation on the left is the ‘Candles' incentive. The higher the 
expiratory flow generated by the child, the more candles are blown out. There is no 
incentive to prolong expiration. This incentive is suitable fo r  early training only, or 
to encourage a peak flow. The right animation is the ‘Flying Toaster ’ incentive. A 
prolonged expiration causes the toaster to fly  into the air, catch the toast, loop-the- 
loop, burn the toast, and spit it out. Although school-age children enjoy this 
incentive, many preschool children are baffled by it.
2 .3 .4  S p ir o m e tr y  d a ta  in s p e c t io n  a n d  r e p o r t in g  in  p r e s c h o o l  c h ild r e n
All traces were initially exported from the Jaeger Masterscope system to a separate 
PC workstation. This procedure was necessary because standard Jaeger software 
does not allow
a) reporting of all necessary parameters
b) data to be excluded but saved for future re-analysis.
Use of a workstation allowed data to be ‘passed’ and then exported for further 
analysis, or excluded but saved for future re-analysis. All volume-time and flow- 
volume curves were then visually inspected by the author and by at least one other 
investigator (C Oliver or C Saunders). Borderline traces were also examined by 
Prof J Stocks.
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Figure 2.5 Spirometry incentive animations from the Jaeger 
Masterscope system suitable for full forced expiratory measurement in 
preschool children
Legend: The animation on the left is the ‘Balloon ’ incentive. A prolonged 
expiration fills the balloon up and causes it to rise up to the spike, where it bursts. 
The animation on the right is the ‘Bowling ’ incentive. A prolonged expiration 
causes the ball to roll down the lane and knock down the skittles. The common 
feature o f these incentives is that they encourage prolonged expiration, and that 
they are simple to understand, being based upon common children’s games. It is 
necessary to adjust the difficulty o f  the game between attempts, so that the child 
does not achieve the objective too easily, but also does not become discouraged. 
Used with care, these are suitable animations for encouraging maximal expiratory 
manoeuvres in preschool children.
Criteria for visual inspection of curves were identical to those applied for school- 
age children and described above (Section 2.3.2). Duration of expiration was 
recorded, but was not a criterion for acceptance. Examples of acceptable and 
unacceptable recordings are provided in Figures 2.6 to 2.10.
Results were exported from the workstation into an Access relational database 
(Microsoft Corporation, Redmond, WA, USA) in which demographic and clinical 
information on the study subjects was also stored.
74
Figure 2.6 Acceptable flow-volume and volume-time traces from a 
healthy boy, aged five years.
Flow [I/s ] F /V ex
1.0
F /V in
0 0 1 Vol [I] 
0 .1- \
02
0.3
0.4
0.5
0.6
0.7
0.9
Time [s]
1.0
2.0 2 J5 3.01.0 1.50.0 0.5
Legend: For Figures 2.6 to 2.10: The flow-volume trace is on the left, and the 
volume-time trace is on the right. For the flow-volume trace, flow is presented in 
L s '1, and volume (labelled Vol) is presented in L. F/V in identifies the inspiratory 
limb. F/V ex identifies the expiratory limb. For the volume-time trace, volume 
(labelled Vol) is presented in L, and time is presented in seconds (s).
For Figure 2.6: Note a) that the inspiratory loop is o f smaller volume than the 
expiratory loop (this is partly because the boy started inspiration before putting his 
mouth on the mouthpiece); b) that the expiratory duration is less than one second, 
but that the volume-time trace ‘turns the corner ’ indicating a complete expiration. 
FVC, FEV0.5, FEV0.75, MMEF are reportable from this effort. FEVj is not 
reportable.
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Figure 2.7 Trace from four-year old girl with CF, first attempt.
F/V ex
0 2 -
0 .4 -
0.6
2.0 2.S1.00.5
1.0 -
1 2
1.4
Time [*]
F/V In 3.02 52.01j50.5 1.00.0
Legend: Initial expiratory effort using the Jaeger ‘Candle ’ incentive is inadequate. 
Although there is a satisfactory start to the test, there is no peak flow and there is 
early termination. This effort was excluded on visual inspection.
Figure 2.8 Trace from four-year old girl with CF, later attempt.
Vol [I]
2.00.5 1.0 1.5
F/V in
02
0.4
0.6
0.8
1.0
1.4
1.6
1.8
Time [s]
2.0
3.02.51.5 2.01.00.0
Legend: Same child as in Figure 2.7, same test occasion, 8th attempt. The child is 
now using the Jaeger ‘Bowling’ incentive and is able to produce a fu ll forced  
expiration. This effort was passed on visual inspection.
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Figure 2.9 Trace from five-year old boy with CF.
F/V ex
2.01.50.5
F/V in
0.0-iVol [I]
0.4
0.6
1.0
1.4
1.6
T im e[s]
2.0
3.02.0 2.50.5 1.50.0 1.0
Legend: This effort was excluded on visual inspection because it does not show an 
adequate peak flow.
Figure 2.10 Trace from four-year old boy with CF.
2.0 0.0F/V ex
1.5
0.4
1.0
0.6
0.8
Vol [I]
0.0 1.0
0.5 1.0 1.5 2.0
0.5
1.4
1.0
1.6
1.5
Time[*]F/V in2.0 2.0
0.0 0.5 1.0 1.5 2.0 2.5 3.0
Legend: The interruption to expiratory flow is due to cough. This curve was 
excluded on visual inspection.
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The method for calculating back-extrapolated volume (VBE) is described in Figure 
2.11. VBE was recorded for every technically acceptable expiration.
Figure 2.11 Schematic diagram of volume-time trace illustrating 
calculation of back-extrapolated volume.
Time ------ ►
Legend: Axis orientation is identical to Figures 2.6-2.9. The heavy solid line 
represents the recorded volume-time trace. A regression line from maximum flow is 
hack-extrapolated to the starting volume (broken line), and the starting point o f  the 
expiration (vertical axis) is defined as the point at which this back-extrapolated line 
reaches the starting volume (A). All timed expired volumes are measuredfrom this 
point. The back-extrapolated volume (VBE) is the difference between the starting 
volume A, and the point at which the volume-time trace crosses the vertical axis.
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2.4 Multiple-breath washout
2.4.1 Multiple-breath washout equipment: pneumotachometer-transducer- 
demodulator system
The flow meter used in this study was a pneumotachometer-transducer-demodulator 
system. The pneumotachometer used was a Fleisch number 1 (Fleisch, Lausanne, 
Switzerland) and is displayed in Figure 2.13. One side of the pneumotachometer 
was labelled the inspiratory port, and this orientation was used for all calibrations 
and all measurements. The pneumotachometer was connected to a Validyne 
variable reluctance pressure transducer (Model MP45-14-871, Validyne Corp, 
Northridge, USA) via equal lengths of stiff polyethylene tubing (Tricoflex SA, 
Hozelock Tricoflex, Vitry-le-Fran5ois, France). The output from the pressure 
transducer was connected to a high gain carrier demodulator plug-in module (Model 
CD 19, Validyne Corp, Northridge, USA), which was part of a multi-channel 
modular transducer system (Model MCI, Validyne Corp, Northridge, USA). Prior 
to connection of the pneumotachometer, the transducer and demodulator were 
calibrated and balanced by use of an output voltmeter as recommended by the 
manufacturer.
Linearity of the pneumotachometer-transducer-demodulator system was tested at 
the beginning of the study (September 2000) and repeated at the conclusion of the 
study (August 2003). This was performed using a wall-mounted calibrated 
rotameter, providing flows up to 60 L-sec"1. Results of linearity checks are 
presented in Figure 2.12. There was a change in linearity of the system over the 
course of the study, but even at the end of the study the system was linear up to a 
flow of 40 L-min'1, or 667m Lsec1, which is consistent with manufacturers 
specifications, and satisfactory for this application, where flows of greater than 
600mL-sec_1 are not expected (Section 2.4.5).
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Figure 2.12 Pre- and post-study linearity checks for 
pneumotachometer system
, 4 - r
LU
CD
£_i
O markers
•  exp, end-study
• insp, end-study 
exp, pre-study
• insp, pre-study
700 10 20 30 40 50 60
FLOW  (L-min'1)
Legend: Voltage polarity on inspiratory flow has been reversedfor the purpose o f  
this analysis.
At the beginning o f  the study, the system was linear up to 60 L-min1 fo r  both 
inspiratory flow and expiratory flow.
At the end o f  the study, the system was linear up to 40 L-min1 for both inspiratory 
flow and expiratory flow, but alinear at flows above this.
Slope o f  regression line = 6.1mV (L-min1) '1
2 .4 .2  M u l t ip le - b r e a th  w a s h o u t  e q u ip m e n t:  r e s p ir a to r y  m a s s  s p e c t r o m e te r  
The gas analyser used in this study was an AMIS 2000 respiratory mass 
spectrometer (Innovision, Odense, Denmark), which is displayed in Figure 2.13.
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Figure 2.13 AMIS 2000 respiratory mass spectrometer
i
C€
1
Legend: This photograph from the manufacturer shows the AMIS 2000 with a re­
breathing bag, which is usedfor measurement o f cardiac output. This additional 
apparatus is not necessary for the current application (see Figure 2.16).
The AMIS 2000 is a quadropole mass spectrometer, which operates by identifying 
gases according to their mass-charge ratio. A gas mixture is drawn into a vacuum 
chamber along a narrow-bore capillary tube. Upon contact with an electrical 
filament, positively charged ions are created, which are accelerated along a voltage 
gradient towards a receptor. An electromagnetic field generated across this pathway 
allows only ions of a preset mass-charge ratio to reach the receptor. The mass- 
charge ratio is determined by the molecular mass of the gas, so only gases of one 
mass-charge ratio (i.e. in most cases, only one gas) can reach the receptor at any 
one time. The resultant electrical signal can be amplified. Although the mass 
spectrometer can identify only one gas at any time, rapid cycling of the accepted
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mass-charge ratio allows multiple gases to be identified quasi-simultaneously. The 
AMIS 2000 is capable of identifying 12 gases, up to a molecular mass of 200 
atomic mass units, at a cycling frequency of 16.7Hz. For the current application the 
AMIS 2000 was programmed to recognise helium (He), nitrogen (N2), oxygen (O2), 
carbon dioxide (CO2), and sulphur hexafluoride (SF6). Sampling time for SF6 was 
set at 10 milliseconds, and for the other gases at 5 milliseconds, giving a cycling 
time of 30 milliseconds and a cycling frequency of 33.3Hz. The gas sampling rate 
of the AMIS 2000 is ISmL-minute'1.
Atomic mass unit peaks for the five test gases were manually optimised when the 
mass spectrometer was set up in September 2000. The AMIS 2000 was two-point 
calibrated once daily using a certified concentration calibration gas (alpha- 
gravimetric standard, British Oxygen Company, Guildford, UK) containing 3.97% 
He, 3.98% SF6, 7.04% C 02, 21.00% 0 2, and 64.01% N2. A signal-noise ratio of 100 
or greater was deemed acceptable. This full calibration included an automatically 
performed re-optimisation of atomic mass unit peaks. Short calibration was 
performed prior to each measurement.
2.4.3 Multiple-breath washout apparatus: facemask and connectors 
School-age children used a mouthpiece and nose-clip apparatus. Preschool children 
used a Rendell-Baker size 2 facemask (Ambu International, Bath, Avon, UK) which 
was applied to the face using therapeutic putty (North Coast Medical, Morgan Hill, 
California, USA) to form an airtight seal. The mouthpiece or facemask were 
connected to the inspiratory port of the pneumotachometer by means of a custom 
made connector, labelled ‘connector 1’. This connector had a side port to 
accommodate the capillary inlet of the AMIS 2000 mass spectrometer. The 
expiratory port of the pneumotachometer was connected via a second custom-made 
connector (labelled ‘connector 2’) to a T-piece (Intersurgical, Wokingham, UK) to 
which large bore anaesthetic breathing-circuit tubing (elephant tubing) was attached 
(Mallinckrodt DAR, Mirandola, Italy). Mr R Taylor, of the Department of 
Biomedical Engineering, Great Ormond Street Hospital for Children, manufactured 
both connectors, using Acetal plastic tubing and Nitrile rubber O-rings. The afferent 
limb of the elephant tubing was connected to a cylinder of medical grade gas,
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containing 4% SF6, 4% He, 21% O2 , and balance N2 (British Oxygen Company, 
Guildford, UK). The efferent limb of the elephant tubing was open to room air. The 
connector 2 / T-piece / elephant tubing assembly were collectively labelled the bias 
flow apparatus, and this term is used for the remainder of this thesis. The facemask 
apparatus is displayed in Figures 2.14 and 2.15.
Dead-space of the facemask was measured as 20mL by water displacement. It was 
estimated that 50% of this dead-space would be occupied by the child’s face when 
the mask was applied, giving an estimated facemask dead-space of lOmL during 
use. Dead-space of the other components was also measured by water displacement.
Figure 2.14 Components of facemask-pneumotachometer apparatus
Side port
Facemask Pneumotachometer T-piece
Connector 1 Connector 2
Legend: Note the side-port on connector 1. This accommodates the capillary inlet 
o f  the AMIS 2000 mass spectrometer. The white cable from the pneumotachometer 
is the heater cable.
The system dead-space was separated into two components:
• The pre-capillary dead-space was defined as the dead-space between the 
child’s lips and the capillary inlet, and was estimated as 12.5mL for the 
facemask system, and 5mL for the mouthpiece system
• The post-capillary dead-space was defined as the dead-space between the 
capillary inlet and the end of the expiratory port of the pneumotachometer, 
and was measured as 15mL
Figure 2.15 Facemask-pneumotachometer apparatus, assembled
Legend: Pre-capillary dead-space and post-capillary dead-space are marked. The 
post-capillary dead-space excludes connector 2 and the T-piece as these are 
removed during washout.
2 .4 .4  M u l t ip le -b r e a th  w a s h o u t a p p a r a tu s :  c a l ib r a t io n , d a ta  a c q u is i t io n  a n d  
p r o c e s s in g
Analogue outputs from the demodulator and from the mass spectrometer were 
recorded at 100Hz by a personal computer (Dell Computers, Round Rock, TX, 
USA) through a 16-channel AD-conversion board (Model RS485, Keithley 
Metrabyte, Taunton, MA, USA) using custom written software based on a
Pre-capillary Post-
dead-space capillary
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commercially available data acquisition software pack (TestPoint, Capital 
Equipment Corp., Billerica, MA, USA).
The pneumotachometer was calibrated prior to use with separate calibration 
constants for inspiratory and expiratory flows using a 241mL precision syringe 
(manufactured by Mr R Taylor, Department of Biomedical Engineering, Great 
Ormond Street Hospital for Children). Recorded inspiratory and expiratory flows 
and volumes were converted to BTPS conditions. Gas samples and flow signals 
were aligned in time. Delay to the gas signal was measured using a custom-made 
delay switch (manufactured by Mr E Bergsten, Swedish Defense Research Agency, 
Department of Defense Medicine, Linkoping, Sweden). This system measured the 
delay between gas appearing at the capillary inlet o f  the mass spectrometer 
(enabled by opening the switch) and that gas bolus being recorded by the software. 
Once daily a series o f 20 delay recordings were performed, and the median delay 
and rise times obtained were used to align flow and gas signals from subsequent 
recordings. The software corrected the flow signal sample-by-sample for changes in 
dynamic viscosity caused by the variations in gas composition. Prior to use the 
pneumotachometer was heated to 37°C (Heater model FWS4D, Hugo Sachs 
Elektronik, March, Germany).
2.4.5 Data collection in school-age children
The participants were investigated in the sitting position during tidal breathing. 
During the MBW tests the subjects watched an entertainment video on a television 
screen (Aiwa integrated television/video cassette recorder model VX-D2120K,
Sony Corporation, Tokyo, Japan), whilst the investigator watched the tidal volume 
trace on a computer screen. If the subject’s tidal volume fell below SmL-kg'1 or rose 
above 15mL-kg_1 body weight the subject was asked to increase or decrease their 
tidal volume respectively. Other than this, subjects were encouraged to breathe 
comfortably.
Each MBW ‘run’ consisted of two phases. During the wash-in phase the subject 
inspired a dry gas mixture containing 4% SF6,4% He, 21% O2 and balance N2. The 
gas was provided using a bias flow applied on the expiratory port of the 
pneumotachometer (Section 2.4.3). The bias flow was set at a level greater than the
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maximum inspiratory flow produced by the subject, so that rebreathing did not 
occur. In most cases this was between 400 and bOOmL-sec'1. Wash-in was continued 
until the inspiratory and expiratory SF& concentrations were stable and equal plus 
another 15 seconds. At this moment the wash-in was stopped by disconnecting the 
bias flow assembly during expiration, and washout was started. The washout phase 
continued until the end-tidal SF6 concentration was below 0.1% (i.e. 1 /40th of the 
starting concentration). The output obtained during washout is displayed in Figure 
2.17. Irregularities of breathing pattern, such as pauses or sighs, were accepted. A 
minimum of three wash-in-washout runs was recorded on each test occasion.
2.4.6 Data collection in preschool children
The participants were investigated in the sitting position. During the MBW test the 
room was darkened and the child was encouraged to watch a children’s 
entertainment video, which they had previously selected. The aim of the video was 
to distract the child and encourage tidal breathing. One investigator (C Oliver or C 
Saunders) held the mask to the child’s face throughout the washout, ensuring a 
good seal and keeping the child settled. The second investigator (the author) 
monitored the flow and gas signal outputs in real time on a computer screen. All 
participants breathed through a Fleisch No.l pneumotachometer (PNT) via a 
Rendell-Baker facemask, which was applied to the child’s face using therapeutic 
putty (Section 2.4.3). Figure 2.16 displays the set-up for the wash-in phase of MBW 
in a preschool child.
Each test consisted of two phases. During the wash-in phase the subject inspired a 
dry gas mixture containing 4% SF6,4% He, 21% O2 and balance N2. The bias flow 
was set at a level greater than the maximum inspiratory flow produced by 
the subject, so that rebreathing did not occur. In most cases this was between 250 
and 400mL sec'1. Wash-in was continued until the inspiratory and expiratory SF6 
concentrations were stable and equal plus another 10 seconds. At this moment the 
wash-in was stopped by disconnecting the bias flow assembly during expiration, 
and washout was started. The washout phase continued until the end-tidal SF6 
concentration was below 0.1% (i.e. 1 /40th of the starting concentration). The output 
obtained during washout is displayed in Figure 2.17.
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Figure 2.16 A three-year old child performing the wash-in phase of 
multiple-breath washout
Legend: The investigator is supporting the back o f the child’s head with her right 
hand, and holding the facemask apparatus to the child’s face with her left hand.
This ensures an airtight seal, which must be maintained throughout the wash-in and 
washout. The child is distracted by an entertainment video playing on a television 
screen o ff the left o f  the picture. The second investigator is able to monitor flow and 
gas concentration on the computer screen at the top left o f  the picture. At the end o f  
wash-in the bias flow is disconnected and the washout phase commences.
A recording was considered technically acceptable as long as there was no evidence 
of leak during the latter part of the wash-in or at any stage during the washout. If 
the child adopted a ‘panting’ breathing pattern, the recording was stopped, and the 
child distracted and settled before restarting. Other irregularities of breathing 
pattern, such as pauses or sighs, were accepted. A minimum of three wash-in- 
washout manoeuvres were recorded on each test occasion.
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Figure 2.17 Washout curve
0 1000 2000 3000 4000 5000 6000 7000 0000 9000 10000
Legend: The black trace represents flow (left axis). The green trace represents SF6 
concentration (right axis). A is the end o f the wash-in, where SF6 concentration 
during inspiration and expiration is identical, and equal to the SF6 concentration in 
the test gas cylinder. The bias flow is disconnected at point B, andfrom this point 
the SF6 concentration during inspiration is zero, as the child is inhaling air. The 
SF6 concentration on expiration falls with each breath (C), as the resident gas o f  
the lung is progressively diluted by the inspired air.
2.4.7 Analysis o f washout curve
The functional residual capacity (FRC) was determined from the cumulative 
exhaled SF6 divided by the difference in end-tidal SF6 concentration at the start of 
the washout and end-tidal SF6 concentration at completion of the washout. A 
proportion of the marker gas expired at each breath remained within the post­
capillary apparatus dead-space at the end of expiration and was re-inspired on the 
next breath. This re-inspired marker gas was measured, and the calculation of 
cumulative exhaled marker gas was corrected accordingly. The calculated FRC 
therefore excludes the post-capillary apparatus dead-space, but includes the pre­
capillary apparatus dead-space.
The cumulative expired volume (CEV) from the beginning to the end of the washout 
was calculated by integration of the flow signal. The post-capillary apparatus dead- 
space was subtracted from each breath, so that the CEV, like the FRC, was 
corrected for post-capillary apparatus dead-space, but not for pre-capillary 
apparatus dead-space.
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The lung clearance index (LCI) was calculated by dividing the CEV by the FRC. 
LCI therefore represents the number of FRC turnovers (TO) required to dilute the 
inspired SF6 to 1/40* of its starting concentration 48.
CEV
LCI = --------------
FRC
Where
LCI = Lung Clearance Index 
CEV = Cumulative Expired Volume 
FRC = Functional Residual Capacity
The FRC and LCI were calculated, by the method described, using custom-written 
software (TestPoint, Capital Equipment Corp., Billerica, MA, USA). This data 
acquisition and processing software was written by Mr E Bergsten (Swedish 
Defense Research Agency, Department of Defense Medicine, Linkoping, Sweden).
2.4.8 Calculation o f  phase I I I  slopes
For each breath during the washout the SF6 and He concentrations were plotted as a 
function of expired volume. The phase III slope was calculated for both gases for 
each breath by a least square fit over the interval of 65% to 95% of the expired 
volume. All breaths were visually inspected, and if the 65% to 95% interval 
appeared to include the phase II slope or the phase IV slope, or if the regression line 
was distorted by cardiogenic oscillations or signal noise, then the regression line 
was manually refitted by adjusting the interval45;49. The phase III slope was 
normalised by the mean tracer gas concentration over the phase III interval, to give 
the normalised phase III slope (SnIII).
Figure 2.18 presents a phase III slope calculated automatically over 65-95% of 
expired volume. Figures 2.19 and 2.20 show traces where a prominent phase IV is 
present. If the regression is performed over 65-95% of expired volume then an 
erroneously high value for SnIII is obtained.
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Figure 2.18 Phase III slope fitted over 65% to 95% of expired volume
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Legend: Phase III slope in a healthy 3-year old child. The black trace is tracer gas 
concentration plotted against expired volume. The blue line represents least-square 
regression over the interval 65-95% o f expired volume. The red line is continuation 
o f the regression line. The slope o f  the regression, i.e. the slope ofphase III, is 0.28 
L l.
Figure 2.19 Phase III slope fitted over 65% to 95% of expired volume, in 
presence of pronounced phase IV
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Legend: Plot from a 14-year old girl with CF. There is a pronounced phase IV, so 
regression over the 65-95% interval over-estimates SnIII, giving a result o f  1.01 L'1.
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Figure 2.20 Phase III slope fitted over 55% to 85% of expired volume, in 
presence of pronounced phase IV
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Legend: Same trace as Figure 2.18. Regression over 55-85% o f expired volume 
gives an SnIII o f  0.80 L'1.
In previous studies of adult subjects reported by the Paiva-Engels group, subjects 
were required to maintain a fixed tidal volume during MBW. This volume was most 
commonly defined as 0.75 or 1.0L. During pilot studies for the current investigation 
it was noted that children are not always able to maintain the same tidal volume 
throughout MBW. Two issues relating to this were identified. First, if tidal volume 
falls below a certain minimum, it will not be possible to identify a phase III slope 
(Fig 2.21). Second, even if a phase III slope can be identified, the value may be 
influenced by changes in tidal volume.
A minimum breath size was therefore stipulated for phase III slope to be reported. 
This was expressed as a minimum starting point for phase III, and a total minimum 
breath size. The first point was determined by the equation:
Phase III starting volume = (2 • body weight [kg] + precapillary dead-space) • 2 
(in mL)
The rationale for this minimum starting point for regression of phase III is that the 
apparatus and airway dead-space must be cleared (i.e. phase I and II must be 
completed) before phase III commences. Precapillary dead-space has been
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estimated by water displacement (see above), whilst the airway dead-space (in mL) 
is predicted by the formula 2 • body weight (kg). Minimum total breath size was 
determined by the equation:
Minimum breath size = (3.5 • body weight [kg] + precapillary dead-space) • 2 
(in mL)
The rationale for this total breath volume is that a minimum phase III duration of 
3mL/kg bodyweight is required to obtain an adequate regression. It is accepted that 
this figure is arbitrary, but it is argued that some minimum regression duration must 
be set.
Figure 2.21 Calculation of SnIII from a small volume expiration
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L e g e n d : O n  f i r s t  in s p e c tio n  th e re  d o e s  a p p e a r  to  b e  a  p h a s e  II I  s lo p e , a lth o u g h  it  
a p p e a r s  r a th e r  la te  in  e x p ira tio n , a n d  is  s te e p  (S n III=  4 .1 3 ) . H o w e v e r , th is  c h i ld  is  
3 -y e a r s  o ld , a n d  w e ig h s  1 6  kg. T he to ta l  e x p ir e d  v o lu m e  o f  th is  b r e a th  is  j u s t  
7 .5m L  • k g '1, a n d  it  is  u n lik e ly  th a t a  tru e  p h a s e  II I  s lo p e  is  v is ib le . To e m p h a s is e  
th e  p o in t ,  th is  b re a th  is  f r o m  th e  sa m e  M B W , in  th e  s a m e  ch ild , a s  th a t p r e s e n te d  in  
F ig u re  2 .1 7 , w ith  th is  b e in g  th e  s e c o n d  b re a th  o f  M B W , a n d  2 .1 7  b e in g  th e  th ir d  
b rea th . N o te  th e  d if fe re n c e  in  e x p ir e d  v o lu m e  a n d  c a lc u la te d  S n III  b e tw e e n  th e  tw o  
p lo ts .
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Phase III slopes from breaths of inadequate volume were excluded from S COnd and 
Sacin analysis, but were retained on the database so that values could be compared 
with those obtained from breaths of adequate volume (Chapter 4). The relationship 
between SnIII and tidal volume in breaths where phase III can be calculated is 
explored in Chapter 4.
2.4.9 Calculation o f  Sacin and Scond
Sacin and Scond were calculated by the method of Verbanck et a l45. The normalised 
phase III slope for each breath was plotted against turnover (TO). In each case an 
aggregate SnIII versus TO plot was produced from results obtained from 3 MBW 
runs. Scond is defined as the normalised slope difference per unit TO over the portion 
of the MBW where only conducting airways contribute to the generation of 
ventilation inhomogeneity. In adults this portion is theoretically predicted52’54 and 
experimentally confirmed49 as being between 1.5 and 6.0 TO (Figure 2.14). The 
analysis from which prediction of the linear portion of the SnIII versus TO plot is 
derived is based upon morphological data from the adult lung58. Similar data 
describing the paediatric lung are not available, and the current study is the first 
attempt to experimentally test this model in young children. Scond was therefore 
calculated by two methods:
a) as the normalised slope difference per unit TO over the period 1.5 to 6.0 TO
b) as the normalised slope difference per unit TO over the period 2.5 to 6.0 TO 
For each method Scond was calculated by least square regression over the specified 
interval. For the method (b) the breaths closest to 1.5 and 2.0 TO were identified, 
and the residual from the regression line was calculated for these breaths. By this 
method the linear portion of the SnIII-TO relationship was identified.
Sacin was determined by subtracting that part attributable to the conducting airways 
from the slope of the first breath, as described by the equation:
Sacin — SIIIbi — Scond ' TObi
Where
SIIIbi = Total phase III slope of first breath
TObi = Expired volume of first breath as function of FRC
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If the first breath from an MBW was excluded (e.g. because of inadequate breath 
volume, or signal noise), then this MBW run was excluded from analysis. If more 
than one third of the breaths over the period of S COnd regression were excluded, then 
this MBW run was also excluded from analysis. The impact of excluding breaths 
from the SnIII versus TO plot is presented in Figures 2.22 and 2.23.
Figure 2.22 SnIII versus TO plot in school-age child with cystic 
fibrosis, aggregated raw data
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Legend: The closed circles represent values o f SnIII (averagedfrom three MBW  
runs) plotted against TO. The open triangles represent the slope o f Scond, calculated 
by least-square regression over the 1.5 to 6.0 TO interval. There is no clear pattern, 
and a negative Scond is calculated.
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Figure 2.23 SnIII versus TO plot in school-age child with cystic 
fibrosis, aggregated data after exclusion of breaths of inadequate 
volume
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Legend: These are the same data as presented in Figure 2.22. Note the amendment 
to the y-axis, otherwise labelling between the two figures is identical. SnIII results 
calculated from breaths o f inadequate volume, or where there was excessive signal 
noise (i.e. breaths where SnIII was probably not visible), have been excluded. No 
other corrections have been performed. There is now a clear relationship between 
SnIII and TO, with a positive Scond-
2.4.10 Summary of quality control criteria for calculation of SCOnd and Sacin
The quality criteria for analysing phase I I I  slopes and calculating S acin and S COnd are 
summarised below:
• SnIII is calculated over 65-95% of expired volume whenever possible
• All slopes are visually inspected. If visual inspection indicates that the 65-
95% interval is inappropriate then this interval is altered manually
• For any breath, the interval over which He SnIII is calculated is the same as
that over which the SF6 SnIII is calculated
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• A minimum volume from which SnIII can commence, and minimum total 
breath volumes are defined according to subject weight
• SnIII is not reported from any breaths where it is not (or is unlikely to be) 
clearly visible, whether because of inadequate breath volume or signal noise
• SCond and Sacin are calculated according to the method of Verbanck et al
• If the first breath from a run cannot be reported, or if more than one third of 
breaths over the SCOnd regression interval cannot be reported, then that MBW 
is excluded from analysis. Scond and SaCin can only be reported if results from 
three MBW runs are available.
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Chapter 3: Feasibility and quality control for spirometry in 
preschool children
3.1 Introduction
Spirometry is the most frequently used method for measuring lung function. The 
reliability of this test is dependent upon using standardised methodology, 
particularly with regard to how quickly the subject increases flow at the beginning 
of the expiration, sustained effort throughout the expiration, the duration of the 
expiratory manoeuvre, and repeatability. Detailed criteria for data collection and 
interpretation have been published by the American Thoracic Society (ATS), and 
by the European Respiratory Society (ERS)34’35. Application of these criteria when 
collecting and interpreting spirometry data is considered mandatory in adult 
pulmonary function laboratories.
Spirometry is not only employed in adults; it is also commonly performed in 
paediatric pulmonary function laboratories. The test was previously limited to 
school-age children (those aged 6 to 16 years), but recent reports have confirmed 
that preschool children (those aged 2 to 5 years) are also able to attempt these 
manoeuvres24,36,40'42. Both the ATS and ERS guidelines were written for adult 
patients, and Arets and colleagues have already demonstrated that many school-age 
children have difficulty meeting some of the quality control criteria44. Recent 
reports of spirometry in preschool children have focused upon feasibility24,40,41; use 
of incentive devices41; and recording of reference values in healthy populations24;40, 
rather than upon the issue of quality control.
3.2 Hypothesis and aims
3.2.2 Hypothesis
Children aged 2 to 5 years are unable to meet some of the quality control criteria for 
spirometry, but alternative criteria may be feasible.
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3.2.2 Aims and objectives
The primary aims and objectives of this investigation were
a) To analyse results from spirometry performed by preschool children against 
quality control criteria recommended for such measures in adults
b) To identify which of these criteria are easily achieved by preschool children, 
and which are not
c) To determine whether success in meeting these criteria is affected by 
presence of lung disease or by subject age
d) To identify possible modifications which could be applicable in preschool 
children.
The secondary aims and objectives were to compare results obtained in healthy 
children at the Institute of Child Health with those previously reported from other 
centres, and to assess whether reference ranges published by those centres apply to 
the current study population.
3.3 Subjects and Methods
3.3.1 Subjects
All subjects attending the CF clinic at Great Ormond Street Hospital who met the 
inclusion and exclusion criteria below were identified and approached. This 
recruitment method was judged unlikely to yield the number of subjects required, so 
the other four CF centres participating in the London Collaborative Cystic Fibrosis 
Study (LCCFS) were also approached. The LCCFS is a recently completed study of 
the effect of CF upon lung function in infancy10’14. The participating centres are 
Great Ormond Street Hospital for Children, King’s College Hospital, Royal 
Brompton Hospital, The Royal London Hospital, and University Hospital, 
Lewisham. Subjects with CF who were tested in infancy as part of the LCCFS were 
in most cases too young to enter the current study. The LCCFS centres therefore 
identified a small number of preschool children with CF who met the inclusion and 
exclusion criteria below, and recruited them to this study. No attempt was made to 
recruit random or representative samples of children from these four CF centres.
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Healthy control children were primarily recruited from local schools and 
playgroups. Local Education Authorities were contacted for permission to approach 
schools and playgroups. Head teachers were then contacted for permission to 
approach parents. Parents were then contacted by letter in the first instance. Any 
parents expressing an interest in the study received a follow-up telephone call and 
recruitment form to determine whether their child met the eligibility criteria for the 
study. In a small number of cases friends and siblings of children with CF were 
recruited as controls. In all cases, for healthy children and those with CF, verbal and 
written information was provided to the parents or guardians prior to the day of 
testing, and written consent was obtained.
Copies of letters sent to Local Education Authorities and schools, recruitment 
letters and screening forms, and consent forms and information sheets for this study 
are provided in appendices D-F.
Inclusion criteria for subjects with CF:
• CF diagnosed by a positive sweat test and / or two known CF disease- 
producing mutations identified by DNA analysis
• Subject aged > 2.0 years and <6.0 years at time of testing.
Exclusion criteria for subjects with CF:
• Congenital cardiac disease that requires medical therapy, has previously 
required surgical therapy, or is awaiting surgical therapy
• Preterm birth, defined as birth before 34 weeks gestational age
• Neuromuscular or bone disease likely to result in weakness of respiratory 
muscles or restriction of the thorax.
Inclusion criteria for healthy control children
• Subject aged > 2.0 years and <6.0 years at time of testing.
Exclusion criteria for healthy control children
• Any previous hospitalisation for a respiratory condition
• More than 5 courses of antibiotics for respiratory symptoms (including 
upper respiratory symptoms) in the previous 12 months
• Any physician diagnosis of asthma or reactive airways disease at any time in 
the past
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• Use of anti-asthma medication on more than one occasion in the previous 12 
months
• Any history of chronic productive cough, recurrent wheezing, or shortness 
of breath within the previous 12 months
• Congenital cardiac disease that requires medical therapy, has previously 
required surgical therapy, or is awaiting surgical therapy
• Preterm birth, defined as birth before 34 weeks gestational age.
• Low birthweight, defined as birthweight less than 2.3kg
• Neuromuscular or bone disease likely to result in weakness of respiratory
muscles or restriction of the thorax.
3.3.2 Study design
This was a cross-sectional study, with data limited to spirometry attempts made
during the child’s first laboratory visit.
3.3.3 Data collection
Collection and analysis of spirometry data, including criteria for accepting or
discarding results, is described in Section 2.3.
3.4 Analysis
3.4.1 Outcome measures
The following measures were reported from each test:
• The two highest technically acceptable forced vital capacity (FVC) 
measurements
• The two highest technically acceptable measurements of forced expired 
volume in one second, 0.75 seconds, and 0.5 seconds (FEVi, FEV0.75, 
FEV0.5)
• The duration of the expiration that resulted in the largest FVC (forced 
expiratory time [FET])
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• The back-extrapolated volume (VBE) calculated as per ATS guidelines34 
(Figure 2.10), reported as an absolute value, and as a percentage of FVC 
(VBE/FVC%)
• The mean forced expired flow between 25 and 75% of expired volume 
(MMEF) was reported from the expiration that had the highest sum of FVC 
and FEV0.75, unless FET was less than 0.75 seconds, in which case this flow 
was reported from the expiration that had the highest sum of FVC and 
FEV0.5.
3.4.2 Comparison with previously published data
Data obtained in healthy children were compared with published reference values. 
This was achieved in two ways. First, original data collected by Eigen and 
colleagues from 214 healthy children tested in Indianapolis, USA,24 were obtained 
from the authors. FVC, FEVi, and FEF25.75 results from Indianapolis were plotted 
against subject height along with data obtained in this study. Data were plotted 
separately for all healthy children at both centres, and for white children only. 
Second, reference equations derived from the Indianapolis population, and 
equations derived from a separate study of 603 preschool children in Oslo, 
Norway40, were used to calculate z-scores for our healthy population. The 
Indianapolis reference equations were calculated from the 184 white children in 
their study. Ethnic data were not available for the Oslo study.
3.4.3 Statistical analysis
The CF and control populations were compared for age, weight, and height. Success 
in producing FVC, FEVi, FEV0.75, FEV0.5, and FEF25.75 was compared by age 
group, and by diagnosis. FET was plotted against age and height. Start of test was 
examined by plotting VBE and VBE/FVC against age. Repeatability was examined 
by calculating the difference between the two highest FEV0.75 readings (AFEV0.75), 
and between the two highest FVC readings (AFVC). Timed expired volumes as 
fractions of FVC (FEV0.5/FVC, FEV0.75/FVC, and FEVj/FVC) were calculated. All 
parameters were compared by age group and by diagnosis.
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Summary statistics are presented as mean and standard deviation (SD) if normally 
distributed, and median and interquartile range (IQR) if non-normally distributed. 
Proportions were compared by Chi2 test. T-tests or Mann-Whitney tests were 
employed for comparison of two groups; ANOVA and post-hoc analysis by 
Tukey’s honestly significant difference (HSD) were used to compare three or more 
groups. Where interaction between multiple factors was suspected this was 
investigated by multiple regression. Summary data for z-scores for our population 
were calculated separately for all healthy children, and for white children only. For 
all analyses a p-value of 0.05 is regarded as significant.
3.4.4 Power o f study
The power calculation for this sample was based upon the requirements of the 
analysis presented in Chapter 5, where results obtained from the different lung 
function techniques are compared for CF and control groups. For this study, a 
sample size of 50 subjects in each group was calculated to be sufficient to detect a 
difference of 0.5 SD in sRaW, F E V 0 .5 ,  F E F 2 5 -7 5 , LCI and CVlci between groups. 
Interim analysis performed in 2002114 indicated that the difference between 
populations for the primary outcome measures was likely to be greater than 0.5 SD, 
and the study population was therefore recalculated as 30 subjects per group.
For the current study, all subjects meeting the entry criteria and attempting 
spirometry on their first visit to the laboratory were included. Post hoc power 
calculation demonstrated that for the tests of published prediction equations, a 
sample size of nine subjects would detect a difference from predicted values of one 
z-score with 90% at the 5% significance level, whilst a sample size of 16 subjects 
would detect a difference from predicted values of 0.75 z-scores with 90% at the 
5% significance level.
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3.5 Results
3.5.1 Subjects
Forty-two children with CF and 37 healthy children were recruited. The study 
population is summarised in Table 3.1.
Table 3.1 Characteristics of study population, summarised by 
diagnosis
Cystic 
Fibrosis 
(n = 42)
Healthy 
Control 
(n = 37)
Mean difference 
(95% Cl for difference)
Sex (% male) 45% 60% -15 (-36, 8)
Ethnicity (% white) 88% 70% 18(0, 36)*
Age (years) 4.14(0.90) 4.14(0.85) 0 (-0.39, 0.40)
Height (cm) 100.9 (7.3) 104.2 (7.9) -3.3 (-6.6, 0.1)
Weight (kg) 16.7(2.9) 18.6 (3.8) -1.9 (-3.4, -0.4)*
Height z-score -0.42(1.13) 0.26(1.23) -0.68 (-1.22, -0.13)*
Weight z-score -0.01 (1.11) 0.71 (1.23) -0.72 (-1.26, -0.18)*
Legend: Results are presented as mean (SD) unless otherwise stated. 
Difference calculated as CF -  control, * = p<0.05.
Although matched for age, the children with CF were significantly lighter and 
shorter than the control children.
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3.5,2 Success rates
The median number of spirometry manoeuvres attempted was 12 (range 6-22). 
Success in producing a reportable FVC, FEV0.5, FEV0.75, FEVi, and FEF25-75 is 
presented in Table 3.2.
Table 3.2 Success rates in obtaining forced expiratory parameters
All
children
(n=79)
Cystic
Fibrosis
(n=42)
Healthy
Controls
(n=37)
2-<4 
years 
(n=39)
4-<5 
years 
(n=25)
5 -6
years
(n=15)
FVC 59 30 29 25 21 13
(75%) (71%) (78%) (64%) (84%) (87%)
FEV0.5 59 30 29 25 21 13
(75%) (71%) (78%) (64%) (84%) (87%)
FEVo.75 53 28 25 20 20 13
(67%) (67%) (68%) (51%) (80%) (87%)
FEV! 46 26 20 16 18 12
(58%) (62%) (54%) (41%) (72%) (80%)
MMEF 59 30 29 25 21 13
(75%) (71%) (78%) (64%) (84%) (87%)
Legend: Results are expressed as number o f children and percentage, summarised 
by age group and diagnosis. As only six o f the children were aged less than three 
years, children aged 2-<4 years were analysed together.
Fifty-nine of the 79 children were able to produce acceptable spirometry loops 
(Figure 2.6). Nine of these children could produce only two acceptable loops, while 
the remaining 50 children produced between three and nine acceptable loops each 
(median was four). Of the 29 healthy children who completed spirometry, 18 were 
white, three were black and eight were of mixed ethnic group. Of the 30 children 
with CF who completed spirometry, 25 were white, one was black, two were South 
Asian, and two were of mixed ethnic group.
During visual inspection of the spirometry curves it was discovered that the Jaeger 
Masterscope software can report timed expired volumes inappropriately, so that
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some children appeared to have a FEVi equal to FEV0.75 or a FEV0.75 equal to 
FEV0.5. In such cases the FET was invariably greater than 1 second. After 
communication with the manufacturer it was determined that the Jaeger system 
determines end of expiration by detecting absolute cessation of expiratory flow. If 
there is a slight expiratory offset on the flow signal, and the child removes their 
mouth from the apparatus before their next inspiration, then expiration can continue 
to be recorded. This is explained further in Figure 3.7. Verification of the data was 
therefore undertaken. First, all reports where FET was less than one second, and/or 
where FEV0.75 or FEVi were equal to FVC, were identified. These curves were then 
visually inspected and timed volumes that had been inappropriately reported were 
excluded. By this method, six children who had produced satisfactory FEV0.5, but 
from whom FEVo 75 should not have been reported, and seven children who had 
produced satisfactory FEV0.5 and FEV0.75, but from whom FEVi should not have 
been reported, were identified.
There was no significant difference between the CF and control groups in success 
rate for any of the parameters. Children aged 2-<4 years were significantly less 
likely to produce FEV0.75 or FEVi than children aged 4-<5 years or children aged 5- 
6 years. No other differences in success rates by age group were seen.
3.5.3 Start o f  test criteria
Values for back-extrapolated volume (VBE) and VBE/FVC are summarised in 
Table 3.3. Mean (SD) VBE for all children was 65 (17) mL; VBE/FVC was 7.2 
(2.8)%.
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Table 3.3 Start of test criteria and repeatability criteria
All
children
Healthy
Controls
Cystic
Fibrosis
2-<4 
years
4-<5 
years
5-<6 
years
VBE (mL) 65 (17) 63 (20) 67(14) 64(16) 67(12) 66 (25)
VBE/FVC (%) 7.2 (2.8) 6.4 (2.3) 7.9 (3.0) 7.7 (2.7) 7.2 (2.8) 5.9 (2.6)
FET (sec) 1.5 
(1.1, 2.2)
1.4 
(1.1, 1.8)
1.5 
(1.2, 2.2)
1.3 
(1.1,2.1)
1.6 
(1.1, 2.2)
1.6 
(1.1, 2.4)
AFVC (mL) 34 
(16, 63)
34 
(14, 77)
33 
(16, 58)
34 
(14, 63)
31 
(18, 73)
36
(11,66)
AFVC (%) 3.5 
(1.7, 7.0)
4.2 
(1.6, 7.6)
3.1 
(1.7, 6.5)
4.3 
(1.5, 7.6)
3.3 
(1.8, 7.1)
2.9 
(1.5, 5.5)
AFEVo.75 (mL) 32
(11,53)
38 
(15, 62)
23 
(10, 44)
23
(11,40)
36 
(9, 59)
34 
(14, 73)
AFEV0.75 (%) 3.4 
(1.4, 5.2)
4.0 
(1.5, 5.6)
3.1 
(1.4, 5.1)
3.2 
(2.3, 4.3)
3.9 
(1.0, 6.2)
3.4 
(1.3, 6.5)
Legend: Results are summarised by age group and diagnosis
VBE = back extrapolated volume
FET = duration o f manoeuvre producing the best FVC
AFVC = difference between best and second best FVC
AFEV0.75 = difference between best and second best FEV0.75
VBE and VBE/FVC results are presented as mean (SD). All other results are
presented as median (IQR)
There was no relationship between VBE and height (Figure 3.1) or VBE and age 
(Figure 3.2), and all but 4/59 children (7%) produced a VBE less than or equal to 
80mL.
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Figure 3.1 Back-extrapolated volume (VBE) plotted against subject 
height.
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Legend for Figures 3.1 and 3.2: Children with CF plotted as closed circles, healthy 
children as open circles. Broken line represents a possible quality control cut-off o f  
80mL. There is no relationship between VBE and height or VBE and age.
Figure 3.2 Back-extrapolated volume plotted against age
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Figure 3.3 demonstrates the relationship between VBE/FVC and height (r2 = 0.27, 
p<0.0005). Although younger children tended to have higher VBE/FVC this 
difference was not significant (Figure 3.4). Only 16/59 children (27%) were able to 
produce VBE/FVC <5%. Seven children (12%) produced a VBE/FVC greater than 
10%, of whom two produced a VBE/FVC greater than 12.5%.
Figure 3.3 Back-extrapolated volume / FVC plotted against subject 
height
16-r
o
> .0 u. 12-
<DE3 I0-
o>“O® ft.
JSoQ.
2
*  6‘ <D
O
(0 4 -CQ
o o
12011090 10080
height (cm)
Legend: Children with CF plotted as dosed circles, healthy children as open 
circles. The four children with back extrapolated volume greater than 80mL are 
marked with arrows.
Broken line represents a possible quality control cut-off o f  12.5%.
There was no relationship between diagnosis and VBE. Children with CF had a 
significantly higher VBE/FVC. After correction for height, the diagnosis of CF was 
no longer significantly related to VBE/FVC (partial coefficient for diagnosis vs.
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VBE/FVC 0.19 %, p = 0.1; partial coefficient for height vs. VBE/FVC 0.49 %-cm'1, 
p<0.0005).
Figure 3.4 Back-extrapolated volume I FVC plotted against age
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Legend: Children with CF plotted as closed circles, healthy children as open 
circles.
Curves with VBE greater than 80mL and curves with VBE/FVC greater than 12.5% 
were re-examined, and compared with curves that had been excluded on visual 
inspection (Figures 3.5 to 3.7).
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Figure 3.5 Trace from three-year old girl with CF
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Legend: This curve was excluded on visual inspection because o f slow start. The 
back extrapolated volume was llOmL, and the back extrapolated volume /F VC  was 
18.2%.
Figure 3.6 Trace from healthy three-year old boy
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Legend: Although this curve was passed on visual inspection the back extrapolated 
volume is 120mL, and the back extrapolated volume /F V C  is 11.6%..
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Figure 3.7 Trace from five-year old girl with CF
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Legend: Although this curve was passed on visual inspection as having a 
satisfactory start to expiration, the back extrapolated volume is 120mL and the back 
extrapolated volume /FVC is 12.7%.
The Jaeger Masterscope system continues to record expiration until absolute 
cessation o f expiratory flow is detected. This feature allows complete recording o f  
expiration in subjects with severe airflow limitation. However, i f  there is a slight 
expiratory offset on the flow signal, expiration will continue to be recorded until the 
subject takes an inspiration. This child removed her mouth from the mouthpiece at 
the end o f expiration, prior to taking her next inspiration. In such circumstances 
(see Section 3.5.4) the spirometer continues recording until terminated manually by 
the operator. The forced expiratory time is therefore recorded as 2.3s rather than 
0.9s (A). There is a small offset at zero flow, so the FVC is recorded as 0.92L rather 
than 0.89L. The MMEF will also be inaccurate. The child produced a satisfactory 
effort later in the test session.
3.5.4 Duration o f  manoeuvre
FET, summarised by age group and diagnosis, is also presented in Tables 3.3 and 
3.4. Twelve of the 59 children produced a FET of less than one second.
I l l
Table 3.4 Expiratory duration of longest FVC (FET) cross-tabulated 
against age group
2-<4 years 4-<5 years 5-6 years All children
<0.75s 3 0 0 3
0.75-<ls 3 4 2 9
l-<2s 12 10 6 28
>2s 8 6 5 19
Totals 26 20 13 59
Legend: An error in the Jaeger program regarding recording o f FET was noted. 
This error led to some o f the values being over-estimated.
Table 3.5 presents timed forced expired volumes expressed as a proportion of FVC, 
summarized by age group.
Table 3.5 Timed forced expired volumes as a proportion of forced vital 
capacity
All
children
Healthy
Controls
Cystic
Fibrosis
2-<4 
years
4-<5 
years
5 -6
years
FEV0.5/FVC (%) 81
(72, 87)
84
(73, 89)
78
(71,87)
82 
(73, 88)
81 
(70, 88)
74 
(71, 82)
FEV0.75/FVC (%) 91 
(85, 97)
92 
(84, 98)
91 
(85, 96)
92 
(85, 95)
91 
(84, 98)
86 
(83, 97)
FEV i/FV C  (%) 94
(91,98)
94 
(90, 97)
94 
(89, 98)
96 
(93, 98)
93 
(85, 98)
93 
(90, 98)
Legend: Results are summarised by age group and diagnosis. Results are presented 
as median (IQR). For the majority o f children FEVi/FVC was greater than 90%, 
irrespective o f age group or diagnosis. By contrast, for the majority o f  children 
FEV0.5/FVC was less than 90%.
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Individual data are presented in Figures 3.8 to 3.10.
Figure 3.8 FEV0.5/FVC plotted against subject height
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Legend for Figures 3.8 to 3.10: Children with CF presented as closed circles, 
healthy children as open circles. Note the relationships between FEV0.5/FVC and 
height (r2 = 0.22, p  = 0.009, Figure 3.8), and between FEV0.75/FVC and height (r2 
= 0.27, p  = 0.008, Figure 3.9) in the healthy population. There is no relationship 
between FEVj/FVC and height in the healthy population (Figure 3.10).
In healthy children there was a significant negative relationship between 
FEV0.5/FVC and height (r2 = 0.22, p = 0.009, Figure 3.8), and FEV0.75/FVC and 
height (r2 = 0.27, p = 0.008, Figure 3.9) but no relationship between FEVi/FVC and 
height (Figure 3.10). There was no relationship between FEV/FVC parameters and 
height in the CF population.
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Figure 3.9 FEV0.75/FVC plotted against subject height
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3.5.5 Within occasion repeatability
Differences between the two highest values of FVC (A FV C ), and FE V 0.75 
(A FEV 0 .75) are displayed in Table 3.3 and Figures 3.11 and 3.12. The population 
median for all age groups was less than 4 %  for AFEV 0 .75, and less than 5% for 
AFVC, with no significant difference for either parameter by age group. Twenty- 
four children (41%) had AFVC greater than 5%, of whom five (9%) had AFVC  
greater than 10%. Fifteen children (28%) had AFEV 0.75 greater than 5%, of whom 
three (6%) had AFEV 0.75 greater than 10%.
Figure 3.11 Difference between the two best FVC, as a percentage of 
best FVC, plotted against subject height
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L e g e n d :  F iv e  c h ild r e n  h a d  A F V C  o f  g r e a t e r  th a n  1 0 %  (b r o k e n  lin e ) .
A F V C  =  d if fe r e n c e  b e tw e e n  th e  tw o  b e s t  F V C , a s  a  p e r c e n t a g e  o f  b e s t  F V C
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Figure 3.12 Difference between the two best FEV0.75> as a percentage of 
best FEV0.75, plotted against subject height
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Legend: Three children had AFEV0.75 greater than 10% (broken line).
AFEV0.75 = difference between the two best FEV0.75, as a percentage o f  best FEV0.75
3.5.6 Comparison with published reference data
Figures 3.13 to 3.18 present FVC, FEVi, and MMEF results from Indianapolis and 
ICH. Results are presented for healthy children of all ethnic groups, and separately 
for all white children. When white children alone were plotted there was good 
concordance between results obtained in the two centres.
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Figure 3.13 FVC plotted against height in healthy children of all ethnic
groups
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Legend (for Figures 3.13 to 3.18): Children measured at ICHplotted as black 
closed markers. Children measured in Indianapolis plotted as red open markers.
Figure 3.14 FVC plotted against height in healthy white children
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Figure 3.15 FEVi plotted against height in healthy children of all ethnic
groups
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Figure 3.16 FEVi plotted against height in healthy white children
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Figure 3.17 MMEF plotted against height in healthy children of all
ethnic groups
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Figure 3.18 MMEF plotted against height in healthy white children
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Z-scores for spirometry parameters were calculated for the healthy children. Of the 
29 children who produced reportable results, 18 were white; 3 were black, and 8 
were mixed race. Summary results are presented for the whole control population, 
and for the white children alone in Table 3.6.
Table 3.6 Z-scores for spirometry parameters in healthy children
All healthy 
children 
(n=29)
Healthy white 
children 
(n=18)
95% Cl of difference 
from zero, for healthy 
white children§
FVC z-score 
(Oslo)
0.18(0.70) 0.43 (0.52) 0.17, 0.67**
FVC z-score 
(Indianapolis)
-0.76(1.21) -0.30 (0.79) -0.70, 0.09
FEV0.5 z-score 
(Oslo)
-0.11 (0.84) 0.08 (0.77) -0.30, 0.46
FEVi z-score 
(Oslo)
0.17(0.66) 0.31 (0.47) 0.02, 0.59*
FEVi z-score 
(Indianapolis)
0.13(1.1) 0.37 (0.71) -0.06, 0.80
MMEF z-score 
(Indianapolis)
-0.35(1.44) -0.29(1.30) -.94, 0.36
Legend: Results presented as mean (SD unless otherwise stated.
 ^Comparison between z-scores obtained in healthy white children vs zero, by one­
sided t-test. *p<0.05, **p<0.005. Provided the published reference equations are 
accurate, and the populations are comparable, all z-scores should be close to zero, 
with a standard deviation o f one. Note that this does not hold here for all z-scores 
tested, and also that the total population has mean z-scores lower than the white 
population. This will be investigatedfurther below.
Z-scores for healthy white children measured at ICH, calculated from Indianapolis24 
and Oslo40 reference equations, and plotted against age, are presented in Figures 
3.19 to 3.24.
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Figure 3.19 FVC z-score (Oslo) for healthy white children measured at
ICH, plotted against height
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Legend for Figures 3.19 to 3.24: Z-scores calculated from reference equations 
derivedfrom healthy children measured in Oslo, Norway (Figures 3.19, 3.21, and
3.23), or healthy children measured in Indianapolis, USA (Figures 3.20, 3.22,
3.24). Broken lines represent mean and predicted limits o f  normality (+/-1.96 z- 
scores). Z-scores obtained in children measured at ICH are significantly greater 
than zero for FVC and FEVi z-scores calculatedfrom Oslo reference data, but are 
not significantly different from zero for all other parameters (Table 3.6).
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Figure 3.20 FVC z-score (Indianapolis) for healthy white children
measured at ICH, plotted against height.
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Figure 3.21 FEVi z-score (Oslo) for healthy white children measured at 
ICH, plotted against height.
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Figure 3.22 FEVi z-score (Indianapolis) for healthy white children
measured at ICH, plotted against height.
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Figure 3.23 FEV0.s z-score (Oslo) for healthy white children measured 
at ICH, plotted against height.
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Figure 3.24 MMEF z-score (Indianapolis) for healthy white children
measured at ICH, plotted against height.
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3.5.7 Comparison o f  results by ethnic group
Comparison of z-scores obtained in healthy white children with those obtained in 
healthy children of all other ethnic groups is presented in Table 3.7. Non-white 
children had significantly lower FV C  z-scores, and tended to have lower F E V 0.5 and 
F E V i z-scores, though these differences were not statistically significant.
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Table 3.7 Spirometry z-scores in healthy children, analysed by ethnic
group
White children 
(n=18)
Non-white children 
(n=ll)
Mean difference 
(95% Cl of difference)
FVC z-score 
(Oslo)
0.43 (0.52) -0.23 (0.78) 0.65 (0.16,1.15)*
FVC z-score 
(Indianapolis)
-0.30 (0.79) -1.52(1.42) 1.22 (0.38, 2.06)**
FEV0.5 z-score 
(Oslo)
0.08 (0.77) -0.43 (0.88) 0.51 (-0.13, 1.14)
FEVi z-score 
(Oslo)
0.31 (0.47) -0.09 (0.91) 0.40 (-0.24, 1.04)
FEVi z-score 
(Indianapolis)
0.37(0.71) -0.32 (1.45) 0.69 (-0.31, 1.70)
MMEF z-score 
(Indianapolis)
-0.29(1.30) -0.46(1.69) 0.17 (-0.97, 1.32)
Legend: Results presented as mean (SD) unless otherwise stated. Difference 
calculated as white -  non-white.
*p<0.05
**p<0.01
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3.6 Discussion
3.6.1 Summary o f  results
In this study results from spirometry attempts in 79 two to five year old children 
were analysed in detail, in order to determine whether the results met published 
quality control criteria for adult spirometry. All flow-volume and volume-time 
traces were first visually inspected and passed or rejected. Forced expired volumes 
and flows obtained in healthy children were similar to those reported by other 
groups. The criteria tested were: start of test, assessed by back extrapolation; 
duration of expiration, and the timed expired volumes that are influenced by this; 
and repeatability. For all of these parameters, modifications to quality control 
criteria appear necessary for application to preschool children.
3.6.2 Visual inspection
Visual inspection of the flow-volume curve and the volume-time curve is a 
mandatory first step for quality control of spirometry. Some of the faults that 
require results to be excluded are self-evident. These include: cough or glottic 
closure; double expiration (seen as a double peak on the flow-volume curve); and 
failure to produce an adequate peak flow. Previous studies of spirometry in this age 
group have used similar criteria for accepting or discarding loops24,40’41.
Evaluation of end of test by visual inspection is more difficult. In older children and 
adults the volume-time trace asymptotes to horizontal towards the end of 
expiration34. In preschool children, particularly the youngest, this asymptote is 
frequently not seen, even in children who appear to have produced a complete 
expiration. The abrupt cessation of expiration in very young children complicates 
assessment of end of test, as curves such as that shown in Figure 2.6 should not be 
excluded inappropriately. Eigen and colleagues (from the Indianapolis group) have 
suggested excluding curves where expiratory flow abruptly ceases from a point 
greater than 25% of peak flow24; Marostica and colleagues (also from the 
Indianapolis group) have proposed excluding curves where expiratory flow abruptly 
ceases from a point greater than 10% of peak flow39; whilst Vilozni and colleagues
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have suggested excluding curves where cessation occurs abruptly from a flow of 
300 mL-s'1 or more41. All suggestions have merit, particularly if consensus could be 
reached, but many spirometry software systems do not provide such information 
automatically. The current study design, where all curves are inspected by at least 
two experienced researchers, and “borderline” curves by at least three, is not 
possible in daily practice. It is therefore suggested that manufacturers should 
modify software, so that information on change in rate of lung emptying towards 
the end of expiration is easily available, with automatic identification and display of 
critical cut-off points as suggested above. In those curves where incomplete 
expiration is identified, timed expired volumes and peak flows may still be 
reportable110, even though FVC and forced expiratory flows cannot be reported 
from such manoeuvres.
3.6.3 Quantitative start of test criteria
ATS guidelines recommend that start of test be assessed quantitatively by 
calculating the volume of back extrapolation (VBE), and that this volume should be 
no greater than 5% of FVC, or an absolute volume of 150mL, whichever is the 
greater34. ERS criteria use 5% of FVC, or absolute volume of lOOmL as the cut­
offs35. Although the majority of school-age children can achieve the 5% criterion44, 
this does not appear to be the case amongst preschool children. In this study only 16 
(27%) children produced a VBE/FVC of less than 5%, suggesting that this cut-off is 
too strict, whereas a cut-off of 150mL is too high to be of any value in a preschool 
population. In Figure 3.3 the four children who produced a VBE greater than 80mL 
have been marked: all of these children had VBE/FVC less than 12.5%.
All of the curves included in this analysis had been passed visually as showing 
acceptable rise to peak flow. After re-inspection of curves with high VBE or 
VBE/FVC, it was concluded that the initial visual inspection had included and 
excluded curves correctly. It is therefore suggested that expirations with VBE 
greater than 80mL or VBE/FVC greater than 12.5% should be visually re-inspected 
to ensure acceptable rise to peak flow, but should not necessarily be excluded.
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3.6.4 Quantitative end o f test criteria and timed expired volumes 
ATS criteria recommend that expiration continues until there is a clear plateau on 
the volume-time trace, and that FET should be at least 6  seconds, or that there 
should be no volume change for one second. Although these ATS recommendations 
state that a shorter exhalation time is acceptable in children they do not specify 
what this time should be. ERS criteria do not quantify duration of expiration for 
quality control. A previous study has demonstrated that a 6 -second forced 
expiration is impossible even for school-age children to achieve44, and this study 
intended to examine this in our preschool population. Unfortunately, the FET 
results obtained from the Jaeger system were found to be unreliable.
Duration of expiration determines which time limited volumes are reportable. If 
FET is less than one second, then FEVi cannot be reported from that expiration. 
Success in producing FEVi was dependent on age in this study, with only 41% of 
children younger than 4 years able to produce a FEVi, compared with 80% of those 
over 5 years of age. There was no difference in the success rates of the healthy and 
CF groups. Previous researchers have reported similar findings. Eigen and co­
workers only reported results from children who were able to expire for at least one 
second, but still recorded a creditable success rate of 83% in a slightly older 
population than that reported here (mean (SD) age 5.0 (0.9) years)24. Crenesse and 
co-workers reported results in 473 children aged 3 to 5 years. Seventy-five percent 
(355) were able to produce at least one acceptable forced expiratory manoeuvre. Of 
these, only 75% of 3-<4 year olds, 73% of 4-<5 year olds, and 87% of 5-<6 year 
olds were able to produce a FET of at least one second . Nystad and colleagues 
reported results from 630 children aged 3-6 years, and found that 10% were unable 
to expire for 1 second40. It is therefore recommended that spirometry software 
should calculate FEV0.5 and FEV0.75, and that all laboratories should analyse and 
report both these parameters in addition to FEVi for children aged under 6  years, in 
order to allow comparison with others of similar age. For many 2-4 year old 
children, only the shorter timed volumes will be reportable. The Jaeger software 
currently allows timed expired volumes to be reported incorrectly. Operators should 
ensure that their own software does not contain similar errors. Any timed volume 
that is reported as equal to FVC should be considered potentially erroneous.
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Even when FEVi is attainable, the clinical value of this parameter in this age group 
is questionable. Compared with older children and adults, infants and preschool 
children have large airways relative to their lung volume, and therefore empty their 
lungs more rapidly. As a result, the FEVi/FVC ratio is over 90% in the majority of 
preschool children, including those aged 5 to 6  years, and regardless of whether 
these children have lung disease. In support of this point, it is noted that there is no 
relationship between FEVi/FVC and height in healthy preschool children, whereas 
negative relationships between FEVo 75/FVC and height and FEV0.5/FVC and height 
were demonstrated. Thirty years ago, a report by Cogswell and colleagues 
identified FEV0.75 as an appropriate outcome measure in school-age children111. 
Reporting of FEV0.4 or FEV0.5 in infants is now accepted110, and assessment of 
FEV0.5 or FEV0.75 may be more clinically relevant than FEVi in the preschool age 
group.
3.6.5 Repeatability
ATS criteria recommend that the difference between the two highest values of FVC 
and FEV1 should ideally be less than 200mL, whereas ERS criteria stipulate that 
such differences should be less than 1 OOmL, or 5% of the best effort, whichever is 
the greater. In the present study, the repeatability of FVC and FEV0.75 were 
assessed. All but five children had AFVC less than lOOmL, and all had a AFEV0.75 
less than lOOmL. However, as FVC and FEV0.75 are much lower in this age group, 
use of absolute values as measures of repeatability may not be appropriate. Arets 
and colleagues44 have previously reported that 8 8 % of school-age children can 
produce a second FVC within 5% of their highest, and 87% can produce a second 
FEVi within 5% of their highest. In comparison, only 59% of the current study 
population were able to produce a second FVC and 72% a second FEV0.75 within 
5% of the highest. However, for both parameters, almost all were able to produce a 
second effort within 10% of the highest. These figures are similar to those 
previously reported by Nystad and colleagues40. It is therefore suggested that either 
an absolute value of lOOmL, or 10% of best effort, would be achievable 
repeatability targets for FVC and FEV0.75 in this age group. As recommended for
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adults, failure to meet repeatability criteria should not necessarily invalidate the 
manoeuvre34.
3.6.6 Comparison with previously published data
In order to test whether results in healthy children were similar to those reported by 
other groups these data were plotted alongside those previously reported by Eigen 
and colleagues24, and z-scores were calculated from published reference 
equations24,40. Original data were not available from the Oslo group, so it was not 
possible to plot the current data alongside those obtained in Oslo, nor was it 
possible to calculate composite reference equations from data collected in both Oslo 
and Indianapolis. Furthermore, there were differences in the exclusion criteria for 
the two reported studies, with the Indianapolis group excluding children with a prior 
history of asthma, whilst the Oslo group included such children. However, the Oslo 
group reported that their results were similar to those reported from Indianapolis, 
and also reported that children with a history of asthma did not have significantly 
different results from those with no history of asthma40.
The population measured in the current study had a higher proportion of non-white 
children (11 out of 29 successful children, or 38%) than that reported by Eigen and 
colleagues (30 out of 214, or 14%)24. This may explain why concordance between 
the two populations is better for white children only than when data from children 
of all ethnic groups is combined. From data presented in Figures 3.13 to 3.16 and 
Table 3.6, it appears that non-white children have lower FVC and lower timed 
expired volumes than white children of the same height. Small numbers and the 
heterogeneity of the non-white population prevent further conclusions being drawn 
from the data currently available. However, this findings is consistent with reports 
from older children.
Ethnic group was not specified by the Oslo group, but Oslo has a very small non­
white population. Summary statistics were therefore calculated for the entire 
healthy population and separately for the healthy white children. Z-scores for the 
control population should be zero, with a standard deviation of 1, for all parameters, 
provided that the equipment and methodology are similar to that used by previous 
groups, and that the control population is similar to those from whom the reference
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equations were derived112. For the white population in the current study, this was 
true for FEV0.5 z-scores calculated from Oslo data, for FVC and FEF25-75 z-scores 
calculated from Indianapolis data, and arguably true for FEVi z-scores calculated 
from Indianapolis data. FVC and FEVi results did not fit the reference equations 
reported by the Oslo group.
3.6.7 Methodological issues and strengths and limitations 
When FET results obtained from the database were compared with volume-time 
traces for the corresponding expirations it was apparent that FET had been 
overestimated in some cases (Figure 3.7). The reason for this is that some children 
removed their mouths from the mouthpiece immediately after ceasing expiration, 
rather than taking another inspiration through the mouthpiece. The Jaeger 
Masterscope system continues to record expiration until absolute cessation of 
expiratory flow is detected. This feature allows complete recording of expiration in 
subjects with severe airflow limitation. However, if there is a slight expiratory 
offset on the flow signal, expiration will continue to be recorded until the subject 
takes an inspiration.
In this study children were tested in the seated position wherever possible, and 
asked to wear nose-clips. Very young children may rebel against such instructions 
and in such cases these criteria should be relaxed if this is the only means of 
obtaining results. ATS guidelines suggest that subjects can be tested either seated or 
standing, but that this should be reported with the data34. A recent report from 
school-age children who were tested with and without nose-clips found no 
systematic effect upon FEVi or FVC 113.
Incentive software can be distracting for older children43, but in this study it was 
found to be helpful. The Jaeger incentive programme (which is routinely available 
with Jaeger spirometry software) was used for all children. Vilozni and colleagues 
have reported that only 2% of 3 to 6 year old children are able to produce a FEV1 
with the Jaeger incentive software, as compared to 49% of children who could 
produce a FEVi with their own Spirogame incentive software41. It is noted that in 
Vilozni’s study only the Jaeger ‘Candle’ incentive (which encourages rapid 
expiration) was used, and that, unlike in this study, the investigators did not move
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on to alternative incentives that encourage prolongation of expiration. This 
methodological difference may explain the marked discrepancy between the current 
results (in a younger population) and those previously reported by Vilozni’s group. 
On a related matter, children in the current study performed a maximum of 22 
expiratory manoeuvres, rather than the eight recommended by the ATS34. The 
reason for this is that many younger children initially produced incomplete 
expirations, particularly when using the ‘Candle’ incentive. The Jaeger system does 
not allow easy recording of repeated manoeuvres, and does not allow borderline or 
excluded traces to be stored for later reanalysis. Overcoming these hurdles required 
considerable effort, including the use of custom written software, and is a strength 
of this study.
The most notable weakness of the current study is that children were tested towards 
the end of a two-hour laboratory visit. It is likely that some children were fatigued 
by the time they performed spirometry, and success rates may have been adversely 
affected. It is unlikely that other parameters would have been influenced by this 
methodological issue. By contrast, one factor that may have increased the success 
rate was the use of a specially adapted preschool laboratory, with data collection 
performed by trained operators. This set-up is not always available in the clinical 
setting.
Suggestions for alternative quality control criteria for preschool children are 
discussed further in Chapter 7.
3.6.8 Conclusion
In conclusion, data presented in this chapter have demonstrated that children aged 2 
to 5 years are unable to meet some of the quality control criteria for spirometry 
recommended for adults, but alternative criteria may be feasible. These alternative 
criteria are discussed further in Chapter 7.
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Chapter 4: Feasibility and quality control for multiple-breath 
inert gas washout
4.1 Introduction
Early studies using the MBW technique were performed in adults and older 
children, and required subjects to breathe in a controlled manner, with a regular 
respiratory rate and tidal volume. This methodology is not possible in younger 
children, where measurements must be performed during natural tidal breathing. 
During spontaneous tidal breathing, subjects may vary their respiratory rate (RR), 
tidal volume (V t) and/or functional residual capacity (FRC).
A small number of studies in adults have examined the effect of changes in RR, Vt 
and FRC upon MBW indices such as the lung clearance index (LCI), the mixing 
ratio (MR) and the phase III slope 2'7. The breathing patterns employed during these 
studies were beyond the limits of normal physiological tidal breathing.
Furthermore, these studies have all been performed in adults, and it is known that 
somatic growth can greatly influence lung function parameters (Chapter 3).
Prior to examining whether the LCI and indices derived from phase III slope 
analysis can be used to distinguish health from disease, it is necessary to examine 
the effect of subject characteristics and breathing pattern variability upon these 
parameters.
4.2 Aims and hypotheses
4.2.1 Hypotheses
a) In healthy subjects, the LCI is independent of subject age, age group {i.e. 
preschool or school-age), sex, and body size. In all subjects, the LCI is 
independent of variations in RR, V t , and FRC seen during spontaneous tidal 
breathing
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b) In healthy subjects, the phase III slope is negatively related to tidal volume 
and FRC, but otherwise independent of subject age, age group, sex, and 
body size.
4.2.2 Aims and objectives
The aim of this study was to examine the effect of breathing pattern and various 
analysis methods upon MBW indices. The specific objectives of this study were:
a) To examine the precision of the Lung Clearance Index and the first breath 
phase III slope, over three repeated measures
b) To investigate whether subject age, age group, sex, and body size influence 
the Lung Clearance Index and the phase III slope
c) To investigate whether spontaneous variations in RR, V t, and FRC during 
normal tidal breathing are sufficient to influence the Lung Clearance Index 
and the phase III slope
d) To examine the effect of excluding SnIII results from breaths of inadequate 
volume (Chapter 2) upon the SnIII versus lung volume turnover relationship
e) To determine whether the SnIII versus lung volume turnover relationship is 
linear over 1.5 to 6.0 turnovers, in spontaneously breathing children.
4.3 Subjects and methods
4.3.1 Subject recruitment
The study was performed in both school-age and preschool children, with and 
without CF.
School-age children with CF were recruited from the CF clinic at Great Ormond 
Street Hospital. All subjects were approached by the author. Subjects were recruited 
opportunistically: i.e. no attempt was made to recruit all children with CF who were 
eligible for participation in the study, or to recruit a random or representative 
sample from the clinic. The study was explained verbally, and written information 
leaflets were also provided. Written informed consent was obtained from parents, 
and from all children aged 12 years or greater. Younger children gave verbal assent.
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Children with CF were asked to bring one or more friends with them on the day of 
testing to act as healthy controls. Additional controls were recruited through the 
families of CF children participating in this study and from friends and family of 
members of laboratory staff. In all cases, verbal and written information was 
provided prior to the day of testing, and written consent was obtained as for the 
children with CF.
Inclusion criteria for school-age subjects with CF:
• CF diagnosed by a positive sweat test and / or two known CF disease- 
producing mutations identified by DNA analysis
• Subject aged > 6.0 years and <17.0 years at time of testing.
Exclusion criteria for school-age subjects with CF:
• Congenital cardiac disease that requires medical therapy, has previously 
required surgical therapy, or is awaiting surgical therapy
• Neuromuscular or bone disease likely to result in weakness of respiratory 
muscles or restriction of the thorax.
Inclusion criteria for school-age healthy control children:
• Subject aged > 6.0 years and <17.0 years at time of testing.
Exclusion criteria for school-age healthy control children:
• Any previous hospitalisation for a respiratory condition
• Use of anti asthma medication on more than one occasion in the previous 12 
months
• Any history of chronic productive cough, recurrent wheezing, or shortness 
of breath within the previous 12 months
• Congenital cardiac disease that requires medical therapy, has previously 
required surgical therapy, or is awaiting surgical therapy
• Children with neuromuscular or bone disease likely to result in weakness of 
respiratory muscles or restriction of the thorax.
Recruitment of preschool subjects is described in Section 3.3.1.
Copies of consent forms and information sheets for both school-age and preschool 
children are provided in Appendices B-D.
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4.3.2 Study design
This was a cross-sectional study. All school-age subjects successfully completing 
spirometry and MBW were included in the analyses presented in this chapter. No 
school-age subjects were recalled for a second visit. Preschool subjects were 
participating in a study comparing spirometry, body plethysmography, and MBW 
results. Subjects who did not complete all three measurements were asked to return 
to the laboratory six months after their first visit for repeat measurements. The 
study was continued until 30 subjects with CF and 30 healthy subjects had 
completed all three measurements. MBW results from these 60 children are 
presented in this chapter.
4.3.3 Data collection
Collection and analysis of MBW data, including criteria for accepting or discarding 
results; and derivation of the indices listed below, are described in Chapter 2.
Some breaths were considered to be of inadequate volume for estimation of SnIII 
(Section 2.4.8). Nevertheless, for these breaths, the SnIII was calculated over 65- 
95% of expired volume, and the results recorded to allow comparison with breaths 
of larger volume.
4.4 Analysis
4.4.1 Outcome measures
The following measures were reported from each MBW run (note: these values will 
be identical for SF6 and He analyses):
• The mean respiratory rate during the washout (R R m ean )
• The mean expired volume during the washout (VTmean)
• The expired volume of the first breath of the washout (first breath V eXp ). 
Both VTmean and first breath V exp were corrected for apparatus dead-space.
The following measures were reported from each SF6 MBW run:
• The Lung Clearance Index (LCI)
• The Functional Residual Capacity (FRC).
The following measure was reported separately for each SF6 and He run:
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• The normalised phase III slope (SnIII) calculated from the first breath of the 
washout.
For all the above measures the mean value from three runs was also calculated and 
reported.
The following measures were calculated from mean data collected from three SF6 
and He MBW runs, and reported separately for SF6 and He data:
• The slope of the regression of SnIII versus lung volume turnover (TO) over
1.5 to 6.0 TO:
a) calculated from all SnIII data (raw Scond, [S COndR])
b) calculated after excluding SnIII results obtained from breaths of 
inadequate volume (see chapter 2, corrected S cond, [ S COn d c ])
• The slope of the regression of SnIII versus lung volume turnover (TO) over
2.5 to 6.0 TO, calculated after excluding SnIII results obtained from breaths 
of inadequate volume ( S COnd2.5)
• The square of the correlation coefficient (r2) for the regressions of S condR and
ScondC •
4.4.2 Analysis
Subject characteristics (age, sex, weight, height, and weight and height z-scores) 
were compared by diagnosis and by age group.
The precision of L C I  was determined by calculating the coefficient of variation 
(CoV) as 100 ' SD • mean'1 (%) and by Bland-Altman analyses of the mean L C I  
calculated over three runs ( L C I mean ), versus the mean L C I  calculated from the first 
two runs ( L C I  1,2), and the L C I  calculated from the first run only ( L C I i ) .
The relationships between subject characteristics and L C I  were examined by 
regression analyses, with L C I mean as the dependent variable. The relationships 
between L C I  and breath characteristics were then examined, with data from 
individual MBW runs (rather than mean data from three runs) entered into the 
regression models. These analyses were performed for four populations: healthy 
preschool children; preschool children with CF; healthy school-age children; and 
school-age children with CF. For each population, a series of univariate analyses 
was performed first, followed by multivariate analysis. As the final stage in these
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analyses, data from the entire study population was entered into a regression model, 
with subject characteristics, breath characteristics, and diagnosis included as 
predictor variables.
The effect of breathing pattern upon L C I  was examined further by a within-subject 
comparison. This was performed by calculating: the difference between the L C I  
obtained from the first run with the L C I  obtained from the third run ( A L C I 1 .3 ) ,  and 
relating this to the difference in F R C  between the first and third run ( A F R C 1 .3 ) ;  the 
difference in VTmean between the first and third run (A V r m e a n i-3 );  and the difference 
in RRmean between the first and the third run (ARRmeani-3), by scatter plot and 
regression analysis.
The effect of small breath volume on SnIII was assessed by comparing SnIII results 
from breaths considered to be of adequate volume against SnIII results obtained 
from breaths of inadequate volume. This was performed by identifying children in 
whom either one or two of the three first breaths had been identified as small 
volume. In the former case, a mean SnIII value and a mean breath volume was 
calculated for the two breaths of adequate volume. In the latter case, a mean SnIII 
value and mean breath volume was calculated for the two breaths of inadequate 
volume. SnIII values for breaths of adequate and inadequate volume could then be 
compared within subject for this population. Examples of phase III slopes 
calculated from breaths of small volume are presented in Chapter 2. Precision of 
SnIII was assessed as for LCI, i.e. by calculating the CoV, and by Bland-Altman 
analysis of the SnIII results from three runs (SnIIImean) against the mean SnIII result 
from the first two runs (SnIII 1,2) and the SnIII result from the first run only (SnIIIi). 
The effect of subject characteristics and breathing pattern upon SnIII was examined 
as for LCI: i.e. by univariate and multivariate regression analyses examining the 
relationships between subject characteristics and first breath SnIIImean; the 
relationships between breath characteristics (FRC and first breath Vexp) and first 
breath SnIII from individual runs; and within subject comparisons examining 
change in first breath SnIII, FRC and first breath Vexp from the first breath of the 
first run to the first breath of the third run.
The effect of excluding breaths of inadequate volume upon the calculation of Scond 
was examined by comparing the fit (r2) of the Scond regression line over 1.5 to 6.0
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lung volume turnovers before and after the exclusion process, and by comparing 
ScondR and ScondCj separately for SF6 and He data. The origin of the linear portion of 
the SnIII versus TO relationship was examined by comparing SC0ndc with S COnd2 .5 , 
separately for SF6 and He data.
Group results were expressed as mean (SD) or median (IQR). Group comparisons 
were by one or two-sided t-test, or by their non-parametric equivalents. T test 
results were expressed as mean difference (95% confidence interval of difference) 
as well as by p-values. Comparison of results obtained by two methods was by 
Bland-Altman analysis. Regression model fit was expressed by r2, whilst partial 
regression coefficients were calculated to demonstrate contribution of predictor 
variables to multivariate models. For each model the residual standard deviation 
(RSD) was also calculated. A p-value equal to or less than 0.05 was regarded as 
statistically significant.
4.4.3 Power o f  study
The power calculation for this sample was based upon the requirements of the 
analysis presented in Chapter 5, where results obtained from MBW and spirometry 
are compared for CF and control groups (see section 3.4.4). For Chapter 5, sample 
sizes of 22 school-age subjects in each group, and 30 preschool subjects in each 
group were predicted to be sufficient to detect significant differences in lung 
function parameters. Full details of this analysis are presented in Section 5.4.4.
4.5 Results: washout curve analysis
4.5.1 Study population
Fifty-seven school-age children were studied. From two children with CF the 
spirometry results failed to meet the criteria laid out in the methods. Results from 
these children were therefore excluded from further analysis. All subjects 
completed three successful washouts.
Information regarding the remaining 55 children is summarised in Table 4.1. There 
were 22 subjects with CF, aged 6.4 to 16.5 years, and 33 control subjects, aged 5.9 
to 16.8 years. CF and control subjects were well matched for age, height and
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gender. The children with CF were significantly shorter and significantly lighter 
than the control subjects.
Table 4.1 School-age subject characteristics
CF 
(n = 22)
Controls 
(n = 33)
Mean difference 
(95% Cl of difference)
Sex (% male) 50% 42% 8% (-18, 42)
Age (years) 11.5 (3.2) 11.3 (3.1) 0.2 (-1.6, 2.0)
Weight (kg) 36.9(11.8) 41.1 (14.7) -4.2 (-11.8,3.3)
Weight z-score -0.41 (0.96) 0.37 (0.78) -0.78 (-1.2, -0.3)*
Height (cm) 142.5(18.6) 147.4(18.3) -4.9 (-15.1,5.2)
Height z-score -0.61 (1.20) 0.50 (0.74) -1.11 (-1.6, -0.6)*
Legend: Except for sex, results are given as mean (SD). Mean difference calculated 
as CF - control. * p<0.05
Of the 22 school-age children with CF, 15 were homozygous for the AF508 
mutation, whereas the other seven had one AF508 mutation and one other mutation. 
Forty preschool children with CF and 37 healthy preschool children were recruited. 
Although matched for age, the children with CF were significantly lighter and 
significantly shorter than the control children (Table 4.2).
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Table 4.2 Characteristics of initial preschool study population
CF 
(n = 40)
Controls 
(n = 37)
Mean difference 
(95% Cl of difference)
Sex (% male) 45% 61% -16 (-36, 6)
Age (years) 4.13 (0.90) 4.22 (0.87) -0.09 (-0.48, 0.30)
Weight (kg) 16.6 (2.8) 18.8(3.7) -2.1 (-3.6, -0.65)**
Weight z-score -0.04(1.11) 0.70(1.16) -0.74 (-1.24, -0.24)**
Height (cm) 100.8 (7.4) 104.8 (8.0) -4.0 (-7.4, -0.6)*
Height z-score -0.42(1.13) 0.29(1.14) -0.71 (-1.21,-0.21)**
Legend: Except for sex, results are given as mean (SD). Mean difference calculated 
as CF - control
*p<0.05, **p<0.01
Success in completing MBW measurements at first laboratory visit is presented in 
Table 4.3. There was no significant difference in success by age or diagnosis for 
LCI.
Table 4.3 Success in completing MBW measurements on first visit: all 
preschool children
All Cystic Healthy 2-<3 3-<4 4-<5 5 - 6
children Fibrosis Controls years years years years
(n=77) (n=40) (n=37) (n=6) (n=32) (n=24) (n=15)
MBW 61 30 31 3 25 20 13
(79%) (75%) (84%) (50%) (78%) (83%) (87%)
Legend: Results presented as number (%). Comparisons between groups by Chi 
squared or Fisher's exact test are presented in the text.
In addition to completing MBW measurement, preschool children were required to 
successfully complete spirometry and body plethysmography measurements. On the
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first visit, 27 healthy children and 23 children with CF were able to complete this 
protocol (see Figure 2.2). On repeat visits a further four healthy controls and seven 
children with CF were able to complete the protocol, giving a total study population 
of 31 healthy children and 30 children with CF. However, it was noted that the CF 
and control populations were not matched for ethnicity, and so the study was 
continued until a further five white children had completed the protocol. The three 
healthy black children who had completed the protocol and the last three healthy 
children of mixed race who had completed the protocol were excluded from the 
control group for this study. Summary data for the final preschool study population 
are presented in Table 4.4.
Table 4.4 Characteristics of final preschool study population
CF
(n=30)
Healthy
controls
(n=30)
Mean difference 
(95% Cl for difference)
Sex (%M) 43% 60% -17% (-42, 8)
Ethnicity (% 
white)
87% 80% 7% (-12, 25)
Age (years) 4.43 (0.77) 4.31 (0.84) 0.13 (-0.29, 0.55)
Weight (kg) 17.7 (2.6) 18.8 (3.4) -1.2 (-2.7, 0.4)
Weight z-score 0.15(1.07) 0.69(1.19) -0.57 (-1.15, 0.02)
Height (cm) 103.9 (6.3) 105.3 (7.7) -1.4 (-5.0, 2.2)
Height z-score -0.24(1.15) 0.27(1.25) -0.49 (-1.11,0.13)
Legend: Except for sex, results are given as mean (SD). Mean difference calculated 
as CF - control.
Comparison of subject characteristics for preschool and school-age groups is 
presented in Table 4.5. As preschool children were younger, they were also 
significantly shorter and lighter. There was no significant difference in weight z- 
scores or height z-scores between the two groups.
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Table 4.5 Characteristics of total study population, compared by age 
group.
Preschool 
(n = 60)
School-age 
(n = 55)
Mean difference 
(95% Cl for difference)
Sex (% male) 52% 45% 6 (-12, 24)
Age (years) 4.37 (0.80) 11.34 (3.17) -6.97 (-7.81,-6.12)***
Height (cm) 104.6 (6.9) 145.4(18.4) -40.8 (-45.9, -35.7)***
Weight (kg) 18.2 (3.1) 39.4(13.7) -21.2 (-24.8,-17.6)***
Height z-score 0.02(1.21) -0.03 (0.82) 0.05 (-0.97, 1.02)
Weight z-score 0.42(1.11) -0.01 (0.86) 0.43 (-0.49,1.35)
Legend: Except for sex, results are given as mean (SD). Mean difference calculated 
as preschool -  school-age. *** p<0.001
There was no significant difference in weight z-scores or height z-scores between 
the two groups.
4.5.2 Precision o f  Lung Clearance Index
The relationship between CoVlci, age, and diagnosis is presented in Figure 4.1. 
Only 10 of the 115 children had CoVlci greater than 10%, of whom six were 
preschool children with CF.
C oV lci was compared by age group and diagnosis. Children with CF had 
significantly higher C oV lci than healthy children: (7 .1 8 %  [4 .4 6 ] versus 5.18%  
[2 .5 6 ], mean difference -1 .9 9 %  [ -3 .3 1 , -0 .6 8 ]) .  Preschool children tended to have 
higher C oV lci than school-age children, but this difference was not significant 
(6 .43%  [4 .3 3 ] versus 5 .7 1 %  (2 .7 6 ) , mean difference 0.72%  [-0 .6 4 , 2 .0 7 ]) .
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Figure 4.1 Coefficient of variation for LCI, plotted against age, in all 
children
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Legend: CoVlci = Coefficient o f  variation for LCI. Children with CF presented as 
closed circles, healthy children as open circles. Broken line is at CoVlci o f 10%. 
Only 10 o f the 115 children had CoVlci greater than 10%, o f whom six were 
preschool children with CF.
A Bland-Altman comparison of LCI results obtained from the first two runs (LCIi;2) 
with those obtained from all three runs ( L C I mean) is presented in Figure 4.2. There 
was no significant group difference in LCI results obtained from two versus three 
runs, either for the population as a whole, or for the preschool, school-age, healthy 
and CF subgroups (Table 4.6). Limits of agreement were narrow, being -0.54, 0.49 
for the population as a whole (Table 4.6). Results presented later in this chapter and 
in Chapter 5 demonstrate that these differences are smaller than those seen between 
CF and control groups.
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Figure 4.2 Bland-Altman plot of mean LCI result obtained from two 
runs, compared with mean LCI result obtained from three runs, in all 
children
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Legend: LCI 12 = LCI result obtained as mean o f first two runs.
LCImean =  L C I result obtained as mean o f all three runs.
Difference calculated as LCI 12 -  LCImean- Children with CF presented as closed 
circles, healthy children as open circles. Broken lines represent 95% limits o f  
agreement, calculated as mean +/- 1.96SD, from fu ll population (CF and control, 
see Table 4.6).
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Table 4.6 Bland-Altman analysis of mean LCI result obtained from two 
runs, compared with mean LCI result obtained from three runs
Mean (SD) 
difference
95% Cl of 
difference
95% limits of 
agreement
All children 
(n=115)
-0.03 (0.26) -0.08, 0.02 -0.54, 0.49
All children with CF 
(n=52)
-0.06 (0.35) -0.16, 0.03 -0.74, 0.62
All healthy children 
(n=63)
0.00 (0.16) -0.04, 0.04 -0.31,0.31
All preschool 
children (n=60)
-0.01 (0.31) -0.09, 0.07 -0.61,0.59
All school-age 
children (n=55)
-0.05 (0.21) -0.10, 0.01 -0.45, 0.36
Legend: The 95% Cl o f difference o f the mean is calculated by one-sided t-test, 
against zero, as mean difference +/- (1.96' Standard Error o f the mean). This 
analysis indicates whether there is a significant group difference between the 
results. The 95% limits o f agreement, calculated as mean +/- 1.96SD,from full 
population (CF and control) indicate the agreement between the two methods. Both 
these values are discussedfurther in Section 4.7.
Difference calculated as LCI 12 - LCImean
There was no significant group difference between LCI12 and LCImean.
A Bland-Altman comparison of LCI results obtained from the first run with those 
obtained from all three runs is presented in Figure 4.3.
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Figure 4.3 Bland-Altman plot of LCI result obtained from the first run, 
compared with mean LCI result obtained from three runs, in all 
children
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Legend: LCli — LCI result obtained from the first run only.
LCImean = LCI result obtained as mean o f all three runs.
Difference calculated as LCI\ -  LCImean. Children with CF presented as closed 
circles, healthy children as open circles. Broken lines represent 95% limits o f 
agreement, calculated as mean + /-1.96SD, from fu ll population (CF and control, 
see Table 4.7).
There was a trend for lower results for L C l i  compared with L C I mean- This difference 
was significant when school-age children were analysed as a subgroup (Table 4.7). 
This phenomenon is examined further in section 4.5.6.
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Table 4.7 Bland-Altman analysis of LCI result obtained from one run, 
compared with mean LCI result obtained from three runs
Mean (SD) 
difference
95% Cl of 
difference
95% limits of 
agreement
All children 
(n= 115)
-0.10(0.57) -0.21, 0.00 v -1.22, 1.01
All children with 
CF (n=52)
-0.14(0.75) -0.35, 0.07 -1.62, 1.34
All healthy children 
(n=63)
-0.07 (0.36) -0.16, 0.02 -0.77, 0.63
All preschool 
children (n=60)
-0.05 (0.60) -0.20, 0.11 -1.23, 1.13
All school-age 
children (n=55)
-0.16(0.54) -0.31,-0.02* -1.22, 0.90
Legend: Difference calculated as L C I /  -  L CImean-
¥p=0.056, *p<0.05 
There was a trendfor lower results fo r  LC I] compared with LCImean- This difference 
was significant when school-age children were analysed as a subgroup.
4.5.3 Effect o f  subject characteristics on Lung Clearance Index 
For all analyses presented in this section, the mean L C I  result calculated from three 
washouts (LCImean) is the dependent variable. Figure 4.4 demonstrates the 
relationship between age and L C I mean in healthy children.
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Figure 4.4 LCimean plotted against age in healthy children
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Legend: The broken line marks the division between the preschool and school-age 
groups. There is a weak negative relationship between LC Imean and age, but it is not 
clear from the Figure whether this relationship is linear, or whether there is a step 
change between the two age groups. This relationship is examinedfurther by 
regression analysis (see text).
The relationships between L C I mean and subject characteristics in healthy children 
were examined further by regression analyses. By univariate analyses, there were 
significant negative relationships between height and L C I mean, between weight and 
L C I mean, and between age and L C I mean- There was no relationship between sex and 
LCImean- When age group was tested as a categorical variable, with preschool coded 
as zero, and school-age as one, there was a significant negative relationship. Results 
of multivariate analysis of L C I mean against subject characteristics are presented in 
Table 4.8.
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Table 4.8 Results of multivariate regression of subject characteristics 
against LCimean in healthy children
Coefficient (B) Standard Error of B p-value
Constant 7.86 1.10 <0 .001
Age (years) 0.171 0.071 0 .0 2
Sex -0.0255 0 .121 0 .8
Height (cm) -0.0182 0.014 0.4
Weight (kg) -0.0240 0.015 0.1
Age group -0.646 0.244 0.01
Legend: Sex is coded as zero for female, and one for male. Age group is coded as 
zero for preschool and one fo r school-age. After correction for other variables, 
both age and age group make a significant contribution to the model fit, but the 
greatest contribution is made by the constant. For the model as a whole, the RSD is 
0.463, and the r2 is 0.241, indicating that 24.1% o f the variability o f LCImean in 
healthy children is explained by this regression model.
Figure 4.5 demonstrates the relationship between age and L C I mean in children with 
CF. There is a positive relationship between age and L C I mean in the school-age 
population, but this relationship does not appear to extend to the preschool 
population.
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Figure 4.5 LCImean plotted against age in children with CF
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Legend: The broken line marks the division between the preschool and school-age 
groups. Note the difference in y-axis scale compared with Figure 4.4. There is a 
positive relationship between LClmean and age in the school-age CF population, but 
this relationship does not appear to extend to the preschool population. The 
relationship is examinedfurther by regression analysis.
For children with CF, by univariate analyses, there were significant positive 
relationships between age and L C I mean, height and L C I mean, weight and L C I mean and 
age group and L C I mean. There was no relationship between sex and L C I mean. Results 
of multivariate analysis of L C I mean against subject characteristics are presented in 
the Appendix. None of the entered variables were significant independent predictors 
of L C I mean. The r2 for the model was 0.218, indicating that only 2 1 .8% of the 
variability of L C I mean in children with CF is explained by the model.
As the last step in these analyses, results for all children in the study were examined 
by multivariate analysis, first modelling subject characteristics as predictor
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variables, and then adding diagnosis (as a categorical variable) to this model. The 
first model included age, sex, height, weight and age group as predictor variables. 
For this model, the RSD was 2.40, and the r2 was 15.4%.
Table 4.9 presents the results of the same regression analysis after including 
diagnosis as a predictor variable. Addition of diagnosis to the model increased the r2 
from 15.4% to 57.1%. The regression coefficient for diagnosis was 3.55, indicating 
that children with CF had an LCI 3.55 higher than healthy children, after adjustment 
for other variables.
Table 4.9 Results of multivariate regression of subject characteristics
and diagnosis against L C Imean in all children
Coefficient (B) Standard Error of B p-value
Constant 4.76 2.92 0.1
Age (years) 0.486 0.169 0.005
Sex 0.320 0.323 0.3
Height (cm) 0.0118 0.036 0.7
Weight (kg) -0 .1 0 0 0.044 0.03
Age group -1.17 0.654 0.08
Diagnosis 3.55 0.344 <0 .001
Legend: Sex is coded as zero for female and one for male. Age group is coded as 
zero for preschool and one for school-age. Diagnosis is coded as zero for healthy, 
and one for CF. Diagnosis is by far the most important predictor o f  LCimean within 
this model, with a regression coefficient o f  3.55, indicating that children with CF 
had an LCI 3.55 higher than healthy children, after adjustment for other variables. 
For the model as a whole, the RSD was 1.71, and the r2 was 0.571, indicating that 
57.1% o f the variability o f LCImean is explained by this regression model.
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4.5.4 Effect of breathing pattern upon Lung Clearance Index: between subject 
comparisons
For these analyses, the FRC, V rniean , and R R m ean measured for each individual run 
was tested against the LCI calculated from each individual run. For these analyses, 
both breathing pattern (intra-subject variability), and subject characteristics 
(between-subject variability) will be expected to influence LCI. The results of these 
analyses are presented in detail in the Appendix. In summary, a weak negative 
relationship between LCI and Vimean was noted in healthy children, and a weak 
positive relationship between LCI and FRC was noted in children with CF. When 
all children were included in the analyses, a model including FRC, Vimean, and 
RRmean explained only 4.1% of the variability of LCI. Addition of age, age group, 
sex, height, and weight to the model increased the r to 23.0%, whilst further 
addition of diagnosis to this model increased the r2 to 58.3%.
4.5.5 Change in LCI over three consecutive MBW runs
It was noted in section 4.5.2, that LCI results from the third run tended to be higher 
than those obtained from the first run, particularly in children with CF. This was 
examined further. A Bland-Altman plot of LCI results obtained from the first run 
with those obtained from the third run is presented in Figure 4.6. The difference 
between these values is ALCI1-3.
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Figure 4.6 Bland-Altman plot of LCI result obtained from first run, 
compared with LCI result obtained from third run, all children
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Legend: LCI] = LCI result obtained from the first run.
LCI3 = LCI result obtained from the third run.
Difference calculated as LCI) -  LCI3. Children with CF presented as closed circles, 
healthy children as open circles. Dashed lines represent 95% limits o f  agreement, 
calculated as mean +/- 1.96SD, from control population; dotted lines represent 
95% limits o f agreement calculated from CF population (Table 4.10).
LCIi was significantly lower than LCI3 for the population as a whole. By subgroup 
analysis this trend was seen in all populations, but the difference was only 
significant in the school-age subgroup (Table 4.10).
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Table 4.10 Bland-Altman analysis of LCI results obtained from first 
run, compared with LCI results obtained from third run
Mean (SD) 
difference
95% Cl of 
difference
95% limits of 
agreement
All children 
(n=115)
-0.17(0.89) -0.34, -0.01 * -1.91, 1.57
All children with 
CF
(n=52)
-0.28(1.16) -0.61,0.04 -2.55,1.99
All healthy children 
(n=63)
-0.08 (0.58) -0.22, 0.07 -1.22, 1.06
All preschool 
children (n=60)
-0.10(0.93) -0.34, 0.14 -1.92, 1.72
All school-age 
children (n=55)
-0.25 (0.86) -0.48, -0.02 * -1.94, 1.44
Legend: Difference calculated as LCI/ -  LCI3.
*p<0.05
LCI1 was significantly lower than LCI3 for the population as a whole. By subgroup 
analysis this trend was seen in all populations, but the difference was only 
significant in the school-age subgroup. Note that limits o f  agreement differ for  
control and CF groups.
The largest difference between LCIi and LCI3 were seen for the school-age 
subgroup, and the CF subgroup. The relationship between ALCI1.3 and age is 
presented in Figure 4.7. No significant relationship was seen.
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Figure 4.7 Scatter plot of ALCI1 .3  against age, all children
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Legend: Children with CF presented as closed circles, healthy children as open 
circles. Broken lines represent 95% limits o f  agreement, calculated as mean +/- 
1.96SD, from full population (CF and control, see Table 4.10).
4.5.6 Effect o f  breathing pattern on Lung Clearance Index: within subject 
comparisons
The relationship between breathing pattern and LCI was examined further by 
examining change in FRC, Vimean, RRmean and LCI from the first run to the third 
run, within subjects. These breathing pattern characteristics will be expected to vary 
between the first and third runs, whilst the subject characteristics will remain 
unchanged. Effect of breathing pattern upon LCI can therefore be examined, with 
the confounding effect of between- subject variability eliminated. The relationship 
between ALCI1.3 and AFRC1-3 is presented in Figure 4.8. There was a weak 
negative relationship between ALCI1.3 and AFRC1.3 (r2 = 0.11).
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Figure 4.8 Scatter plot of ALCI1.3 against AFRC1.3, all children
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Legend: Children with CF presented as closed circles, healthy children as open 
circles. There was a weak negative relationship between ALCIj.3 and AFRC1.3 (r2 = 
0.11).
Figure 4.8 suggests that many children with CF have A L C I 1 .3  less than zero, i.e. the 
LCI result obtained from the third run was higher than the result obtained from the 
first run. This is explored further in Section 4.5.6.
There was no relationship between A L C I 1 .3  and AV-rm eani-3 (Figure 4.9).
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Figure 4.9 Scatter plot of ALCI1.3 against AVTmeani-3, all children
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Legend: Children with CF presented as closed circles, healthy children as open 
circles. There was no relationship between A LCI 1.3 and A Vrmemis-
There was no relationship between A L C I1 -3  and A R R meani-3 (Figure 4.10).
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Figure 4.10 Scatter plot of ALCI1.3 against ARRmeani-3 , all children
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Legend: Children with CF presented as closed circles, healthy children as open 
circles. There was no relationship between A LCI 1.3 and ARRj.3.
The relationships between A F R C 1 -3 ,  A V T m eani-3 , A R R m ea n i-3 , and A L C I 1 .3  were 
explored further by regression analyses. Comparisons were first performed 
separately for healthy children and children with CF. These results are presented in 
detail in the Appendix. In summary, A F R C 1 .3  was a significant predictor of A L C I 1 .3  
in both healthy children and those with C F .  However, by multivariate analyses, all 
three variables only explained 12.7% of the variability of A L C I1 -3  in healthy 
children, and 27.9% of the variability of A L C I1 -3  in children with C F .  When all 
children were studied together, the multivariate model predicted 16.1% of the 
variability of A L C I 1 .3  (Table 4.11). For this model, the regression coefficient for 
A F R C 1 .3  was -0.315, indicating that a 10% fall in F R C  would be expected to 
produce a 3.2% increase in L C I .  The coefficient for A R R meani-3 was 0.143, 
indicating that a 10% rise in RR would be expected to produce a 1.4% increase in
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LCI. Addition of diagnosis and age group to this analysis had no significant effect 
upon model fit.
Table 4.11 Results of multivariate regression against ALCI1.3, in all 
children
Coefficient
(B)
Standard error of B p-value
Constant -1.96 0.913 0.03
A F R C 1 -3  ( % ) -0.315 0.073 <0.001
A V xm ean l-3 ( % ) 0.085 0.061 0.2
A R R m ea n l-3 ( % ) 0.143 0.047 0.003
■j
Legend: For the model as a whole, the RSD was 0.548, and the r was 0.161, 
indicating that for healthy children studied under this protocol, 83.9% o f the 
variability o f ALC11 .3  was unrelated to changes in FRC, Vrmean, or R R mean-
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4.6 Results: Phase III slope analysis
4.6.1 Exclusion of first breaths during quality control
Phase III slope analysis criteria included a mechanism for excluding breaths that 
were of such small volume that the phase III slope was unlikely to be visible 
(Figure 2.20). The effect of this approach was examined in first breaths, as these are 
essential for calculation of Sacin, and as they are less affected by breathing pattern 
than subsequent breaths in the MBW. In 10 children, the first breath was excluded 
in one of the three runs. In six children, the first breath was excluded in two of the 
three runs. In one child, the first breath was excluded in all three runs. In the 
remaining 98 children, the first breath was of adequate volume in all three runs. 
Mean SnIII values and mean breath volume for breaths of adequate and inadequate 
volume were calculated for the 16 children in the first two groups, as described in 
Section 4.4.2.
By paired Wilcoxon test, SnIII values for adequate volume breaths were 
significantly lower than SnIII values for inadequate volume breaths (Table 4.12).
Table 4.12 Comparison of SnIII and breath volume between first 
breaths of adequate volume and first breaths of inadequate volume
Adequate volume Inadequate volume Z- p-value
score
SnIII (L*1) 0.23 (0.18,0.38) 1.38(0.65,3.09) 3 3  0001
Breath volume (L) 0.30(0.22,0.47) 0.15(0.11,0.31) -3.5 <0.001
Legend: Results presented as median (IQR). Comparison by Wilcoxon signed ranks 
test.
A Bland-Altman plot of the paired SnIII results is presented in Figure 4.11. Due to 
the skewed nature of these data, limits of agreement could not be calculated. 
However, this plot demonstrates that in 13 of the 16 children, the adequate volume
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SnIII -  inadequate volume SnIII result was less than -0.3 L '1. In other words, in the 
majority of cases where small first breaths could be identified, the SnIII calculated 
from these breaths was at least 0.3 L '1 greater than the SnIII calculated from first 
breaths of adequate volume obtained during the same test session.
Figure 4.11 Bland-Altman plot of first breath SF6 SnIII results from 
breaths of adequate and inadequate volume
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Legend: Children with CF presented as closed circles, healthy children as open 
circles. 1st breath SnIII, ad -  inad = SnIIIfrom breaths o f adequate volume -  SnIII 
from breaths o f inadequate volume. 1st breath SnIII, mean o f ad, inad = mean o f  
SnIIIfrom breaths o f  adequate volume and SnIIIfrom breaths o f  inadequate 
volume. The data are skewed, so Limits o f Agreement cannot be calculated.
These analyses were not repeated for the first breath He SnIII data, as there was a 
close correlation between the SnIII results obtained from SF6 traces, and those 
obtained from the corresponding He traces (Section 4.6.3). For the analyses 
presented below, only breaths of adequate volume are considered. However, the 
effect of breath volume upon SnIII is addressed further in Chapter 6.
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4.6.2 Precision of first breath SnIII
All three first breaths were of adequate volume in 49 healthy children (21 
preschool, 28 school-age), and in 45 children with CF (26 preschool, 19 school- 
age). The precision of first breath SF6 SnIII results was assessed in these 94 
children. The median (IQR) CoVsniii for the entire population was 42.5% (24.6,
62.8). The relationship between the coefficient of variation for first breath SF6 SnIII 
(CoVsniii) and age is presented in Figure 4.12.
Figure 4.12 Coefficient of variation for first breath SF6 SnIII, plotted 
against age
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Legend: CoVsniii = Coefficient o f variation for first breath SF6 SnIII. Children with 
CF presented as closed circles, healthy children as open circles.
CoVSnin was compared by age group and diagnosis, using Mann-Whitney U Test. 
Children with CF had significantly lower CoVsniii than healthy children: (30.6% 
[14.9, 50.7] vs. 45.1% [36.2, 57.9], Z -2.99, p 0.003). There was no significant 
difference in CoVsniii between preschool and school-age children (44.5% [23.8,
53.8], vs. 38.4 [21.2, 56.4], Z -0.6, p 0.6).
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A Bland-Altman comparison of first breath SF6 SnIII results obtained from the first 
two runs (SnIII 1,2) with those obtained from all three runs (SnIIImean) is presented in 
Figure 4.13.
Figure 4.13 Bland-Altman plot of mean first breath SF6 SnIII result 
obtained from two runs, compared with mean first breath SF6 SnIII 
result obtained from three runs, all children
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Legend: SnIII12 = First breath SF5 SnIII result obtained as mean o f first two
runs.
SnIIImean = First breath SF6 SnIII result obtained as mean o f all 
three runs.
Difference calculated as SnIII 12 -  SnIIImean. Children with CF presented as closed 
circles, healthy children as open circles.
There was no significant group difference in first breath SF6 SnIII results obtained 
from two versus three runs, either for the population as a whole, or for the 
preschool, school-age, healthy and CF subgroups. However, it can be seen from
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Figure 4.13 that the data are widely scattered. The data distribution is 
heteroscadastic, i.e. as the mean first breath SnIII increased, so the magnitude of the 
difference between SnIII 1,2 and SnIIImean also increased. However, the polarity of 
this difference was not consistent. The heteroscadastic distribution prevents 
calculation of limits of agreement.
A Bland-Altman comparison of first breath SF6 SnIII results obtained from the first 
run only (SnIII 1) with those obtained from all three runs (SnIIImean) is presented in 
Figure 4.14.
Figure 4.14 Bland-Altman plot of first breath SF6 SnIII result obtained 
from first run, compared with mean first breath SF6 SnIII result 
obtained from three runs, all children
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Legend: SnIII 1 = First breath SF6 SnIII result obtained from first run.
SnIIImean — First breath SF6 SnIII result obtained as mean o f all 
three runs.
Difference calculated as SnIII 12 -  SnUlmean- Children with CF presented as closed 
circles, healthy children as open circles.
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There was no significant group difference in first breath SF6 SnIII results obtained 
from one versus three runs, either for the population as a whole, or for the 
preschool, school-age, healthy and CF subgroups. However, limits of agreement 
were wide. As for Figure 4.13, the data distribution displayed in Figure 4.14 is 
heteroscadastic, and limits of agreement cannot be calculated.
4.6.3 Relationships between first breath SnIII and subject characteristics: 
between subject comparisons
For the 94 subjects who had three first breaths of adequate volume, the mean first 
breath SnIII was calculated from the SF6 trace, and from the He trace. There was 
close correlation between these results (r2 = 0.90, p<0.001, Figure 4.15).
Figure 4.15 mean first breath SF* SnIII plotted against mean first 
breath He SnIII, all subjects
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Legend: Children with CF plotted as closed circles, healthy children plotted as 
open circles. There was close correlation between the SF6 and He results (r2 = 
0.90, p<0.001).
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For all further analyses in this chapter, SF6 data alone are analysed. Further 
comparisons of SF6 and He SnIII are presented in Chapter 6.
Mean first breath SF6 SnIII was related to subject characteristics. Only subjects who 
had three first breaths of adequate volume were included in the analyses presented 
in this section. In healthy children, preschool children had significantly higher first 
breath SF6 SnIII than school-age children (0.46 [0.26] vs. 0.18 [0.12] L"1, mean 
[95% Cl] difference 0.29 L '1 [0.17,0.40, p<0.001]).
In healthy preschool children, by univariate analyses, and by multivariate analysis: 
age, sex, height and weight were not significant predictors of first breath SnIII, 
either independently or in combination (r for multivariate model 0.03, p 0.5).
In healthy school-age children, by univariate analyses, age, height, and weight were 
all significant predictors of first breath SnIII (all negative relationships), whereas 
sex was not a predictor. By multivariate analysis, none of the four variables were 
significant independent predictors of first breath SnIII, and the multivariate model 
was a weak but statistically significant predictor (r2 0.22, p 0.05, model presented in 
the Appendix).
When all healthy children were studied together, with age group also modelled as 
an explanatory variable, none of the five variables were significant independent 
predictors of first breath SnIII. However, the multivariate model was a significant 
predictor (r2 0.38, p<0.001, Table 4.13).
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Table 4.13 Results of multivariate regression against mean first breath 
SnIII in all healthy children
Coefficient (B) Standard Error of B p-value
Constant 1.521 0.540 0.007
Age (years) 0.0533 0.034 0.1
Sex -0.0110 0.058 0.9
Height (cm) -0.0123 0.007 0.08
Weight (kg) 4.16 • 10'4 0.007 1.0
Age-group -0.14 0.113 0.2
Legend: Sex is coded as zero fo r  female, and one for male. Age-group is coded as 
zero for preschool, and one for school-age. By multivariate analysis, none o f the 
variables were independent predictors. The multivariate model was a significant 
predictor o f first breath SnIII (RSD 0.191, r2 0.38, p<0.001).
Results for children with CF are presented in the Appendix. In summary, none of 
the variables were predictors of first breath SF6 SnIII by multivariate analysis. 
Finally, results from all children were modelled together: first without and then with 
diagnosis included as an explanatory variable. The first multivariate model was a 
significant predictor of first breath SF6 SnIII (r2 0.27, p<0.001). Addition of 
diagnosis to the model increased the r2 to 0.33. After correction for other variables, 
diagnosis was the most significant explanatory variable, though height and age were 
also significant predictors (Table 4.14).
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Table 4.14 Results of multivariate regression against mean first breath 
SF6 SnIII in all children, including diagnosis as a predictor
Coefficient (B) Standard Error of B p-value
Constant 1.553 0.507 0.003
Age (years) 0.0744 0.029 0.01
Sex 0.0285 0.054 0.6
Height (cm) -0.0134 0.006 0.04
Weight (kg) -0.0026 0.008 0.7
Age-group -0.143 0.106 0.2
Diagnosis 0.178 0.058 0.003
Legend: Sex is coded as zero for female, and one for male. Age-group is coded as 
zero for preschool, and one fo r school-age. Diagnosis is coded as zero for control, 
and one for CF. By multivariate analysis, the diagnosis o f  CF was the most 
important predictor o f first breath SF6 SnIII, though subject age and height were 
also significant independent predictors. The multivariate model was a significant 
predictor o f first breath SnIII (RSD 0.260, r2 0.33, p<0.001).
The regression coefficient for diagnosis was 0.178, indicating that children with CF 
had a first breath SF6 SnIII 0.178 L '1 higher than healthy children, after adjustment 
for other variables. Further comparison of SnIII results between CF and healthy 
populations is presented in Chapter 6.
4.6.4 Relationships between first breath SF6 SnIII and breath characteristics: 
between subject comparisons
In healthy children, the relationships between first breath SF6 SnIII, and breath 
characteristics were examined for the 171 first breaths that were of adequate 
volume. Figure 4.16 displays the relationship between first breath SF6 SnIII and 
subject age. A negative relationship was noted (r 0.23, p<0.001).
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Figure 4.16 First breath SF6 SnIII plotted against subject age for all
runs in all healthy children
2.0t
1.5-
1. 0 -c
CO<o
LL
CO
JO
•4—'
<D .5- o o
LL o.o-
6 10 12 14 162 8 184
Age (years)
Legend: Only breaths o f  adequate volume are included. There is a negative 
relationship between first breath SF6 SnIII and age (r2 0.23, p<0.001).
Figure 4.17 displays the relationship between first breath SF6 SnIII and breath 
volume. A hyperbolic relationship was noted.
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Figure 4.17 First breath SF6 SnIII plotted against expired volume for all
runs in all healthy children
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Legend: Only breaths o f  adequate volume are included. There is a hyperbolic 
relationship between first breath SF$ SnIII and expired volume.
Figure 4.18 displays the relationship between first breath SF6 SnIII as a product of 
expired volume, and subject age. There was no significant relationship between the 
two variables (r2 0.004, p=0.4).
The relationship between subject characteristics and first breath SF6 SnIII as a 
product of expired volume was examined further by multiple regression in healthy 
children. To allow direct comparison with the regression analysis presented in 
Table 4.13, the first breath SF6 SnIII as a product of expired volume was calculated 
for each run, the mean of the three results was calculated, and this mean was the 
dependent variable for the regression analysis. Only subjects who had three first 
breaths of adequate volume were included in the analysis. None of the five
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explanatory variables (age, sex, height, weight, or age-group) was a significant 
predictor of the mean first breath SF6 SnIII as a product of mean expired volume, 
either independently or in combination (r2 for multivariate model 0.017, p 0.3).
Figure 4.18 First breath SF6 SnIII as a product of expired volume, 
plotted against subject age for all runs in all healthy children
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Legend: Only breaths o f  adequate volume to allow SnIII estimation are included. 
There was no significant relationship between the two variables (r2 0.004, p=0.4).
Finally, the first breath SF6 SnIII as a product of expired volume was calculated for 
breaths that were excluded from the above analyses because of inadequate breath 
volume. Eighteen such breaths were identified in healthy children. The first breath 
SF6 SnIII as a product of expired volume was significantly higher for these 
‘excluded’ breaths than for the 171 ‘included’ breaths that had been considered of 
adequate volume for phase III slope estimation (0.191 [0.115] versus 0.076 [0.042], 
mean difference excluded -  included 0.115 [0.058, 0.173] p=0.001). Figure 4.19
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suggests that for some of these excluded breaths the phase III slope may have been 
estimated correctly, whilst for others the calculated phase III slope was clearly too 
high.
Figure 4.19 First breath SF6 Snlil as a product of expired volume, 
plotted against subject age for all runs in all healthy children, with 
excluded breaths also plotted
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Legend: Breaths that were considered to be o f  inadequate volume for phase III 
slope estimation are presented as closed markers, whilst breaths that were o f  
adequate volume are presented as open markers. There was a significant difference 
between the two groups (see text).
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4.6.5 Relationships between first breath SnIU and breath characteristics: within 
subject comparisons
The relationships between first breath SF6 SnIII and breath characteristics were 
examined further by examining change in SnIII (Alst breath SnIIIi.3), FRC (AFRCi. 
3) and expired volume (Alst breath VeXpi-3) from the first breath of the first run to 
the first breath of the third run, within subjects. A priori primary outcome measures 
were change in value expressed as a percentage. However, the mean value of SnIII 
was so small for healthy children that A1-3 values were very large for some 
children. For one healthy child Alst breath SnIIIi.3 was 2534%. Analyses were 
therefore repeated using absolute change in value between first and third runs as 
outcome measures.
There was no relationship between Alst breath SnIIIi.3 and AFRC1-3 (Figure 4.20).
Figure 4.20 Scatter plot of A1st breath S11III1.3 against AFRC1.3, all 
children
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Legend: Children with CFpresented as closed circles, healthy children presented 
as open circles. There was no relationship between the two variables.
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There was a weak negative relationship between Alst breath SnIII 1.3 and Alst 
breath VeXpi-3 (r2 0 .11 , p 0 .0 0 1 , Figure 4.21).
Figure 4.21 Scatter plot of A1st breath Snllli.3 against A1st breath 
VeXpi-3, all children
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Legend: Children with CFpresented as closed circles, healthy children presented 
as open circles. There was a weak negative relationship between the two variables 
(r2 0.11, p  0.001).
These relationships were explored further by regression analyses, performed 
separately for healthy children and for those with CF. In healthy children, neither 
AFRC1.3, nor Alst breath Vexpi-3 were significant predictors of Alst breath SnIIIi.3, 
either separately, or in combination (r2 for multivariate model 0.01, p 0.3). For 
children with CF, AFRC1.3 was not a significant predictor of Alst breath SnIIIi.3, 
but Alst breath Vexpi-3 was (negative relationship, r2 0.26, RSD 0.240, p<0.001). 
This relationship was not altered by the addition of AFRC1-3 to the regression 
model.
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4.6.6 Effect of small breaths upon the Scond regression
The effect of excluding breaths of inadequate volume upon the calculation of S COnd 
was examined by comparing the fit of the S COnd regression line over 1.5 to 6.0 lung 
volume turnovers before and after the exclusion process. For this analysis, 
exclusion of all small breaths over the Scond regression interval was examined, 
rather than first breaths. Of the 94 children in this analysis, 22 did not have any 
breaths excluded in any of the three runs. The median number of breaths excluded 
over three runs was two (one, six). There was a trend for children with CF to have 
fewer breaths excluded than healthy children (1 vs. 3, Z -1.94, p 0.05), and for 
preschool children to have fewer breaths excluded than school-age children (1.5 vs. 
2, Z -1.46, p 0.2).
Results from SF6 washout are presented in Table 4.15. For all subject groups the 
regression fit, as measured by r2, was significantly better after exclusion of small 
breaths.
Table 4.15 Comparison of fit of S COnd regression from S F 6 washout, 
before and after exclusion of small breaths
Raw r Corrected r2 Z p-value
All children 
(n=94)
0.186 
(0.029, 0.643)
0.410 
(0.055, 0.745)
-4.39 <0.001
All children with CF 
(n=45)
0.551
(0.243,0.761)
0.729 
(0.502, 0.827)
-3.62 <0.001
All healthy children 
(n=49)
0.044 
(0.015, 0.169)
0.090 
(0.017, 0.348)
-2.32 0.02
All preschool 
children (n=47)
0.423 
(0.067, 0.747)
0.552 
(0.128, 0.780)
-2.71 0.007
All school-age 
children (n=47)
0.096 
(0.015, 0.370)
0.254 
(0.033, 0.602)
-3.48 0.001
Legend: Raw r2 calculated from all data. Corrected r2 calculated after excluding 
breaths o f  inadequate volume, r2 results presented as median (IQR). Comparison 
between groups is by Wilcoxon signed ranks test.
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Results from He washout are presented in Table 4.16. For all subject groups the 
regression fit, as measured by r , was better after exclusion of small breaths, though 
this difference was not significant when healthy children were analysed as a 
subgroup.
Table 4.16 Comparison of fit of S COnd regression from He washout, 
before and after exclusion of small breaths
Raw r2 Corrected t1 Z p-value
All children 
(n=94)
0.166 
(0.036, 0.545)
0.269 
(0.059, 0.651)
-4.18 <0.001
All children with CF 
(n=45)
0.523
(0.181,0.721)
0.659 
(0.516, 0.812)
-4.05 <0.001
All healthy children 
(n=49)
0.065 
(0.020, 0.165)
0.075 
(0.023, 0.232)
-1.37 0.17
All preschool children 
(n=47)
0.225 
(0.094, 0.642)
0.546 
(0.130, 0.752)
-3.34 0.001
All school-age children 
(n=47)
0.074 
(0.022, 0.299)
0.154 
(0.028, 0.596)
-2.55 0.01
Legend: Raw r2 calculated from all data. Corrected r2 calculated after excluding 
breaths o f  inadequate volume, r2 results presented as median (IQR). Comparison 
between groups is by Wilcoxon signed ranks test.
The effect of exclusion of small breaths upon the value of S COnd was examined by 
Bland-Altman analysis. A plot of S COnd results obtained from raw S F 6 data with 
those obtained from corrected SF6 data is presented in Figure 4.22. There were no 
significant group differences between S COnd results calculated by the two methods 
(Table 4.17). The majority of children had S condR -  S COndc close to zero. Limits of 
agreement were broad, but this was because of a small number of outliers. There 
was a positive relationship between the difference and the mean for these data. This 
is discussed in Section 4.7.
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Figure 4.22 Bland-Altman plot of S COnd results obtained from raw SF6
data with those obtained from corrected SF6  data
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Legend: S condR =  S cond result obtainedfrom raw data.
Scondc = Scond result obtained from corrected data.
Difference calculated as S condR -  S condc• Children with CF presented as closed 
circles, healthy children as open circles. Two healthy children had S condR less than -  
2, but Scondc o f greater than zero. These two outliers are not displayed on the plot. 
The majority o f  children had S condR -  S C0ndc close to zero, but limits o f  agreement 
were broad, due to the effect o f  outliers. These limits o f  agreement are not therefore 
presented. There is a positive relationship between the difference and the mean for  
these data.
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Table 4.17 Bland-Altman analysis of S COnd results obtained from raw
SF6 data with those obtained from corrected SF6 data
Mean (SD) 
difference
95% Cl of 
difference
All children 
(n=94)
-0.049 (0.591) -0.170, 0.072
All children with CF 
(n=45)
0.033 (0.278) -0.051,0.116
All healthy children 
(n=49)
-0.123 (0.770) -0.344, 0.098
All preschool children 
(n=47)
-0.117(0.830) -0.361,0.127
All school-age children 
(n=47)
0.020 (0.084) -0.005, 0.045
Legend: Difference calculated as ScondR -  Scondo
There was no significant group difference between ScondR and Scondc-
Limits o f  agreement are distorted by outliers, and are not therefore presented.
A plot of Scond results obtained from raw He data with those obtained from 
corrected He data is presented in Figure 4.23. There were no significant group 
differences between Scond results calculated by the two methods (Table 4.18). As for 
the SF6 data, the majority of children had S condR -  S COndc close to zero. Again, 
limits of agreement were broad, but this was because of a small number of outliers. 
There was a positive relationship between the difference and the mean for these 
data. This is discussed in Section 4.7.
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Figure 4.23 Bland-Altman plot of S COnd results obtained from raw He
data with those obtained from corrected He data
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Legend: ScondR = Scond result obtainedfrom raw data.
Scondc = Scond result obtained from corrected data.
Difference calculated as ScondR -  SCOndc Children with CF presented as closed 
circles, healthy children as open circles. Two healthy children had ScondR less than -  
2, but Scondc o f greater than zero. These two outliers (the same children who were 
outliers fo r  SF6 data) are not displayed on the plot. As fo r  the SF6 data (Figure 
4.22), the majority o f  children had ScondR ~ ScondC close to zero, but limits o f  
agreement were broad, due to the effect o f outliers. There is a positive relationship 
between the difference and the mean for these data. Limits o f  agreement are not 
presented, as these are distorted by outliers.
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Table 4.18 Bland-Altman analysis of S COnd results obtained from raw He
data with those obtained from corrected He data
Mean (SD) 
difference
95% Cl of 
difference
All children 
(n=94)
-0.079 (0.778) -0.170, 0.072
All children with CF 
(n=45)
0.017(0.381) -0.097, 0.132
All healthy children 
(n=49)
-0.167(1.012) -0.458, 0.124
All preschool children 
(n=47)
-0.171 (1.091) -0.361,0.127
All school-age children 
(n=47)
-0.014(0.123) -0.022, 0.050
Legend: Difference calculated as ScondR ~ SCOndc-
There was no significant group difference between S COndR and S COndc-
Limits o f  agreement are distorted by outliers, and are not therefore presented.
4.6. 7  Calculation of Scond over 1.5 to 6 turnovers vs. 2.5 to 6 turnovers
Scond results calculated over 1.5 to 6.0 turnovers were compared with results 
calculated over 2.5 to 6.0 turnovers by Bland-Altman analysis, separately for SF6 
and He data. Corrected data (Section 4.6.6) were employed for these analyses. A 
Bland-Altman plot of the SF6 data is presented in Figure 4.24. There were no 
significant group differences between S cond results calculated by the two methods 
(Table 4.19). The majority of children had Scondc -  S COnd2.5 close to zero, with no 
relationship between the difference and the mean.
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Figure 4.24 Bland-Altman plot of SF6 S COnd results calculated over 1.5
to 6.0 turnovers with those calculated over 2.5 to 6.0 turnovers
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Legend:
Scondc = Scond result obtainedfrom corrected data, over 1.5 to 6.0 TO.
SCOnd2.5 = SCond result obtainedfrom corrected data, over 2.5 to 6.0 TO.
Children with CF presented as closed circles, healthy children as open circles. 
Broken lines represent 95% limits o f agreement, calculated as mean +/- 1.96SD, 
from fu ll population (CF and control, see Table 4.19). The majority o f  children had 
SF6 Scondc ~ SCOnd2.5 close to zero, and there was no relationship between the 
difference and the mean.
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Table 4.19 Bland-Altman analysis of SF6 S COnd results calculated over
1.5 to 6.0 turnovers with those calculated over 2.5 to 6.0 turnovers
Mean (SD) 
difference
95% Cl of 
difference
95% limits o f 
agreement
All children 
(n=94)
-0.014(0.104) -0.020, 0.017 -0.220, 0.192
All children with CF 
(n=45)
0.008 (0.100) -0.022, 0.039 -0.190, 0.206
All healthy children 
(n=49)
0.018(0.107) -0.013,0.049 -0.194, 0.230
All preschool 
children (n=47)
-0.018(0.131) -0.021,0.056 -0.277, 0.241
All school-age 
children (n=47)
0.010(0.067) -0.010, 0.030 -0.143,0.123
Legend: Difference calculated as Scondc -  Scond2.5-
There were no significant group differences between SC0ndc and Scond2.5-
There was no relationship between S F 6 Scondc - S COnd2.5 and age (Figure 4.25). 
A Bland-Altman plot of the He data is presented in Figure 4.26.
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Figure 4.25 Difference between SF* Scond results calculated over 1.5 to
6.0 turnovers and those calculated over 2.5 to 6.0 turnovers, plotted 
against age, all children
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Legend:
Scondc ~ Scond result obtained from corrected data, over 1.5 to 6.0 TO.
SCOnd2.5 -  Scond result obtainedfrom corrected data, over 2.5 to 6.0 TO.
Children with CF presented as closed circles, healthy children as open circles. 
Broken lines represent 95%  limits o f  agreement, calculated as mean +/- 1.96SD, 
from fu ll population (CF and control, see Table 4.19). There was no relationship 
between SF6 Scondc - SCOnd2.s and age.
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Figure 4.26 Bland-Altman plot of He S COnd results calculated over 1.5 to
6.0 turnovers with those calculated over 2.5 to 6.0 turnovers
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Legend:
Scondc = Scond result obtainedfrom corrected data, over 1.5 to 6.0 TO.
SCOnd2.5 = Scond result obtainedfrom corrected data, over 2.5 to 6.0 TO.
Children with CF presented as closed circles, healthy children as open circles. 
Broken lines represent 95% limits o f  agreement, calculated as mean +/- 1.96SD, 
from fu ll population (CF and control, see Table 4.20). The majority o f  children had 
He Scondc ~ SCOnd2.5 close to zero. Some children with a high mean Scond appeared to 
have a negative difference, suggesting that the slope o f Scond2.5 is greater than the 
slope o f Scondc for these children. The author is unable to provide an explanation for  
this finding.
There were no significant group differences between S COnd results calculated by the 
two methods (Table 4.20). The majority of children had SC0ndc -  S COnd2.5 close to 
zero. Some children with a high mean S cond appeared to have a negative difference,
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suggesting that the slope of S cond2.5 is greater than the slope of S COndc for these 
children. This is discussed further in Section 4.7. There was no relationship 
between He S C0nd c  -  S COnd2.5 and age (Figure 4.27).
Table 4.20 Bland-Altman analysis of He S COnd results calculated over 
1.5 to 6.0 turnovers with those calculated over 2.5 to 6.0 turnovers
Mean (SD) 
difference
95% Cl of 
difference
95% limits of 
agreement
All children 
(n=94)
-0.001 (0.090) -0.020, 0.017 -0.179,0.177
All children with CF 
(n=45)
-0.006 (0.016) -0.040, 0.026 -0.038, 0.026
All healthy children 
(n=49)
0.004 (0.069) -0.016, 0.024 -0.133, 0.141
All preschool 
children (n=47)
-0.014(0.115) -0.048, 0.020 -0.242, 0.214
All school-age 
children (n=47)
0.012(0.057) -0.005, 0.028 -0.101,0.125
Legend: Difference calculated as SC0ndc -  SCOnd2.5-
There was no significant group difference between Scondc and Scond2.5-
186
Figure 4.27 Difference between He S COnd results calculated over 1 .5 to
6.0 turnovers and those calculated over 2.5 to 6.0 turnovers, plotted 
against age, all children
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Legend:
Scondc = Scond result obtainedfrom corrected data, over 1.5 to 6.0 TO.
SCOnd2.5 =  Scond result obtainedfrom corrected data, over 2.5 to 6.0 TO.
Children with CF presented as closed circles, healthy children as open circles. 
Broken lines represent 95% limits o f  agreement, calculated as mean +/- 1.96SD, 
from fu ll population (CF and control, see Table 4.20). There was no relationship 
between He Scondc - Scond2.5 and age.
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4.7 Discussion
4.7.1 Summary of most important results
In this study, the relationships between subject characteristics, breathing pattern and 
MBW indices were studied. All school-age children were asked to adopt a 
comfortable tidal breathing pattern during three consecutive washouts. Preschool 
children were measured whilst distracted by an entertainment video. In healthy 
children, LCI was remarkably constant across age groups, despite a wide range of 
lung volumes and breathing patterns. When children with CF were included in 
multivariate analyses, the diagnosis of CF was by far the most important 
determinant of LCI. In healthy children, the first breath SnIII was negatively related 
to breath volume, age, and to a lesser extent, to body size. However, if the first 
breath SnIII was expressed as a product of breath volume, then this index was 
independent of subject characteristics (Figures 4.17 and 4.18). When children with 
CF were included in multivariate analyses, diagnosis was the most important 
determinant of first breath SnIII.
The analyses presented in this chapter are pragmatic, i.e. they are based upon data 
that were obtained during normal tidal breathing. These results therefore have 
practical value for the clinical researcher, but it is accepted that further insights into 
physiological mechanisms could be obtained from controlled breathing studies. In 
justification, the primary purpose of this thesis was to explore the use of MBW in 
preschool children, where controlled breathing experiments are impossible.
Analysis of changes observed during spontaneous variation of breathing pattern is 
the only practical approach.
4.7.2 Precision of MBW indices
Precision of LCI was good, with only 10 of 115 children having C oV lci greater 
than 10%. In comparison, the mean CoVsnin in healthy children was 4 5 .1% , and in 
children with CF 30 .6% . This CoVsnin is distorted by the relatively small mean 
values for SnIII, particularly in healthy children. Bland-Altman analyses were 
employed to compare results from one run, and mean results from two runs, with
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the mean results from three runs. The limits of agreement, for the whole population, 
for LC I 12 versus L C Imean were -0.54 and 0.49. I f  the difference in LC I between the 
populations to be studied (e.g. healthy children versus those with CF) is greater than 
0.54, then it is possible to detect these differences using LC I calculated from two 
runs, rather than three. Similar arguments apply to the Bland-Altman analyses 
presented in Table 4.7. This issue will be examined further in Chapters 5 and 6, 
when the MBW results between populations will be presented in more detail.
It is noted at this point that the Bland-Altman relationships for SnIIImean and S n lli^  
and SnIIImean and SnIII] are distributed heteroscadastically. In other words, the 
difference between results obtained by the methods increases as the value of first 
breath SnIII increases. This should be noted when comparing results between 
individuals who have high SnIII.
From the results presented in Figure 4.3, Section 4.5.5, and 4.5.6, it is clear that 
some children have higher LCI results from their third MBW run than from their 
first MBW run. This finding was not consistent between individuals, and a 
significant group difference was only seen in the school-age subgroup (Table 4.19). 
One possible explanation for these results is that school-age children were not given 
sufficient time between the three MBW runs, and so commenced the third run 
without having completely cleared all SF6 inspired during the previous two runs.
4.7.3 Effect of subject characteristics and breathing pattern upon MBW indices
This study has demonstrated that LCI is largely independent of subject 
characteristics and breathing pattern. In healthy children aged two to 16 years, only 
30.2% of the variability of LCI is explained by subject age, sex, height and weight 
(Table 4.8). If children with CF are also included in this multivariate analysis, then 
only 19.1% of the variability of LCI is explained by this model, whilst addition of 
subject diagnosis to the model increases the r2 to 59.3% (Table 4.9). Similar results 
are obtained by multivariate analyses of breathing pattern, with FRC, RRmean,
Vjmean explaining only 5.0% of the variability of LCI in all children (Table 4.14). 
Addition of subject characteristics to this model increased the r2 to 24.8% (Table 
4.15), and addition of diagnosis and subject characteristics increased the r2 to 59.4% 
(Table 4.16).
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The relationship between breathing pattern and LCI was examined further by 
within-subject comparisons (Section 4.5.5). Although a weak negative relationship 
between FRC and LCI was noted, changes in breathing pattern accounted for only 
10.8% of the within-subject variability of LCI.
Similar techniques were employed to study the relationships between subject 
characteristics, breathing pattern, and first breath SnIII. The most important finding 
from these analyses was the negative relationship between SnIII and expired 
volume (Figure 4.18). Multivariate analyses suggest that this relationship is 
responsible for the apparent effect of subject characteristics upon SnIII. When 
subject characteristics were modelled against SnIII in healthy children, 38% of the 
variability of SnIII was explained. However, the product of SnIII and expired 
volume was independent of subject characteristics in healthy children (r2 6%,
Figure 4.20).
4.7.4 How can these results be explained?
Most measures of lung function are partly dependent upon lung (and therefore 
subject) size, and upon breathing pattern. The LCI is calculated in such a way that 
differences in body size, and within subject alterations in FRC and Vr should be 
compensated.
As described previously
LCI=CEV/FRC
Any increase in FRC will increase the volume of tracer gas that needs to be washed 
out of the lung, and thus the CEV (the numerator in this equation) will also be 
increased. Including the FRC as the denominator in the equation to calculate LCI 
should compensate this effect. Any increase in Vt is likely to reduce the number of 
breaths required for the subject to reach the end-point of the washout. However, as 
these breaths will be of larger volume, the CEV should not be affected. Apparatus 
dead-space is subtracted from any calculation of CEV, but airway dead-space is not. 
Any subject who breathes at a very low tidal volume, such that the majority of 
ventilation is directed at airway dead-space may, theoretically, produce a high LCI. 
This effect was not seen in the spontaneously breathing children studied here, 
presumably because none of them spontaneously adopted such a small tidal volume.
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SnIII is the slope of the expired tracer gas concentration versus expired volume 
relationship, over the portion of the expiration that represents expired alveolar gas.
It is therefore expected that there should be a negative relationship between SnIII 
and expired volume. In theory, this would be best corrected by multiplying the SnIII 
by the volume over which it is calculated. However, correcting the first breath SnIII 
by the total first breath expired volume appears to correct for subject characteristics. 
This is investigated in more detail in Chapter 6, and discussed further in Chapter 7. 
It should also be expected that changes in breathing pattern will have physiological 
effects, altering the extent of ventilation inhomogeneity, and thereby impacting 
upon MBW indices. There have been several previous studies of the effect of Vt 
upon ventilation inhomogeneity, but these have produced conflicting results. Some 
studies have suggested that increases in Vt result in decreased inhomogeneity (as 
measured by the phase III slope)67;l 14, whilst others have suggested the reverse115. 
Crawford and colleagues68 proposed that increases in Vt result in an increase in the 
convection-dependent component of ventilation inhomogeneity, but a decrease in 
inhomogeneity arising from interactions between diffusion and convection. This 
hypothesis has been supported by more recent data 46 and could explain 
discrepancies in the literature. It is notable that many of these earlier studies used 
tidal volumes that were outside the normal physiological range. Thus, while 
Crawford and colleagues required healthy adults to breathe at a Vt ranging from 0.6 
to 1.5L (i.e. up to 200% above normal values), the spontaneous within-subject 
changes observed in this study were considerably smaller.
By contrast, the data presented here suggest that spontaneous changes in FRC 
between washouts may have a minor effect upon LCI, with a weak negative 
relationship seen. There are two possible explanations for this finding. Given that 
LCI should be compensated for FRC for each washout, this observation may reflect 
the physiological effects of altering FRC. In other words, when healthy subjects 
breathe at a higher FRC, the ventilation distribution would be expected to become 
more homogenous, and vice versa. Alternatively, these findings may reflect the way 
in which LCI is calculated. Edelman has suggested that in a uniformly ventilated 
lung, an increase in FRC (with no accompanying change in V t)  will produce a 
decrease in LCI due to the relative effect of airway dead-space47.
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Published data on the effect of FRC upon ventilation inhomogeneity are limited, 
because of the difficulty of controlling FRC in the laboratory. One study which 
aimed to investigate the effect of airway closure on ventilation inhomogeneity 
found increasing inhomogeneity below closing volume both for the slope of phase 
III and for alveolar mixing efficiency66. In the range between closing capacity and 
FRC the normalised slope of phase III consistently increased with higher volumes 
while the alveolar mixing efficiency gave more variable results. In the current 
study, spontaneous changes of FRC were much smaller, and it is unlikely that any 
subject was breathing at or below their closing capacity.
No relationship between RR and LCI was seen. It has been shown that breath- 
holding decreases the phase III slope in single breath washouts67, presumably 
because gas mixing continues by diffusion during the pause. Theoretically a faster 
RR would leave less time for gas mixing within small lung units, but within the 
population studied here, spontaneous changes in RR were not sufficient to affect 
LCI.
4.7.5 Exclusion o f  small breaths fo r  S n III analysis
Some breaths were of inadequate volume for estimation of SnIII (Section 2.4.8). 
These breaths were identified by predetermined criteria, rather than by the SnIII 
calculated. Nevertheless, for these breaths, the SnIII was calculated over 65-95% of 
expired volume, and the results recorded to allow comparison with breaths of larger 
volume. The results presented in Section 4.6.1 demonstrate that SnIII calculated 
from breaths of inadequate volume is significantly higher than for breaths of 
adequate volume. The effect of excluding breaths upon the fit of the S cond regression 
was examined by comparison of r2 values. The value of r2 was significantly better 
after exclusion of SnIII results from small breaths, both in healthy children and in 
those with CF. When results calculated by the two methods were compared by 
Bland-Altman analysis, a positive relationship between the difference (raw minus 
corrected) and mean S cond was seen. The explanation for this is that corrected S cond 
values were closer to the group mean results than the corresponding raw S COnd> 
providing further evidence that exclusion of SnIII results from small breaths 
improves the fit of the S COnd regression.
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It is noted that there was a trend for preschool children to have fewer breaths 
excluded than school-age children, and for children with CF to have fewer breaths 
excluded than healthy children. The former trend can be explained by the larger 
deadspace of the mask apparatus, when compared to the facemask apparatus, which 
would be expected to result in an increase in tidal volume116’117. The latter trend 
may be the result of children with CF adopting a higher tidal volume to compensate 
for poorer ventilation distribution or because children with CF are more accustomed 
to following instructions during lung function testing.
4.7.6 Identification of the linear portion of the SnIII versus lung volume turnover 
relationship
The final analyses presented in this chapter examined whether the linear portion of 
the SnIII versus TO relationship commences by 1.5 TO in spontaneously breathing 
children70’71. This was determined by calculating S cond over 1.5 to 6.0 TO and again 
over 2.5 to 6.0 TO. If the linear portion of this relationship commences after 1.5 
TO, then the value for S C0nd c  should be greater than the value of S COnd2.5- No 
significant group differences were seen, but in a small number of children with high 
He S Cond the opposite phenomenon was seen, i.e. the value of S COndc was less than 
the value of S COnd2.5 (Figure 4.27). This pattern was only seen in a very small 
number of children, and the author is unable to provide an explanation for this 
finding.
4.7.7 Conclusion
The results of this analysis are highly encouraging. It has been demonstrated that 
LCI is almost independent of subject characteristics and breathing pattern, and that 
SnIII is dependent upon expired volume, but not upon other subject or breath 
characteristics. It can be concluded that measurements of LCI or SnIII indices can 
be obtained satisfactorily in children during spontaneous tidal breathing without the 
need to control breathing pattern. This finding supports the contention that MBW 
has potential for measurement of lung function in preschool children, where control 
of breathing is not possible.
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Chapter 5: Comparison of washout curve results with 
spirometry results
5.1 Introduction
As described in Chapter 1, regular lung function testing is an essential part of 
clinical care for children with CF. Over the last two decades, there has been a shift 
towards closer monitoring and more aggressive treatment of early CF lung disease 
20-22;i 18^  interest jn monitoring younger patients increases, so does the need for
alternative, more sensitive measures of lung function that can be obtained in 
children of all ages.
The results presented in Chapters 3 and 4 demonstrate that preschool children can 
successfully perform both spirometry and MBW, and that repeatable results can be 
obtained with both techniques. The purpose of this chapter is to compare results 
obtained from washout curve analysis and from spirometry in children with CF and 
in matched healthy children. Results obtained from school-age children and 
preschool children are presented separately.
5.2 Aims and hypothesis
5.2.1 Hypothesis
• More children with CF will have abnormal washout results than will have 
abnormal spirometry results.
5.2.2 Aims
The primary aims of this study were:
a) To investigate the relationship between parameters derived from MBW 
washout curve analysis and from forced expiration in a population of healthy 
British children and children with CF, aged from two to 16 years
b) To compare MBW and spirometry results from school-age British children 
with those recently reported for Swedish children.
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The secondary aims of this investigation were to relate MBW results, obtained in 
children with CF, to clinical status, as measured by past medical history, cough 
frequency, sputum microbiology, and audible signs on chest auscultation.
5.3 Subjects and methods
5.3.1 Subject recruitment
This is described in Section 4.3.1 for school-age children, and Section 3.3.1 for 
preschool children.
5.3.2 Study design
This was a cross-sectional study. All school-age subjects successfully completing 
spirometry and MBW were included in the analyses presented in this chapter. No 
school-age subjects were recalled for a second visit. Preschool subjects were 
participating in a study comparing spirometry, body plethysmography, and MBW 
results. Subjects who did not complete all three measurements were asked to return 
to the laboratory six months after their first visit for repeat measurements. The 
study was continued until 30 subjects with CF and 30 healthy subjects had 
completed all three measurements. MBW results from these 60 children are 
presented in this chapter.
5.3.3 Data collection
Collection and analysis of spirometry data, including criteria for accepting or 
discarding results, and derivation of the indices listed below, are described in detail 
in Chapters 2 and 3. Collection and analysis of MBW data are described in detail in 
Chapters 2 and 4.
5.3.4 Additional clinical information, and recording of clinical data
For both school-age and preschool children with CF, clinical information was 
obtained from three sources. First, the senior paediatrician (consultant) responsible 
for the child’s clinical CF care was sent a questionnaire in the month prior to the 
child’s visit. Second, at the time of visit the child’s parent was asked to complete a
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symptom questionnaire, which was directly administered by the author. Third, the 
child was examined by the author, and data obtained was analysed. The 
questionnaires differed for school-age and preschool children, and are presented in 
Appendices E. Some of the data collected were to aid future analyses, and will not 
be presented in this thesis. Those data that were required for the current study are 
highlighted below:
Consultant questionnaire fo r  school-age children with CF
• Presence of chronic respiratory infection with Pseudomonas aeruginosa, 
Stenotrophomonas maltophilia, Staphylococcus aureus, or Haemophilus 
influenzae. Chronic infection was defined as three positive cultures over the 
previous six months, each at least one month apart.
Parent questionnaire for school-age children with CF
• Cough frequency over the week prior to testing, classified as never, 
intermittent (less than once daily) or every day.
Clinical examination in school-age children
• Presence of wheeze or crackles on chest auscultation was recorded. 
Consultant questionnaire for preschool children with CF
• Whether the child had ever grown Pseudomonas aeruginosa, 
Stenotrophomonas maltophilia, Staphylococcus aureus, or Haemophilus 
influenzae, on respiratory culture
• Whether the child was still considered to be infected with these organisms 
(with current bacterial infection defined as at least one positive culture of an 
organism from the three most recent samples prior to lung function testing)
• Whether the child had had a chest radiograph, chest computed tomogram, 
or ventilation scan previously, and whether the results had been normal or 
abnormal
• The consultant was asked to complete two visual analogue scores. The first 
was based upon their assessment of the child’s clinical course from birth to 
the time of assessment, with rating from zero (very mild disease) to 10 
(very severe disease). The second was based upon their assessment of the 
child’s respiratory status at the time of assessment, rated from zero (normal) 
to 10 (severely abnormal).
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Parent questionnaire for preschool children with CF
• Cough frequency over the week prior to testing, classified as present or 
absent.
Clinical examination in preschool children
• Presence of wheeze or crackles on chest auscultation was recorded
• At conclusion of assessment, but prior to lung function testing, the author 
rated the child’s clinical status on a visual analogue scale, rated from zero 
(mild lung disease) to 10 (severe lung disease). This assessment was based 
upon responses to the symptom questionnaire, and upon findings on clinical 
examination.
Consultant questionnaires were returned directly to a department secretary (Ms L 
Robinson), and were not seen by the author until November 2003, by which time 
all lung function parameters had been calculated.
Parents of control children also completed symptom questionnaires, and the 
children were examined by the author. The purpose of this assessment was to 
ensure that these children were healthy.
Clinical data from school-age children were transferred manually to a SPSS data 
file (Statistical Program for Social Sciences, SPSS Inc, Chicago, USA) by the 
author. Following all data entry, data were verified by selecting a sample of 10 
cases and cross-checking values entered on the SPSS file against those recorded on 
the original questionnaires.
Clinical data from preschool children were entered into an Access relational 
database (Microsoft Corporation, Redmond, WA, USA) by C Saunders and W 
Kozlowska. Administration (i.e. appointments, chasing up consultant 
questionnaires, sending out results etc.) was performed by Ms L Robinson, 
following protocols written by the author (Appendices I). Results were sent to 
consultants and GPs, and also explained to parents (Appendices J and K).
5.3.5 Ethics
The study was approved by the North Thames Region Multicentre Research Ethics 
Committee, and by the Local Research Ethics Committees of each of the five 
collaborating centres.
197
5.4 Analysis
5.4.1 Outcome measures
FRC and LCI were calculated for each washout. For each parameter, the mean and 
SD from the three recordings was then calculated for each subject. Spirometry 
curves were visually inspected and passed or rejected (Chapter 3, Section 3.5.2). 
For school-age subjects, the highest FEVj recorded from any acceptable curve was 
reported for each child. The M EF25 was calculated from the curve that had the 
highest sum of FV C  and F E V j. M M EF was not reported in school-age subjects, as 
there are no published reference data for M M EF in healthy British schoolchildren. 
For preschool subjects, the highest FEVj and FE V 0.5 recorded from any acceptable 
curve were reported from each child, and the M M EF was calculated from the curve 
with the highest sum of FVC and FE V 0.75. For the analyses in preschool children, 
FE V 0.5 was considered a primary outcome variable and FEVj a secondary outcome 
variable.
Height, weight, F E V i; M EF25, FE V 0 5, and M M EF results were converted into 
standard deviation scores (z-scores) using published reference data24;40;119;120.
5.4.2 Comparison with previously published data in school-age children 
Results obtained from school-age children in this study were compared with data 
previously collected in Swedish school children27. These data were collected at the 
Department of Pediatrics, Central Hospital, Skovde, Sweden, using an identical 
MBW apparatus and analysis system to that employed at the Institute of Child 
Health. Data from the Swedish laboratory were obtained directly from the lead 
investigator of the Swedish research group: Dr P Gustafsson. The Swedish group 
tested healthy children and children with CF aged from three to 18 years, using a 
facemask apparatus for children aged six years and younger. For the current 
analysis, only data from Swedish children aged 16 or younger who had performed 
MBW using a mouthpiece apparatus were included.
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5.4.3 Statistical analysis
Analyses were first performed separately for school-age and preschool populations. 
LCI and spirometry parameters were plotted against age, and against each other.
LCI and spirometry z-scores for the CF and control groups were compared. Limits 
of Normality, defined as mean +/- 1.96 SD were calculated for LCI from the control 
data, and subjects with a LCI above the upper limit of normality were categorised as 
having an abnormal result. Subjects with a FEVj, MEF25, FEV0.5, or MMEF z-score 
less than -1.96 were classified as having an abnormal result.
Group results are presented as mean (SD). Group comparisons were by t-test or 
Chi2 test as appropriate. 95% Cl for difference of means is presented for t-test 
results. A p-value below 0.05 was regarded as statistically significant.
Sensitivity and specificity were determined by cross tabulation, and by calculation 
of the area under Receiver-Operator Characteristic (ROC) curves. This was 
performed by calculating sensitivity and specificity for detecting the diagnosis of 
CF for all values of LCI, FEVi z-score, and M E F 2 5  z-score, plotting the sensitivity 
against 1- specificity for each measure, and calculating the area under this curve 
(AUC). A measure that discriminates between two groups with perfect sensitivity 
and specificity will have an AUC of 1.0. A measure that does not discriminate at all 
will have an AUC of 0.5. For children with CF, lung function results were 
compared with clinical information. Finally LCI and FEVi results were compared 
for CF and control groups for preschool and school-age children together.
5.4.4 Power o f  study
a) School-age children: normal values for LCI are known to be age-
O'!independent in healthy school-age children (Chapter 4). Reference 
equations for FEVi and MEF25, which allow correction for sex and height, 
are well established120. Having corrected for age, sex and height, a sample 
size of 2 2  subjects in each group is sufficient to detect a difference of one 
SD in LCI, FEVi z-score, and MEF25 z-score, between CF and control 
groups, or between children measured at the Institute of Child Health and 
those measured in Skovde, with 90% power at the 5% significance level.
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b) For preschool children, a sample size of 50 subjects in each group was 
initially calculated to be sufficient to detect a difference of 0.5 SD in FEV0.5, 
MMEF, and LCI between CF and control groups. Interim analysis 
performed in 2 0 0 2 114,123 indicated that the difference between populations 
for the primary outcome measures was likely to be greater than 0.5 SD, and 
the required sample size was therefore recalculated as 30 subjects per group.
5.5 Results in school-age children
5.5.1 Subjects
Details of the 55 children included in this analysis are presented in Chapter 4,
section 4.5.1.
5.5.2 Comparison o f  Lung Function results fo r  CF and control groups
Table 5.1 presents results for LCI, FEVi z-score, and MEF25 z-score, analysed by
diagnosis.
Table 5.1 Comparison of MBW and spirometry results for CF and 
control groups
CF Controls Mean difference 
(95% Cl of difference)
LCI 11.53 (2.86) 6.45 (0.49) 5.08 (4.07, 6.10)***
FEVi z-score -2.01 (1.45) 0.28 (0 .8 6 ) -2.29 (-2.92,-1.67)***
MEF25 z-score -1.90 (0.76) -0.06(1.06) -1.83 (-2.36,-1.31)***
Legend: Group results presented as mean (SD) *** p<0.001. Difference calculated 
as CF -  control.
For all parameters the difference between the two subject groups was highly 
significant. For LCI the upper limit of normality (ULN) was calculated as 7.41, and 
lower limit of normality (LLN) 5.49. Figure 5.1 shows the relationship between LCI 
and age for the control subjects and the children with CF. LCI was almost age
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independent in healthy children, and rose with age in children with CF (r 0.30,
p=0.008).
Figure 5.1 LCI plotted against age, school-age children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles.
Broken lines represent limits o f  normality for LCI. Note that normal values for LCI 
are age-independent.
5.5.3 Sensitivity and specificity o f LCI and spirometry parameters 
Receiver-Operator Characteristic curves (ROC curves) for LCI, FEVi z-score and 
MEF25 z-score are presented in Figure 5.2.
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Figure 5.2 Receiver-Operator Characteristic (ROC) curves for Lung 
Clearance Index, FEVi z-score, and MEF25 z-score for school-age 
children
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L e g e n d :  T he o u tc o m e  v a r ia b le  is  th e  d ia g n o s is  o f  c y s t ic  f ib r o s is .
R O C  c u rv e  f o r  L C I  is  p r e s e n te d  in  red , R O C  c u r v e  f o r  M E F 25  is  p r e s e n te d  in  b lu e , 
a n d  R O C  c u rv e  f o r  F E V i is  p r e s e n te d  in  g reen .
The area under the Receiver-Operator Characteristic curve (A U C ro c) for each 
parameter is presented in Table 5.2. All LCI, FEVi and MEF25 results were 
classified as normal or abnormal, as described in Section 5.4.3. Sensitivity and 
specificity of each lung function parameter were calculated from this classification, 
and are also presented in Table 5.2. LCI was more sensitive at discriminating CF 
from control children than either FEVi or MEF25, and had higher A U C ro c  than 
either spirometry parameter.
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Table 5.2 Sensitivity, Specificity, and area under the ROC curve for 
LCI, FEVi, and MEF25
Sensitivity Specificity AUCroc
LCI 95% 97% 0.997
FEVi 50% 100% 0.910
MEF25 45% 100% 0.937
Legend: The outcome variable is the diagnosis o f  cystic fibrosis.
Limits o f normality for calculation o f sensitivity and specificity are defined as 1.96 
SD from mean.
A U C roc  = Area under the Receiver-Operator Characteristic curve.
5.5.4 Relationship between LCI and spirometry parameters
Figure 5.3 demonstrates the relationship between LCI and FEVi for both subject 
groups. In healthy children, there was no relationship between LCI and FEVi. In 
children with CF, LCI and FEVj were negatively correlated (r2 0.63, p<0.001). 
Figure 5.3 also shows that 11 of 22 children with CF had a FEVi within the normal 
range, with some of these children having a FEVi z-score greater than zero. In 
comparison, only one of the 22 children with CF had a normal LCI.
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Figure 5.3 Lung Clearance Index plotted against FEVi z-score
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. Vertical broken line represents lower limit o f  normality 
fo r FEVi z-score. Horizontal broken line represents upper limit o f  normality for  
LCI. Note that many children with CF have FEVi z-score within normal range and 
LCI above normal range.
Figure 5.4 demonstrates the relationship between LCI and M E F 2 5  for both subject 
groups. In healthy children, there was no relationship between LCI and M E F 2 5 . In 
children with CF, LCI and M E F 2 5  were negatively correlated (r2 0.46, p=0.001). 
Figure 5.4 also shows that 12 of the 22 children with CF had a M E F 2 5  result in the 
normal range, though none had a M E F 2 5  z-score greater than zero.
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Figure 5.4 Lung Clearance Index plotted against MEF2 5  z-score
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. Vertical broken line represents lower limit o f  normality 
fo r MEF25. Horizontal broken line represents upper limit o f normality for LCI. Note 
that many children with CF have MEF25 z-score within normal range and LCI 
above normal range.
5.5.5 Relationship between Lung Function Parameters and Clinical Information
Of the 22 children with CF, 10 had chronic respiratory infection with Pseudomonas 
aeruginosa, of whom one was also chronically infected with Stenotrophomonas 
maltophilia. Of the remaining 12 children, five were chronically infected with 
Staphylococcus aureus, one was chronically infected with Haemophilus influenzae, 
and two were chronically infected with both organisms. Four children had no 
evidence of chronic infection with any CF pathogen. The children infected with 
Pseudomonas were significantly older than the other children, with mean age 
difference 3.3 years (0.79, 5.9 years).
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Children infected with Pseudomonas aeruginosa tended to have higher LCI, lower 
FEV i z-score, and lower MEF25 z-score than those not infected with this organism, 
but none of these differences were statistically significant (Table 5.3).
Table 5.3 Comparison of MBW and spirometry results for children with 
CF chronically infected and not chronically infected with 
Pseudomonas aeruginosa
Pseudomonas
positive
(n=10)
Pseudomonas
negative
(n=12)
Mean difference 
(95% Cl of difference)
LCI 12.8(2.7) 10.5 (2.7) 2.3 (0.0, 4.7)<)>
FEVi z-score -2.40(1.17) -1.70(1.63) -0.70 (-1.99, 0.59)
MEF25 z-score -2.03 (0.70) -1.79 (0.81) -0.24 (-0.92, 0.44)
Legend: Results are presented as mean (SD).
Difference is calculated as C F - control 
<(> p  = 0.053
Of the 22 children with CF, 15 reported coughing at least once daily during the 
week prior to assessment, four reported no cough during this week, and three had 
coughed, but less frequently than once daily. Children who coughed at least once 
daily tended to have higher LCI, lower FEVi z-score, and lower MEF25 z-score than 
those who coughed less frequently, but none of these differences were statistically 
significant (Table 5.4).
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Table 5.4 Comparison of MBW and spirometry results for children with 
CF according to frequency of cough in the week prior to assessment
Daily cough Cough less than Mean difference
(n=15) once daily (95% Cl of difference)
 (2=2)________________________________
LCI 12.2 (2.7) 10.1 (2.8) 2.1 (-0.5,4.7)
FEV, z-score -2.39 (1.43) -1.20 (1.21) -1.19 (-2.50,0.11)
MEF25 z-score -2.01 (0.83) -1.64(0.52) -0.37(1.09,0.35)
Legend: Results are presented as mean (SD).
Difference is calculated as Daily cough -  Cough less than once daily.
Of the 22 children with CF, nine had audible crackles on chest auscultation, whilst 
13 had no abnormal chest sounds. Children who had audible crackles tended to 
have higher LCI, lower FEVi z-score, and lower MEF25 z-score than those who had 
no audible crackles, but none of these differences were statistically significant 
(Table 5.5).
Table 5.5 Comparison of MBW and spirometry results for children with 
CF according to presence of audible crackles on chest auscultation
Audible No audible Mean difference
crackles crackles (95% Cl of difference)
____________________ (Ez?)__________ (n=13)______________________________
LCI 12.9(3.2) 10.6(2.2) 2.3 (-0.1,4.8)
FEVi z-score -2.38 (1.47) -1.76 (1.44) -0.62 (-1.94, -0.69)
MEF25 z-score -2.19 (0.84) -1.69 (0.64) -0.50 (-1.16, -0.16)
Legend: Results are presented as mean (SD).
Difference is calculated as audible crackles -  no audible crackles.
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5.5.6 Comparison o f  results obtained a tlC H  with those previously reported from  
the Department o f  Pediatrics, Central Hospital, Skovde, Sweden
Data collected in school-age children tested in Skovde, Sweden were obtained from 
Dr P Gustafsson, as described in Section 5.4.2. LCI, F E V i ,  and M E F 2 5  data from 24 
healthy children aged 7.6 to 15.7 years, and 31 children with CF, aged 7.3 to 16.9 
years were available. When reporting these data Dr Gustafsson calculated predicted 
values for F E V i  and M E F 2 5  from prediction equations derived from healthy 
Swedish children, published in 1980 by Solymar et al121. Prior to comparing results 
obtained in Skovde with those obtained in the current study it was necessary to 
compare F E V i  and M E F 2 5  z-scores derived from the prediction equations of 
Solymar et alm , with those derived from the prediction equations of Rosenthal et
1 jri
al , in the healthy Swedish children. These results are presented in Table 5.6.
Table 5.6 FEVi and MEF25 z-scores for healthy children measured in 
Skovde, Sweden, calculated from Swedish and UK reference equations
Mean (SD) 95% Cl of difference
FEVi z-score 
(Solymar)
-0.39 (0.90) -0.77, -0.01*
FEVi z-score 
(Rosenthal)
0.35 (0.88) -0.02, 0.73
MEF25 z-score 
(Solymar)
-0.80(1.49) -1.43,-0.17*
MEF25 z-score 
(Rosenthal)
0.04(1.07) -0.41, 0.49
Legend: Z-scores calculatedfrom reference equations derived from healthy 
Swedish children, published by Solymar et al121 (labelled Solymar), and from  
reference equations derived from healthy British children, published by Rosenthal
170et al (labelledRosenthal). Analysis is by one-sided t-test, against zero. *p<0.05
Mean z-scores for the Swedish control population should be zero, with a standard 
deviation of one, for all parameters, provided that equipment and methodology are 
similar to that used by previous groups; that the control population is similar to
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those from whom the reference equations were derived; and that the equations 
describe the data accurately. The prediction equations were tested by one-sided t- 
test against zero.
Mean z-scores for FEVi and MEF25 derived from the prediction equations o f  
Solymar et al were significantly lower than zero. Z-scores for FEVi derived from 
the prediction equations o f  Rosenthal et al were higher than zero (though this 
difference was not significant), whilst MEF25 z-scores derived from Rosenthal 
equations were not significantly different from zero. For all further analyses 
presented in this section z-scores for FEVj and MEF25 derived from the prediction 
equations o f  Rosenthal et al were em ployed for both the Swedish and the British 
study populations.
Table 5.7 and Figure 5.5 present comparisons o f  results obtained in healthy children 
in the current study with those previously obtained in healthy children tested in 
Sweden.
Table 5.7 Comparison of results obtained from healthy children at ICH 
with those previously obtained from healthy children tested in Sweden
ICH
(n=33)
Skovde
(n=24)
Mean difference 
(95% Cl of difference)
Age (years) 11.3 (3.2) 11.4 (2.2) -0.1 (-1.6, 1.4)
Weight (kg) 41.1 (14.7) 40.3(11.7) 0.8 (-6.5, 8.1)
Height (cm) 147.4(18.3) 148.6(13.0) -1.2 (-10.0, 7.6)
LCI 6.4 (0.5) 6.3 (0.5) 0.1 (-0.1, 0.4)
FEVi z-score 0.28 (0 .86) 0.35 (0.88) -0.07 (-0.54, 0.39)
MEF25 z-score -0.06(1.06) 0.04(1.07) -0.1 (-0.68, 0.48)
Legend: Results presented as mean (SD) unless otherwise indicated. Comparison 
between groups is by t-test, difference calculated as ICH  - Sweden.
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Control populations from the two centres were well matched for age, height and 
weight. Normal values for LCI, FEVi z-score, and MEF25 z-score obtained in the 
two centres were identical.
Figure 5.5 Lung Clearance Index plotted against age for healthy 
children measured at ICH and in Sweden
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Legend: Healthy children measured at ICH presented as closed circles, and healthy 
children measured in Sweden presented as open triangles. Broken lines represent 
limits o f normality for LCI, calculatedfrom ICH data.
Table 5.8 and Figure 5.6 present comparisons of results obtained in the current 
study with those previously obtained in school-age children with CF tested in 
Sweden. CF populations from the two centres were well matched for age. The 
population tested at ICH tended to be shorter and lighter than the population tested
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in Sweden. The population tested at ICH had significantly higher LCI, and 
significantly lower F E V i  and M E F 2 5  z-scores than the population tested in Sweden.
Table 5.8 Comparison of results obtained from children with CF at ICH 
with those previously obtained from children with CF tested in Sweden
ICH
(n=22)
Gothenburg
(n=31)
Mean difference 
(95% Cl of difference)
Age (years) 11.5 (3.2) 11.7 (2.7) -0.2 (-1.9, 1.4)
Weight (kg) 36.9(11.8) 41.2(16.4) -4.3 (-12.5,3.9)
Height (cm) 142.5(18.6) 148.6(16.6) -6.1 (-15.9,3.7)
LCI 11.5 (2.9) 8.3 (2.9) 3.2 (1.6, 4.8)***
FEVj z-score -2.01 (1.45) -0.54(1.73) -1.47 (-2.38, -0.57)**
MEF25 z-score -1.89 (0.75) -0.87(1.14) -1.02 (-1.58, -0.46)**
Legend: Results presented as mean (SD) unless otherwise indicated. Comparison 
between groups is by t-test, difference calculated as ICH  - Sweden.
**p<0.01
***p<0.001
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Figure 5.6 Lung Clearance Index plotted against age for children with
CF measured at ICH and in Sweden
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Legend: Children with CF measured at ICH presented as closed circles, and 
children with CF measured in Sweden presented as open triangles. Broken lines 
represent limits o f  normality for LCI, calculatedfrom ICH data.
Figure 5.7 demonstrates the relationship between LCI and FEVi for both healthy 
and control children tested at both centres. In healthy children, there was no 
relationship between LCI and FEVi. In children with CF, LCI and FEVi were 
negatively correlated (r2 0.64, p<0.001). LCI results were classified as normal or 
abnormal based upon an ULN of 7.41. Thirty-six of 53 children with CF had a 
FEVi within the normal range. In comparison, only 19 of the 53 children with CF 
had a normal LCI.
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Figure 5.7 Lung Clearance Index plotted against FEVi z-score for
healthy children and children with CF measured at ICH and in Sweden
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Legend: Control children measured at ICH presented as open circles, control 
children measured in Sweden as open triangles, children with CF measured at ICH  
presented as closed circles, and children with CF measured in Sweden as closed 
triangles. Vertical broken line represents lower limit o f normality for FEVi z-score. 
Horizontal broken line represents upper limit o f normality fo r LCI, calculatedfrom 
ICH data. Note that many children with CF have FEVi z-score within normal range 
and LCI above normal range.
Figure 5.8 demonstrates the relationship between LCI and M E F 2 5  for both healthy 
and control children tested at both centres. In healthy children, there was no 
relationship between LCI and M E F 2 5 . In children with CF, LCI and M E F 2 5  were 
negatively correlated (r2 0.50, p<0.001). Thirty-eight of the 53 children with CF had 
a M E F 2 5  result in the normal range.
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Figure 5.8 Lung Clearance Index plotted against MEF2 5  z-score for
healthy children and children with CF measured at ICH and in Sweden
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Legend: Control children measured at ICH presented as open circles, control 
children measured in Sweden as open triangles, children with CF measured at ICH  
presented as closed circles, and children with CF measured in Sweden as closed 
triangles. Vertical broken line represents lower limit o f normality for MEF25 z- 
score. Horizontal broken line represents upper limit o f normality for LCI, 
calculated from ICH data. Note that many children with CF have MEF25 z-score 
within normal range and LCI above normal range.
5.6 Results in preschool children
5.6.1 Subjects
Details of the preschool children included in this study are presented in Chapter 4, 
Section 4.5.1.
214
5.6.2 Comparison of Lung Function results for CF and control groups
As the first step in these analyses, z-scores for FEV0.5, MMEF, FVC, and FRC were 
calculated from data obtained in healthy preschool children. These scores were 
based upon regression of lung function parameters against height (Table 5.9).
Table 5.9 Regression of lung function parameters against subject 
height
Constant Coefficient (B) SE (B) RSD
F E V 0 .5  (L) -0.671 0.0144 0.003 0 .1 1 0
MMEF (L-sec1) -0.319 0.0151 0.009 0.380
F V C  (L) -1.654 0.0257 0.003 0.125
F R C  (L) -1.383 0.0186 0.003 0.116
Legend: SE (B) = standard error o f the coefficient.
RSD = residual standard deviation for the regression.
This table allows calculation o f z-scores for lung function parameters, as follows: 
Predicted value for parameter can be obtained from the equation 
Predicted value = Constant + (height[cm] • B)
Standard deviation score (Z score) can be calculatedfrom the equation 
Z-score -  (Observed value -  Predicted value) • RSD'1 
Addition o f subject sex and weight to each o f these models had no significant effect 
upon model fit.
Addition of sex or weight to these models did not significantly affect model fit.
LCI was almost independent of height, weight, and sex in healthy children (Chapter 
4), so z-scores were not calculated for this parameter.
Results for LCI, FRC z-scores, and spirometry z-scores, analysed by diagnosis, are 
presented in Table 5.10. Z-scores were calculated from local data (Table 5.9), and 
also from published reference equations.
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Table 5.10 Lung function test results compared by diagnosis, 
preschool children.
CF
(n=30)
Healthy controls 
(n=30)
Mean difference 
(95% Cl for difference)
LCI 9.61 (2.19) 6.89 (0.44) 2.72(1.90,3.54)***
FEV0.5 z-score (ICH) -0.76(1.31) 0.00(1.00) -0.76 (-1.37, -0.16)*
MMEF z-score 
(ICH)
-0.45(1.15) 0.00(1.00) -0.45 (-1.00, 0.11)
FVC z-score (ICH) -0.27(1.6) 0.00(1.00) -0.27 (-0.97, 0.42)
FRC z-score (ICH) -0.16(0.80) 0.00(1.00) -0.16 (-0.64, 0.30)
FEV0.5 z-score 12 -0.58(1.0) -0.09 (0.80) -0.49 (-0.95, -0.03)*
MMEF z-score9 -0.97(1.75) -0.27(1.61) -0.70 (-1.57, 0.16)
FVC z-score9 -0.87(1.75) -0.68(1.04) -0.19 (-0.93, 0.56)
FRC z-score -1.34 (0.53) -1.14(0.83) 0.19 (-0.17, 0.55)
Legend: Comparison between groups is by t-test, and difference is calculated as 
CF-control. Parameters labelled ICH represent z-scores calculated from the 
current control population.
* p<0.05 ,  ***p< 0 .0 0 1
Children with CF had significantly higher LCI than healthy children (p<0.001), and 
significantly lower FEV0.5 z-scores (p<0.05), irrespective of whether local controls 
or published reference equations were employed for calculation of z-scores. 
Children with CF tended to have lower MMEF than control children, though this 
did not reach statistical significance. There was little difference in FVC or FRC 
results between the two groups. For LCI in preschool children the upper limit of 
normality (ULN) was calculated as 7.76, and lower limit of normality (LLN) 6.02. 
It is also noted that for healthy children, z-scores for FVC calculated from 
Indianapolis reference data, and FRC z-scores calculated from French data are 
lower than zero. Possible reasons for these results are discussed in Section 5.7.
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The relationship between LCI and age is presented in Figure 5.9. As for healthy 
school-age children, LCI was virtually age independent in healthy preschool 
children. In contrast with school-age children with CF, where a positive relationship 
between LCI and age was seen, there was no relationship between LCI and age in 
preschool children with CF.
Figure 5.9 Relationship between LCI and age in preschool children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. Broken lines represent limits o f  normality for LCI. Note 
that normal values for LCI are age-independent. There is no relationship between 
LCI and age in healthy children, or in children with CF.
The relationship between F E V 0 .5  and age is presented in Figure 5.10. For this 
Figure, and for all further analyses presented in this chapter, the F E V 0 .5  z-scores 
presented are those calculated from the control subjects tested for this study. Note 
that there is no relationship between F E V 0 .5  z-score and age in children with CF.
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Figure 5.10 Relationship between FEV0 .5  and age in preschool children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. Broken lines represent limits o f normality for FEV0.5 z- 
score, calculated as +/-1.96 z-scores. Z-scores are corrected for height, so the lack 
o f relationship between FEV0.5 z-score and age in healthy children is expected. It 
should be noted that there is also no relationship between FEV0.5 z-score and age in 
children with CF.
Figure 5.11 presents the relationship between MMEF z-scores and age. For this 
Figure, and for all further analyses presented in this chapter, the MMEF z-scores 
presented are those calculated from the control subjects tested for this study. Note 
that there is no relationship between MMEF z-score and age in children with CF.
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Figure 5.11 Relationship between MMEF and age in preschool children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. Broken lines represent limits o f normality fo r MMEF z- 
score, calculated as + /-1.96 z-scores. Z-scores are corrected for height, so the lack 
o f relationship between MMEF z-score and age in healthy children is expected. It 
should be noted that there is also no relationship between MMEF z-score and age 
in children with CF.
As there was little difference in FVC or FRC results between CF and control 
groups, the age relationships of these parameters are not presented here.
5.6.3 Sensitivity and specificity o f  LC I and spirometry parameters
The area under the Receiver-Operator Characteristic curve (A U C r o c )  for each 
parameter is presented in Figure 5.12 and Table 5.11.
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Figure 5.12 Receiver-Operator Characteristic (ROC) curves for Lung 
Clearance Index, FEV0.5 z-score, and MMEF z-score for preschool 
children
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L e g e n d :  The o u tc o m e  v a r ia b le  is  th e  d ia g n o s is  o f  c y s t ic  f ib r o s is .
R O C  c u rv e  f o r  L C I  is  p r e s e n te d  in  red , R O C  c u rv e  f o r  M E F 25  is  p r e s e n te d  in  b lu e, 
a n d  R O C  c u rv e  f o r  F E V i is  p r e s e n te d  in  g re e n .
All LCI, FEV0.5 and MMEF results were classified as normal or abnormal, as 
described in Section 5.4.3. Sensitivity and specificity of each lung function 
parameter were calculated from this classification, and are also presented in Table 
5.11. As for school-age children, LCI was more sensitive at discriminating CF from 
control children than spirometry parameters.
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Table 5.11 Sensitivity and specificity of LCI, FEV0.5, and MMEF for 
distinguishing CF and control groups.
Sensitivity Specificity AUCroc
LCI 77% 100% 0.95 (0.03)***
FEV0.5 7% 100% 0.66 (0.07)*
MMEF 27% 80% 0.62 (0.07)
Legend: Sensitivity and specificity defined by cut-offs o f  greater than 1.96 z-scores 
for LCI, and less than -1.96 z-scores for FEV0.5 and MMEF.
A U C roc = Area under the Receiver-Operator Characteristic curve.
A U C roc presented as area (SE), where area o f 1.0 represents perfect 
discrimination, and area o f 0.5 represents no discrimination.
*p<0.05, ***p<0.001, where null hypothesis is that A U C roc = 0.5.
5.6.4 Relationship between LCI and spirometry parameters 
Twenty-two of the 30 children with CF had abnormal LCI. Two children with CF 
had an abnormal FEV0.5 (Figure 5.13), and four had an abnormal MMEF (Figure
5.14), all of whom also had an abnormal LCI. None of the children with CF had 
abnormally raised FRC.
In children with CF, weak, but statistically significant correlations between lung 
function parameters were noted. LCI was negatively correlated with F E V 0 .5  (r2 = 
0.21, p=0.01), and MMEF (r2 = 0.28, p=0.003). As for school-age children, there 
was no correlation between LCI and spirometry parameters in healthy children.
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Figure 5.13 Lung Clearance Index plotted against FEV0 .5  z-score in
preschool children
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Legend: Open circles represent healthy children, and closed circles represent 
children with CF. Broken lines represent 95% limits o f  normality, calculated as 
-1.96 z-scores for FEVq.s, and 6.89 + 1.96 • 0.44 for LCI.
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Figure 5.14 Lung Clearance Index plotted against MMEF z-score in
preschool children
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Legend: Open circles represent healthy children, and closed circles represent 
children with CF. Broken lines represent 95% limits o f  normality, calculated as - 
1.96 z-scores for MMEF, and 6.89 + 1.96 • 0.44 for LCI.
5.6.5 Relationship between lung function parameters and clinical information in 
preschool children
Of the 30 children with CF, 22 were homozygous for the AF508 mutation, and eight 
had one AF508 mutation, plus one other. Of these eight children, three had an 
unidentified mutation, and one each had 1717-1G-A; G551D; 1898+1G-A; 
N1303K; and AI507. Fourteen of these children presented with respiratory 
symptoms, whilst the other 16 presented with gastrointestinal symptoms (failure to 
thrive, meconium ileus, or rectal prolapse). Children with respiratory presentations
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were significantly taller, and tended to be heavier than children with gastrointestinal 
presentations, but there was no significant differences in lung function results 
between the two groups (Table 5.12).
Table 5.12 Lung function results in preschool children with CF, 
analysed by mode of presentation
Resp
(n=14)
GI
(n=16)
Mean difference 
(95% Cl for difference)
LCI 9.63 (2.41) 9.58 (2.07) 0.05 (-1.63, 1.72)
FEV0.5 z-score -0.79(1.33) -0.74(1.33) -0.06 (-1.05, 0.94)
MMEF z-score -0.51 (1.26) -0.39(1.08) -0.12 (-1.00, 0.75)
Age (years) 4.29 (0.71) 4.56 (0.82) -0.27 (-0.84, 0.31)
Weight z-score 0.46(1.22) -0.17(0.86) 0.63 (-0.15, 1.41)
Height z-score 0 .2 2 (1.21) -0.62 (0.99) 0.84 (0.02, 1.67)*
Legend: Resp -  respiratory presentation; GI = gastrointestinal presentation. 
Comparison between groups is by t-test, and difference is calculated as resp -  GI. 
*p<0.05
Mothers of six of the 30 children had smoked tobacco during pregnancy. Four of 
these mothers reported still being smokers: whilst another four, who had not 
smoked during pregnancy, reported smoking now. There was no difference in lung 
function results when analysed by pregnancy smoking history. There was a trend 
for children whose mothers were current smokers to have higher LCI (10.34 versus 
9.38, Z= -1.55, p=0.12). There was no difference in spirometry results for these two 
groups.
Nineteen of the children had been infected with Staphylococcus aureus; 15 had 
been infected with Haemophilus influenzae; and 25 had been infected with 
Pseudomonas aeruginosa on at least one occasion previously. Twelve children were 
currently infected with P aeruginosa at the time of lung function testing (Section
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5.3.4). These 12 children had significantly higher LCI, and tended to have lower 
FEV0.5 and MMEF results than those children who were not currently infected with 
P aeruginosa (Table 5.13).
Table 5.13 Lung function results in preschool children with CF, 
analysed by current infection with Pseudomonas aeruginosa
PA positive 
(n=12)
PA negative 
(n=18)
Mean difference 
(95% Cl for difference)
LCI 10.77 (2.49) 8.83(1.61) 1.94 (0.41,3.45)*
FEV0.5 z-score -1.30(1.32) 0.41 (1.20) -0.90 (-1.85, 0.06)
MMEF z-score -0.89(1.08) -0.15(1.13) -0.74 (-1.59, 0.11)
Legend: PA positive = currently infected with P aeruginosa; PA negative = not 
currently infected with P aeruginosa. Comparison between groups is by t-test, and 
difference is calculated as PA positive -  PA negative. * p<0.05
None of the children had undergone chest computerised tomography scanning, and 
only five had undergone radioisotope ventilation scanning. These results were not 
analysed further.
Fourteen of the children had a parental reported history of cough in the seven days 
prior to lung function testing. These children had significantly lower spirometry 
results and a trend to higher LCI than the children with no history of cough (Table
5.14).
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Table 5.14 Lung function results in preschool children with CF, 
analysed by presence of parental reported cough in the seven days 
prior to lung function testing
Cough
(n=14)
No cough 
(n=16)
Mean difference 
(95% Cl for difference)
LCI 10.35 (2.53) 8.95(1.67) 1.39 (-0.19, 2.98)
FEV0.5 z-score -1.29(1.24) -0.30(1.22) -0.99 (-1.91,-0.07)*
MMEF z-score -0.91 (1.20) -0.04 (0.96) -0.88 (-1.69, -0.07)*
Legend: Comparison between groups is by t-test, and difference is calculated as 
cough -  no cough. * p<0.05
Only three children had abnormal chest signs (crackles or wheeze) on physical 
examination. These three children had significantly higher LCI (12.6 [0.38] versus
9.3 [2.06], Z = -2.45, p = 0.01) and lower MMEF z-score, (-1.88 [0.21] versus -0.29 
[1.10], Z = -2.32, p = 0 .0 2 ), and tended to have lower FEV0.5 z-score (-2.20 [1.51] 
versus -0.60 [1.21], Z = -1.69, p = 0.09) than children without chest signs.
The investigator visual analogue score (VASi) was available for 29 of the 30 
children, all completed by the author. In one child, another investigator conducted 
testing, and this score was not completed. There was no significant relationship 
between VASi and LCI (r2 = 0.11, p = 0.09). There were weak, but statistically 
significant, negative relationships between VASi and FEVo.5 z-score (r = 0.20, p = 
0.02), and MMEF z-score (r2 = 0.30, p = 0.002).
Due to an administrative error, consultant questionnaires for nine of the 30 children 
were not completed contemporaneously. Information on genotype, mode of 
presentation, and microbiology should be unaffected by this error. However, the 
visual analogue scores on current status could not be reliably completed 
retrospectively, and the visual analogue scores on past medical history may be 
biased by knowledge of the lung function results. These consultant scores were not 
analysed for this reason.
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5.7 Joint analysis of results in preschool and school-age children
A limited joint analysis of results obtained in the two age groups was performed, 
using LCI and FEVj as outcome measures. The rationale behind the choice of these 
measures, and the important cautions that must be applied to this analysis, are 
presented in Section 5.8.4.
LCI results were available in 63 healthy children, and in 52 children with CF. FEVj 
results were available in 50 healthy children, and 47 children with CF. Eighteen of 
the 60 preschool children were unable to produce an FEVj. Children with CF had 
significantly higher LCI, and significantly lower FEVj z-score, than healthy 
children (Table 5.15).
Table 5.15 Comparison of LCI and FEVi results by diagnosis, all 
children
CF Healthy controls Mean difference
(95% Cl for difference)
LCI 10.41 (2.65) 6.65 (0.52) 3.76 (3.09, 4.43)***
FEVj z-score -1.18(1.71) 0.27 (0.84) -1.44 (-1.98, -0.91)***
Legend: LCI results were available in 63 healthy children, and in 52 children with 
CF. FEVi results were available in 50 healthy children, and 47 children with CF. 
Difference calculated as CF-control. *** p<0.001
As presented in Section 4.5.3, healthy preschool children had significantly higher 
LCI than healthy school-age children. There was no significant difference in FEVi 
z-score (Table 5.16, Figure 5.15). Preschool children with CF had significantly 
lower LCI, and significantly higher FEVj z-score than school-age children with CF 
(Table 5.17, Figure 5.15).
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Table 5.16 Comparison of LCI and FEVi results by age group, in 
healthy children
Preschool School-age Mean difference
(95% Cl for difference)
LCI 6.88 (0.45) 6.45 (0.50) 0.43 (0.19, 0.67)**
FEVj z-score 0.21 (0.81) 0.30 (0.87) -0.08 (-0.59, 0.42)
Legend: LCI results were available in 30 preschool children, and in 33 school-age 
children. FEVi results were available in 17preschool children, and in 33 school- 
age children. Difference calculated as preschool-school-age.
**p<0.01
Table 5.17 Comparison of LCI and FEVi results by age group, in 
children with CF
Preschool School-age Mean difference
(95% Cl for difference)
LCI 9.61 (2.19) 11.53 (2.86) -1.9 (-3.33,-0.52)**
FEVi z-score -0.44(1.59) -2.01 (1.45) 1.57 (0.67, 2.47)**
Legend: LCI results were available in 30 preschool children, and in 22 school-age 
children. FEVi results were available in 25 preschool children, and in 22 school- 
age children. Difference calculated as preschool-school-age.
**p<0.01
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Figure 5.15 LCI plotted against age, all subjects
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. Limits o f  normality are not presented, as these differ for  
the preschool and school-age groups.
The relationship between FEVi and height is presented in Figure 5.16. This plot 
suggests that there is a curvilinear relationship between FEVi and height in healthy 
children. This relationship was not explored further, but is discussed in Section 5.8.
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Figure 5.16 FEVi plotted against height, all children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. There appears to be a curvilinear relationship between 
FEVj and height in healthy children. This relationship is discussed in Section 5.8.
The relationship between FEVi z-score and age is presented in Figure 5.17. The 
majority of preschool children with CF have normal FEVi results, whilst half of the 
school-age children with CF have abnormal FEVi results (see also Section 5.5.3).
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Figure 5.17 FEVi z-score plotted against age, all children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles.
The relationship between FEVi z-score and LCI is presented in Figure 5.18. There 
was no relationship between the two variables for healthy children. In children with 
CF, there was a significant negative relationship (r2 = 0.49, p < 0.001).
231
Figure 5.18 LCI plotted against FEVi z-score, all children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. Limits o f normality are not presented, as these differ for 
LCI for the preschool and school-age groups.
Chrispin-Norman scores were available for 17 of the 26 preschool children with CF, 
and all 19 of the school-age children with CF. The remaining nine preschool 
children had their primary CF care at other London centres, and their chest 
radiographs were not scored. For the 36 children for whom results were available, 
the mean Chrispin-Norman score was 9.3 (5.3). This score was significantly higher 
in the school-age children (11.5 (5.7) versus 6.8 (3.4), mean difference school-age -  
preschool 4.7 (1.5, 7.9), p=0.005). There was a significant positive correlation 
between Chrispin-Norman score and LCI (^=0.19, p=0.02), and a significant 
negative correlation between Chrispin-Norman score and FEVi z-score (r2=0.32,
p=0.01)
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5.8 Discussion
5.8.1 Summary
The aim of this study was to compare LCI with spirometry for children with CF and 
healthy children. Whilst group differences were seen with both techniques, analysis 
of individual results showed that more children with CF had abnormal MBW than 
had abnormal spirometry. These data support the hypothesis presented in Section 
5.2.2.
5.8.2 Selection of outcome measures for spirometry
In school-age children, FEVi and MEF25 were selected as outcome measures for 
spirometry. FEVi is the most commonly reported measure of pulmonary function in 
CF. It is employed in the clinic for tracking progress of individual patients, and is
1 o. 1 q. 199
used as an outcome measure in clinical studies and survival studies ’ ’ .In  
European centres, MEF25 is the most commonly reported measure of airflow during 
forced expiration. Reference equations for MEF25 in healthy British children are 
available120, and MEF25 was an outcome measure in a recent report comparing
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spirometry and MBW results in school-age children measured in Sweden . Data 
from this latter study are analysed further in this chapter.
It is not possible to use FEVi as the main outcome measure in preschool children. 
As described in Chapter 3, many preschool children complete forced expiration in 
less than one second, meaning that FEVi cannot be reported. Further, in those 
children who are able to exhale for one second, the FEVj/FVC ratio is almost 
always greater than 90% (Table 3.5), implying that FEVi is of limited value in 
detecting mild to moderate airway obstruction in this age group. MMEF was 
selected ahead of MEF25 as a measure of airflow in preschool children for practical 
reasons. There are no published data of MEF25 in healthy preschool children. 
Although it would have been possible to calculate z-scores for MEF25 from the 
current control group, it was considered preferable to select a measure that could be 
referenced to control data collected elsewhere. This difference in the choice of 
outcome measures limits the comparisons that can be made between spirometry 
results in preschool and school-age children, and this is discussed further below.
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5.8.3 Relative sensitivity and specificity of spirometry and LCI
In school-age children, approximately half of the children with CF had normal 
spirometry results, whilst nearly all had abnormal ventilation distribution. In 
preschool children, LCI was abnormal in 22/30 children (73%), FEV0.5 was 
abnormal in two children (7%), and MMEF was abnormal in four (13%).
It was expected that MEF25 and MMEF would discriminate between CF and control 
populations better than FEVi and FEV0.5, but this was not demonstrated, suggesting 
that the inter-subject variability of MEF25 and MMEF is too high to reliably detect 
airway dysfunction. This may be technique-related, though it has already been 
demonstrated that MMEF results obtained in healthy children in this study are 
similar to those reported by other investigators (Chapter 3). This suggests that the 
variability of MMEF is a common problem between laboratories, rather than the 
result of poor technique in this study. Alternatively, the poor discriminative ability 
of MEF25 and MMEF may be because young children have larger airways relative 
to lung volume than older children, and in younger children expired volumes and 
flows are therefore determined more by lung capacity, elastic recoil, and muscle 
strength than by airway diameter. The relative merits of timed forced expired 
volumes versus airflows for detection of airway dysfunction at different ages is 
discussed further in Chapter 7.
5.8.4 Comparison with data collected in Sweden
27
There have been previous studies of gas mixing in CF using similar methods 
29;74;75 mQSt recent studied Swedish children using the same methods and 
equipment as now used in our laboratory27, and results obtained from the two 
centres have been compared in this chapter. This comparison was powered to detect 
a difference in LCI of 1 SD between healthy children measured in London and 
those measured in Sweden. As can be seen from Table 5.7, no significant difference 
was observed, with the mean difference in LCI between the two groups being 0.1. 
The upper limit of normality calculated from the two populations was similar, being 
7.49 from the UK population, and 7.23 from the Swedish population. These 
differences between the healthy populations are minor compared to the differences 
between healthy and CF populations (mean difference in LCI in school-age children
234
of 5.1 for the current study). The similarity of results in healthy children from the 
two centres indicates that the MBW technique can be transferred between 
laboratories, and offers the possibility of collating data for future analyses.
The Swedish study also reported LCI from 43 of the 70 children attending the CF 
clinic in Gothenburg, most of who had FEVi and MEF25 results within the normal 
range. The majority of these children were found to have abnormal LCI, although, 
in contrast to findings in the current study, there was only a weak correlation 
between ventilation indices and spirometry indices. In the current study only a small 
subgroup (22/199) of children attending the CF clinic at Great Ormond Street 
Hospital for Children were recruited. As no attempt was made to recruit all children 
attending the clinic, or to take a representative sample, it is likely that some 
selection bias operated in recruitment to this study, since children with more severe 
disease attend the clinic more frequently and were therefore more likely to be 
approached. Children with CF tested at ICH had significantly higher LCI, and 
significantly lower FEVi and MEF25 z-score than children tested in Sweden (Table 
5.8) However, meaningful comparison of CF populations from two centres would 
require recruitment of representative samples, and detailed information on treatment 
history and disease severity. These criteria were not met for the current analysis, but 
the consistency of LCI results in the healthy populations would allow future 
prospective studies, using LCI as an outcome measure.
More detailed discussions of previous studies of MBW, and of previous studies of 
lung function in preschool children, are presented in Chapter 1, and - in the context 
of the current results - in Chapter 7.
5,8.5 Joint analysis of results from preschool and school-age children 
A limited joint analysis of results obtained in both age-groups was performed. 
Before discussing the results, it is necessary to describe important weaknesses of 
this analysis. FEV1 was selected as the outcome measure from spirometry, even 
though 18 of the 60 preschool children were unable to produce an FEVi. However, 
FEV 1 is the only spirometry outcome measure for which reference equations were 
available for both age groups. These reference equations differ for the preschool 
and school-age groups. The reference equation employed for preschool children is
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derived from a study of children tested in Indianapolis, USA24, whilst the reference 
equation employed for school-age children is derived from data collected in the
i onUK . The data presented in Figure 5.17 demonstrate that most of the healthy 
children in this study have FEVi z-scores between +2 and -2, suggesting that these 
two equations are appropriate for our population. However, the analysis would be 
strengthened if a single reference equation could be applied. Data from healthy 
children presented in Figure 5.16 suggests that there is a curvilinear relationship 
between FEVi and height across the 2-16 year age range. It is of interest that a 
recent report from ICH suggests a similar curvilinear relationship between FEV0.5 
and height/length from birth to nine years. It should soon be possible to construct 
reference equations for spirometry variables that span infant, preschool, and school- 
age children. This important and exciting area of research is unfortunately beyond 
the scope of this thesis.
A second, related, caution is that FEV 1 may not measure the same aspects of airway 
function at different ages. In older school-age children and adults, the ratio of FEVi 
to FVC is approximately 70%. As presented in Chapter 3, this FEVj/FVC ratio is 
typically greater than 90% in preschool children. This topic is discussed further in 
Chapter 7.
As described in Chapter 4, healthy preschool children have significantly higher LCI 
than healthy school-age children. Possible reasons for this are discussed in Chapter 
7.
The final caution to this analysis, already mentioned above, is that the school-age 
children with CF included in this study were recruited opportunistically, and 
selection bias may apply. Of the 30 preschool children with CF, 20 were recruited 
from the clinic at Great Ormond Street, representing all eligible children from this 
population (apart from those who refused consent), whilst the remaining 10 children 
were recruited opportunistically from the other centres participating in the LCCFS. 
With these cautions, the joint analysis demonstrates that school-age children with 
CF have higher LCI and lower FEVi z-score than preschool children with CF. It 
also shows that there is no relationship between LCI and FEVi in healthy children, 
and that there is a moderate correlation between LCI and FEVi in children with CF.
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5.8.6 Strengths and weaknesses of this study
All spirometry parameters are affected by subject height, which can confound 
interpretation of differences between populations. Reference equations for FEVi 
and M EF25 in British school-age children are available 120, and were used here. 
Although reference equations for preschool children are now available 24,40, these 
have not yet been widely tested. The current control population was therefore used 
to calculate height-adjusted z-scores for FEVo.5, and M M EF for the primary 
analysis. It was not necessary to calculate z-scores for LCI as this parameter was 
almost independent of age and body size in healthy children.
The order of testing in this study was fixed as MBW first, and spirometry second 
for school-age children. For preschool children the order was MBW first, 
plethysmography second, and spirometry third. Direct comparison of relative 
feasibility for the two methods presented in this thesis is therefore not possible. This 
order of testing was selected because deep inspirations are known to affect airway 
mechanics during subsequent tidal breathing, and measurements of LCI (or sRaw) 
could have been altered if spirometry was performed earlier. As spirometry is 
technique and effort dependent, it is possible that fatigue towards the end of the 
testing session could have resulted in erroneous FE V 0.5 and MMEF results in some 
preschool children. However, data presented in Chapter 3 demonstrates that 
spirometry results obtained in healthy children undertaking the current study 
protocol are very similar to those reported by Eigen et al24.
Limited data on the clinical condition of the subjects with CF are presented. It 
would have been preferable to compare lung function results with measures of 
infection and inflammation obtained from bronchoalveolar lavage, or with 
structural changes measured on computed tomography. These investigations are not 
routinely performed in the clinic, and could not be justified for the purpose of this 
study. It was possible to compare results in preschool children by the presence of 
current Pseudomonas aeruginosa infection, and demonstrate that infected children 
had significantly higher LCI than those who were not infected. It was also possible 
to analyse by the presence of cough, which showed that preschool children with 
cough had significantly worse spirometry results than those who did not cough. 
There was no significant difference in lung function results between preschool
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children who presented with respiratory symptoms and those who presented with 
non-respiratory symptoms. This echoes the report of Ranganathan et a l 14, who 
found no differences in lung function results in infants with CF, when analysed 
according to mode of presentation. In school-age children: those children who were 
infected with Pseudomonas aeruginosa; and those children with worse clinical 
symptoms or signs, tended to have more abnormal lung function results. However, 
none of these differences were statistically significant. All the above were 
secondary analyses, for which this study was not powered. In addition, there were 
methodological differences in how microbiological samples were processed in 
different laboratories, and parental/child report of cough is known to be sometimes 
unreliable123. Results must therefore be interpreted with great caution.
Further discussion of the links between infection, inflammation and lung function in 
early CF lung disease, and of the clinical significance of these results, is presented 
in Chapter 7.
In conclusion, this study has demonstrated that abnormal ventilation distribution, as 
evidenced by an abnormally raised LCI, is found in many children with CF, 
including many preschool children with normal spirometry measurements. One 
interpretation of these findings is that destructive processes in the airways of 
children with CF start early in life, and that these changes are detectable by MBW, 
but not always by more commonly used measures of lung function. These issues are 
discussed in detail in Chapter 7.
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Chapter 6: Results of phase III slope analysis
6.1 Introduction
It has already been demonstrated that the LCI, obtained from washout curve 
analysis of a MBW, is frequently abnormal in children with CF, including in those 
who record normal spirometry results. An abnormal LCI indicates increased 
inhomogeneity of ventilation distribution, or impaired gas mixing. This increased 
inhomogeneity can result from differences in specific ventilation between units 
subtended at branch points within conducting airways (convection dependent 
inhomogeneity [CDI]); or can be generated by size differences in units subtended at 
branch points within the diffusion-convection front, and by differences in airway 
calibre at these branch points (diffusion-convection dependent inhomogeneity 
[DCDI]). These concepts were explained in more detail in Chapter 1.
A number of studies in adult human subjects have described how indices 
representing CDI (conducting zone inhomogeneity [ S COn d ] )  and DCDI (acinar zone 
inhomogeneity [S a c in ] )  can describe the relative contribution of these two 
mechanisms to overall inhomogeneity of ventilation distribution. The MBW studies 
from which these indices were derived were performed during controlled breathing, 
i.e. subjects were asked to breathe at a fixed respiratory rate and tidal volume. In 
contrast, the MBW studies in school-age and preschool children presented in 
Chapters 4 and 5 were performed during uncontrolled, spontaneous breathing.
This chapter presents the results obtained from phase III slope analysis of the MBW 
studies presented in Chapter 5, applying the quality control criteria examined in 
Chapter 4.
Of the phase I I I  slope parameters studied here, the first breath S n I I I COrr is a measure 
of overall ventilation inhomogeneity, whilst S cond,corr, and S acin,corr are measures of 
ventilation inhomogeneity generated by convective dependent mechanisms, and by 
mechanisms dependent on diffusion-convection interaction, respectively. I t  can 
therefore be predicted that the L C I ,  which is a measure of overall ventilation 
inhomogeneity, will be closely related to first breath S n I I I COrr, and less closely 
related to Scond,corr> and Sacin,corr*
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6.2 Aims and hypotheses
6.2.1 Hypotheses
• Children with CF with abnormal washout curve results will also have 
abnormal phase III slope results
• These children will have evidence of both acinar zone and conducting zone 
inhomogeneity
• Both measures of inhomogeneity will be greater in older children.
6.2.2 Aims and objectives
The primary aim of this study was:
• To investigate the relationships between parameters derived from MBW 
phase III slope analysis and age in a population of healthy British children 
and children with CF, aged from two to 16 years.
The secondary aims of this study were:
• To relate phase III slope parameters to those obtained from washout curve 
analysis (i.e. LCI) and forced expiration (i.e. FEVi)
• To relate phase III slope parameters obtained in children with CF to clinical 
status, as measured by cough frequency, sputum microbiology, and chest 
radiograph findings.
6.3 Subjects and methods
6.3.1 Subject recruitment
This is described in Section 4.3.1 for school-age children, and Section 3.3.1 for
preschool children.
6.3.2 Study design
This is described in Section 5.3.2. The same 115 children whose results are
presented in Chapter 5 were entered into the analyses presented in this chapter.
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6.3.3 Data collection
Collection and analysis of spirometry data, including criteria for accepting or 
discarding results, and derivation of the indices listed below, are described in detail 
in Chapters 2 and 3. Collection and analysis of MBW data are described in detail in 
Chapters 2 and 4.
6.3.4 Additional Clinical information and recording of clinical data 
This is described in Section 5.3.4.
6.3.5 Ethics
The study was approved by the North Thames Region Multicentre Research Ethics 
Committee, and by the Local Research Ethics Committees of each of the five 
collaborating centres.
6.4 Analysis
6.4.1 Outcome measures
Calculation of FRC, LCI, and spirometry parameters is described in Section 5.4.1. 
The phase III slope of the first breath of the SF6 washout (first breath SnIII) was 
calculated separately for each run - and the mean of the three results is presented. 
The difference between the first breath SF6 SnIII and the first breath He SnIII 
(SnIIIsF6-He) was calculated separately for each run, and the mean of the three 
results is presented. Conducting zone inhomogeneity (SCOnd) was calculated from an 
aggregated plot of SnIII versus lung volume turnover (TO) - derived from all three 
SF6 washouts - as the slope of the regression over 1.5 to 6.0 TO, calculated after 
excluding SnIII results obtained from breaths of inadequate volume (see Chapters 2 
and 4). Acinar zone inhomogeneity (Sacin) was calculated by subtracting the Scond 
component from the mean first breath SnIII. This Scond component was calculated 
as:
Scond' first breath Vj • FRC'1
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where first breath Vt is the mean expired volume of the first breath, and first breath 
Vt and FRC were presented in the same units.
For all these calculations, first breath V t, FRC, and TO were corrected for Voapp- 
It has already been demonstrated that there is a negative relationship between first 
breath SnIII and age in healthy children (Section 4.6) but that there is no 
relationship between age and the product of first breath SnIII and expired volume. 
All phase III slope parameters were therefore corrected for expired volume:
• first breath SnIII; SnIIIsF6-He; and Sacin were multiplied by the expired 
volume of the first breath
• Scond was multiplied by the mean expired volume from the entire washout.
I n  both cases, this expired volume was calculated as the mean from three runs, after 
correction for Voapp- The resultant volume-corrected parameters (first breath 
S n I I I Corr; S n I I I s F 6 -H e ,c o r r ;  S cond,corr; and S a d n .c o rr )  were the primary outcome variables 
for subsequent analyses.
6.4.2 Comparisons between groups, with other measures, and with clinical status
Analyses were performed jointly for preschool and school-age groups (see power 
calculation, below). Uncorrected phase III slope parameters were compared by 
diagnosis. Volume-corrected parameters were compared by diagnosis and age- 
group. The age relationships of the volume-corrected parameters were examined 
further by scatter plots and tested by regression analyses. The upper limits of 
normality for first breath S n I I I corr ,  S n I I I SF6-He,corr, S cond,corr, and S acin,corr were 
calculated from the data obtained in healthy children as mean + 1.96SD, as 
previously described for LCI (Chapter 5). By these limits, children were defined as 
having normal or abnormal first breath S n I I I corr, S n I I I SF6-H e,corr, S cond,corr, or S acin,corr 
results. Volume-corrected parameters were compared with corresponding LCI and 
FEVi z-score results by scatterplot. Numbers of children categorised as normal or 
abnormal for each of these measures was compared. Finally, volume-corrected 
outcome measures in children with CF were compared by: presence or absence of 
chronic Pseudomonas aeruginosa infection (defined as in Section 5.3.4); by 
presence or absence of cough in the week prior to lung function testing (see Section 
5.3.4); and by Chrispin-Norman score of the most recent chest radiograph.
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6.4.3 Statistical analysis
Group comparisons were by t-test or Chi test as appropriate. 95% Cl for difference 
of means is presented for t-test results. A p-value equal to or below 0.05 was 
regarded as statistically significant.
6.4.4 Power o f  study
The analyses presented in this chapter are secondary to those presented in Chapter 
5, and the number of subjects included is based upon the requirements of those 
primary analyses.
By post-hoc calculation, it was determined that a sample size of 50 subjects in each 
group (as for the joint preschool/school-age analyses) would be sufficient to detect 
a difference of 0.5 S D  in first breath S n I I I COrT, S n I I I SF6-He,corr, S cond,corr, and S acin,corr 
between CF and control groups. A sample size of 22 subjects in each group (as for 
separate preschool/school-age analyses) would be sufficient to detect a difference of 
one S D  in these parameters between CF and control groups.
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6.5 Results
6.5.1 Subjects
All 115 children in whom LCI and spirometry results were successfully obtained 
were entered into this analysis. This population has already been described in Table 
4.5. S Cond and S acin could be calculated in 47/60 preschool children, and in 47/55 
school-age children (Table 6.1). There were no significant differences in success 
rates by age-group or diagnosis.
Table 6.1 Children completing MBW in whom S COnd and S aCin could be 
calculated
Preschool
children
School-age
children
Mean difference (95% Cl) 
preschool-school-age
CF 26/30 (87%) 19/22 (86%) 1% (-19, 21)
Control 21/30 (70%) 28/33 (85%) 15% (-35, 6)
Mean difference 
(95% Cl) CF-control
17% (-2, 38) 2% (-19, 21)
Legend: results presented as n (%). Differences calculated from %. There were no 
significant differences in success by age-group or diagnosis.
Inadequate breath volume was by far the commonest reason for excluding breaths. 
For the 13 preschool children in whom results could not be calculated, one run was 
excluded in seven children, two runs in two children, and all three runs in four 
children. For the eight school-age children in whom results could not be calculated, 
one run was excluded in one child, two runs in three children, and three runs in four 
children. For these 42 excluded runs: 11 were excluded because the first breath was 
of inadequate volume for SnIII calculation; 17 because too many breaths had been 
excluded for the S COnd regression to be calculated; and 14 because neither the first 
breath SnIII nor the S cond regression could be calculated.
For the 94 children in whom S cond and S acjn could be calculated, children with CF 
had significantly lower height and weight z-scores than healthy children (Table 
6 .2).
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Table 6.2 Details of final study population, analysed by diagnosis
CF Controls Mean difference
(n=45) (n=49) (95% Cl of difference)
Age (years) 7.32 (4.05) 8.00 (4.16) -0.68 (-2.36, 1.01)
Height z-score -0.51 (1.19) 0.39 (0.99) -0.80 (-1.32, -0.28)**
Weight z-score -0.22 (1.02) 0.54 (1.04) -0.76 (-1.21, -0.31)**
Legend: Group results presented as mean (SD) *** p<0.001. Difference calculated 
as CF-control.
6.5.2 Analysis of raw phase III slope parameters
When raw results were analysed, a significant difference between CF and control 
groups was noted for all four measures (Table 6.3).
Table 6.3 Raw phase III slope parameters, analysed by diagnosis, for 
all children
CF
(n=45)
Controls
(n=49)
Mean difference 
(95% Cl of difference)
First breath SnIII (L'1) 0.571 (0.330) 0.301 (0.243) 0.270 (0.152, 0.388)***
Scond (L ) 0.297 (0.175) 0.067 (0.116) 0.230 (0.169, 0.292)***
Sacin (L'1) 0.455 (0.319) 0.278 (0.238) 0.178 (0.063, 0.292)**
SnlllsFe-HeO/1) 0.120 (0.115) 0.072 (0.086) 0.047 (0.006, 0.089)*
Legend: Group results presented as mean (SD) *** p<0.001, **p<0.01, *p<0.05. 
Difference calculated as CF-control
In healthy children, there were significant negative relationships between age and 
first breath SnIII (r2=0.33, p<0.001); age and SCOnd (r2=0.12, p=0.02); and age and 
Sacin (r =0.27, p<0.001). The negative relationship between age and SnIIIsF6-He was 
not significant (r =0.07, p=0.08). These relationships are presented in Figures 6.1 to 
6.4.
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Figure 6.1 First breath SnIII plotted against age, all children
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Legend for Figures 6.1 to 6.4: Control children presented as open circles, and 
children with CF presented as closed circles. Note the significant negative 
relationships between: age andfirst breath SnIII; age and Scond; age and SaCm; and 
age and SnIIIsF6-He,corr in healthy children (see text fo r r2 and p-values).
Figure 6.2 S COnd plotted against age
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Figure 6.3 S acin plotted against age
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Figure 6.4 first breath S n l l l SF6-He plotted against age, all children
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6,5.3 Age relationships of volume-corrected phase III slope parameters
To facilitate comparison of results between CF and control groups, results for all 
four outcome variables were transformed as described in Section 6.4.1. The 
resultant volume-corrected outcome measures were virtually age independent in 
healthy children (Figures 6.5 to 6.8), with no significant differences noted between 
preschool and school-age groups (Table 6.4).
Table 6.4 Volume-corrected phase III slope parameters, analysed by 
age-group, healthy children
Preschool
(n=21)
School-age
(n=28)
Mean difference 
(95% Cl of difference)
First breath SnIIICOrr 0.087 (0.393) 0.075 (0.031) 0.012 (-0.009, 0.032)
Scond.corr 0.021 (0.029) 0.011 (0.020) 0.010 (-0.004, 0.024)
Satin,corr 0.079 (0.042) 0.071 (0.031) 0.008 (-0.013,0.029)
S nIIIsF6-H e,corr 0.019(0.022) 0.023 (0.021) -0.004 (-0.016, 0.008)
Legend: Group results presented as mean (SD). Difference calculated as preschool- 
school-age.
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When all children were analysed together, significant differences in first breath 
S n I I I c o r r ,  S cond .co rr, and S acin ,corr were seen for the CF and control groups (Table 6.5). 
When these analyses were repeated separately for preschool and school-age 
children, a marked difference in results was noted. Whilst school age children with 
CF had significantly higher Sacin,corr than healthy school-age children (Table 6.6), no 
difference in S acin,corr was seen in the preschool group (Table 6.7). I n  both age 
groups first breath S n I I I COrr and S COnd,corr were significantly higher in children with 
CF, whilst there was no difference by diagnosis in S n I I I s F 6 -H e ,c o r r -
Table 6.5 Volume-corrected phase III slope parameters, analysed by 
diagnosis, for all children
CF
(n=45)
Controls
(n=49)
Mean difference 
(95% Cl of difference)
First breath SnIIIcorr 0.162 (0.096) 0.080 (0.035) 0.082 (0.052, 0.113)***
Scond.corr 0.074 (0.036) 0.016(0.024) 0.059 (0.046, 0.071)***
Sacin.corr 0.130 (0.096) 0.074 (0.036) 0.056 (0.025, 0.086)***
SnIIIsF6-H e,corr 0.032 (0.030) 0.021 (0.021) 0.010 (-0.001,0.021)
Legend: Group results presented as mean (SD) *** p<0.001. Difference calculated 
as CF-control.
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Table 6.6 Volume-corrected phase III slope parameters, analysed by 
diagnosis, school-age children
CF 
(n= 19)
Controls
(n=28)
Mean difference 
(95% Cl of difference)
First breath SnIIICOrr 0.211 (0.107) 0.075 (0.031) 0.136 (0.084, 0.189)***
Scond, corr 0.078 (0.040) 0.011 (0.020) 0.067 (0.046, 0.087)***
Sacin,corr 0.177 (0.112) 0.071 (0.031) 0.107 (0.052, 0.162)***
SnIIIsF6-H e,corr 0.037 (0.032) 0.023 (0.021) 0.014 (-0.003, 0.031)
Legend: Group results presented as mean (SD) *** p<0.001. Difference calculatet 
as CF-control. Note that children with CF have significantly higher first breath 
SnIIIcorr, Scond,con> and S^ cin, con than healthy children.
Table 6.7 Volume-corrected phase III slope parameters, analysed by 
diagnosis, preschool children
CF
(n=26)
Controls
(n=21)
Mean difference 
(95% Cl of difference)
First breath SnIIIcorr 0.126 (0.070) 0.086 (0.039) 0.040 (0.007, 0.072)*
Scond, corr 0.072 (0.033) 0.021 (0.029) 0.050 (0.032, 0.068)***
Sacin,corr 0.095 (0.064) 0.079 (0.042) 0.017 (-0.015, 0.048)
SnI 11 SF6-He,corr 0.028 (0.028) 0.019(0.022) 0.008 (-0.006, 0.023)
Legend: Group results presented as mean (SD) *** p<0.001, *p<0.05. Difference 
calculated as CF-control. Note that preschool children with CF have significantly 
higher first breath SnIIIcorr and Scond,con than healthy preschool children, but there 
is no difference in Scond,con between the two groups. This contrasts with the results 
seen in school-age children (presented in Table 6.6).
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The age relationships were explored further by scatter-plots. Figure 6.5 presents 
first breath S n I I I COrr plotted against age, for the CF and control groups. The upper 
limit of normality for first breath S n I I I COrr was calculated as 0.149. For the children 
with CF, there was a positive relationship between first breath S n I I I COrr and age (r2 = 
0.41, pO.OOl). Nineteen of the children with CF (6/26 preschool children, and 
13/19 school-age children) had first breath S n I I I COrr above the limit of normality.
Figure 6.5 Volume-corrected first breath Snlll plotted against age, all 
children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. The upper limit o f  normality for first breath SnIIIcorr 
(broken line) was calculated as 0.149. For the children with CF, there was a 
positive relationship between first breath SnIIIcorr and age (r2 = 0.41, p<0.001). 
Nineteen o f  the children with CF (6/26 preschool children, and 13/19 school-age 
children) hadfirst breath SnIIICOrr above the limit o f normality.
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Figure 6.6 presents S cond,corr plotted against age, for all children. The upper limit of 
normality was calculated as 0.063. For the children with CF, there was no 
relationship between S Cond,corr and age (r2 =0.02, p=0.3). Thirty-one of the children 
with CF (16/26 preschool children, and 15/19 school-age children) had S cond,corr 
above the limit of normality. One healthy preschool child had a markedly raised 
Scond,corr- This is addressed later in this chapter.
Figure 6 .6  Volume-corrected S COnd plotted against age, all children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. The upper limit o f normality was calculated as 0.063 
(broken line). For the children with CF, there was no relationship between SCOnd,corr 
and age (r2 =0.02, p<0.3). Thirty-one o f the children with CF (16/26 preschool 
children, and 15/19 school-age children) had SCOnd,corr above the limit o f normality.
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The relationship between S acin ,co rr and age is presented in Figure 6.7. For this index, 
the upper limit of normality was calculated as 0.145. For the children with CF, there 
was a positive relationship between Sadn,corr and age (r =0.36, p<0.001). Only 16 of 
the children with CF (6/26 preschool children, and 10/19 school-age children) had 
Sacin,corr above the limit of normality. Most children under the age of 10 years had 
normal, or near-normal S aCin,corr-
Figure 6.7  Volume-corrected S aCin plotted against age, all children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. The upper limit o f normality was calculated as 0.145 
(broken line). For the children with CF, there was a positive relationship between 
Sacin, corr and age (r2 =0.36, p<0.001). Only 16 o f the children with CF (6/26 
preschool children, and 10/19 school-age children) had SaCm,corr above the limit o f  
normality. Note that most children under the age o f 10 years had normal, or near­
normal Sacin. corr-
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Figure 6.8 demonstrates the relationship between S n I I I s F 6 -H e ,c o r r  and age. For this 
index, there was no significant difference between CF and control groups (Tables
6.5 -  6.7) and no age relationship in children with CF (r2 = 0.07, p = 0.08). The 
upper limit of normality was 0.0622.
Figure 6.8 Volume-corrected SnlllSF6-He plotted against age, all children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. There was no significant difference between CF and 
control groups and no age relationship in children with CF. The upper limit o f 
normality for SnIIIsF6-He,corr was 0.0622 (broken line).
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6.5.4 Relationships between phase III slope parameters and LCI
For the purpose of these analyses, the upper limit of normality for L C I  is taken as 
7.67 (calculated from measurements taken in all healthy children, Table 5.15). As 
there were no significant differences in S n I I I s F 6 -H e ,c o r r  between CF and control 
groups, this measure is not analysed further. The relationship between first breath 
S n I I I c o r r  and L C I  is presented in Figure 6.9.
Figure 6.9 Lung Clearance Index plotted against volume-corrected first 
breath Snlll, all children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. There was a positive relationship between the two 
indices in children with CF (r2 = 0.51, p<0.001). Broken lines represent the upper 
limits o f  normality for the two indices. Note that more children with CF had 
abnormal LCI than had abnormal first breath SnIIIcorr (see text).
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There was a positive relationship between the two indices in children with CF (r2 = 
0.51, p<0.001). Note that 21 children with CF had normal first breath S n I I I c o r r  but 
abnormal LCI, whilst only one child with CF had abnormal first breath S n I I I COrr but 
normal LCI. The relationship between S cond,corr and LCI is presented in Figure 6.10.
Figure 6.10 Lung Clearance Index plotted against volume-corrected 
Scond, all children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. In children with CF, there was a weak positive 
relationship between the two indices (r2=0.12, p=0.02). Broken lines represent the 
upper limits o f normality for the two indices.
There was a weak positive relationship between the two indices in children with CF 
(r2=0.12, p=0.02). As previously described, the majority of the children with CF 
had abnormal S COnd,corr (Figure 6.6). Only nine children with CF had normal S cond,coiT 
but abnormal LCI, whilst one child with CF had abnormal S COnd,corr but normal LCI.
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Figure 6.11 presents S aCin,corr plotted against LCI.
Figure 6.11 Lung Clearance Index plotted against volume-corrected 
Sacin, all children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. In children with CF, there was a positive relationship 
between the two indices (r2 = 0.46, p<0.001). Broken lines represent the upper 
limits o f normality for the two indices. Note that more children with CF had 
abnormal LCI than had abnormal SaCm,corr (see text).
A  positive relationship between the two indices was noted in children with CF (r2 = 
0.46, p<0.001). Twenty-four children with CF had normal S acin ,corr but abnormal 
LCI, whilst only one had abnormal Sacin ,corr but normal LCI.
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6.5.5 Relationships between phase I I I  slope parameters and FEVi 
Figure 6.12 presents the relationship between first breath S n I I I COrr and FEVi.
Figure 6.12 FEVi z-score plotted against volume-corrected first breath 
Snlll, all children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. In children with CF, there was a weak negative 
relationship between the two indices (r2 = 0.29, p<0.001). Broken lines represent 
the limits o f normality. Note that more children with CF had abnormal first breath 
SnIIIcorr than had abnormal FEVi z-score (see text).
In children with CF, there was a weak negative relationship between the two indices 
(r2 = 0.29, p<0.001). Seven children with CF had normal FEVi z-score but 
abnormal first breath SnIIIcorr, whilst only two had had abnormal FEVi z-score but 
normal first breath SnIIICOrr-
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The relationship between S COnd,corr and FEVi z-score is presented in Figure 6.13. 
There was no significant relationship between the two indices in children with CF 
(S=0.06, p=0.14).
Figure 6.13 FEVi z-score plotted against volume-corrected Scond* 3ll 
children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. There was no significant relationship between the two 
indices in children with CF. Broken lines represent the limits o f  normality for the 
two indices. Note that more children with CF had abnormal SCOnd,corr than had 
abnormal FEVi z-score (see text).
Nineteen children with CF had normal FEVi z-score but abnormal S COnd,corT, whilst 
only two had abnormal FEVi z-score but normal S COnd,con--
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The relationship between S acin,corr and FEVi z-score is presented in Figure 6.14. In 
children with CF, there was a weak negative relationship between the two variables
(^=0.22, p=0.002).
Figure 6 .14  FEVi z-score plotted against volume-corrected S aCin, all 
children
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Legend: Control children presented as open circles, and children with CF 
presented as closed circles. There was a weak negative relationship between the 
two indices in children with CF. Broken lines represent the limits o f normality for  
the two indices. In contrast to the Scond,corr and FEVi relationship, almost as many 
children with CF had abnormal FEVi as had abnormal SaCin,corr (see text).
In contrast to the S COnd,corr and FEVi relationship, six children with CF had normal 
FEVi z-score but abnormal Sacin,com whilst four had abnormal FEVi z-score but 
normal S acin,corr- All four of these children had abnormal S COnd,corr and abnormal LCI.
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6,5.6 Relationships between phase III slope parameters and clinical information
in children with CF
Volume-corrected phase I I I  slope outcome measures compared by presence of 
Pseudomonas aeruginosa infection are presented in Table 6.8. Children who were 
infected with Pseudomonas aeruginosa had significantly higher first breath S n I I I COrr 
and S acin ,corr, but there was no difference in S COnd,corr.
Table 6.8 Volume-corrected phase III slope parameters, analysed by 
presence of Pseudomonas aeruginosa infection, all children with CF
Pseudomonas
positive
(n=21)
Pseudomonas
negative
(n=24)
Mean difference 
(95% Cl of difference)
First breath 
S n I I Ic o r r
0.206 (0.112) 0.124 (0.059) 0.082 (0.030, 0.135)**
Scond,corr 0.0836 (0.0343) 0.0656 (0.0352) 0.0180 (-0.0030, 0.0389)
Sacin,corr 0.171 (0.116) 0.094 (0.055) 0.077 (0.023,0.130)**
Legend: Group results presented as mean (SD) ** p<0.01. Difference calculated as 
Pseudomonas positive -  Pseudomonas negative.
These relationships were examined further by regression modelling. The presence 
of Pseudomonas aeruginosa infection explained 17% of the variability of first 
breath S n I I I COrr (p=0.003), 14% of the variability of S acin ,corr (p=0.006), but only 4% 
of the variability of S cond,corr (p=0.09). After correction for age, the presence of 
Pseudomonas aeruginosa infection was still a significant predictor of first breath 
S n I I I c o r r  (p=0.005) and S acin ,co rr (p=0.012).
Results were also compared by presence of cough in the week prior to testing 
(Table 6.9). All three outcome measures were significantly higher in children who 
reported cough. By regression analysis, presence of cough only explained 9% of the 
variability of first breath S n I I I COrr (p=0.02), 7% of the variability of S cond,corr 
(p=0.05), and 7% of the variability of S acin,corr (p=0.05). After correction for age, 
presence of cough was not a significant predictor of any of these variables.
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Table 6.9 Volume-corrected phase III slope parameters, analysed by 
presence of cough, all children with CF
Cough
(n=25)
No cough 
(n=20)
Mean difference 
(95% Cl of difference)
First breath 
S n I IIc o rr
0.191 (0.104) 0.126 (0.072) 0.065 (0.011,0.119)*
Scond,corr 0.0833 (0.0348) 0.0624 (0.338) 0.0209 (0.0001,0.0416)*
Sacin,corr 0.155 (0.108) 0.098 (0.069) 0.057 (0.003,0.110)*
Legend: Group results presented as mean (SD) *p<0.05. Difference calculated as 
cough -  no cough
For the 34 children for whom Chrispin-Norman scores were available, positive 
relationships were seen between the Chrispin-Norman score and first breath S n I I I COrr 
(r2=0.39, p<0.001) and S acin ,co rr (r2=0.40, p<0.001). There was no relationship 
between the Chrispin-Norman score and S COnd,corr (r2=0.01, p=0.6).
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6.6 Discussion
6.6.1 Summary
The primary aims of this study were to compare parameters derived from phase I I I  
slope analysis with age in both preschool and school-age children. Volume- 
correction of phase I I I  slope parameters created indices that were independent of 
age, allowing these relationships to be studied in more detail. First breath S n I I I COrr, 
Scond,corr? and S ^ n , c o r r  were all significantly higher in children with CF than in 
healthy children. Thirty-one of 45 children with CF had S cond,corr above the normal 
range, and no age relationship was seen. I n  marked contrast, only 16 children with 
CF had raised S ac in ,co rr, with higher values seen in older children. One explanation 
for these results is that lung disease in children with CF commences in the 
conducting airways and progresses distally. This and alternative explanations are 
discussed in detail in the next chapter.
A brief discussion of the main results follows. Detailed discussion of the 
physiological and pathophysiological implications of these results is presented in 
Chapter 7.
6.6.2 Volume correction ofphase III slope parameters
The majority of lung function measures are dependent on age and body size in 
healthy subjects120. Whilst the negative relationships between SnIII and age, and 
SnIII and lung volume 124, have been described previously, they have not been 
questioned. The rationale for volume correction of phase III indices is based upon 
the analyses presented in Chapter 4, and upon the observation that other measures 
of ventilation inhomogeneity, such as the LCI, are virtually age-independent, at 
least in the 2 to 16 year age range. Possible explanations for how volume correction 
eliminates age relationships for phase III parameters are presented in the next 
chapter. For now, it is noted that volume correction allows relationships with age 
and with other lung function parameters to be studied in children with CF, without 
the need for regression equations and calculation of z-scores. This has not been 
possible previously.
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6.6.3 Limitations of this study
For analyses presented in this chapter, data collected in preschool children and data 
collected in school-age children are analysed together. Differences in recruitment 
methods and data Collection methods between the two groups weaken this analysis. 
This is discussed further in Chapter 7.
In addition, there were three important weaknesses related to secondary outcome 
measures, which should be noted now. Both relate to the initial study design, which 
considered investigations in school-age children and those in preschool children as 
two separate studies.
First, although measurement of FEVi utilised identical equipment and similar 
measurement and analysis protocols, conversion of the raw FEV i data into z-scores 
required separate equations for the preschool and school-age groups. This has 
already been discussed in more detail in Chapter 5.
Second, the definition of chronic Pseudomonas aeruginosa infection in school-age 
children is slightly different from the definition of current Pseudomonas aeruginosa 
infection in preschool children. In the former case, chronic infection was defined as 
“at least three positive cultures within the previous six months”. In the latter, one 
positive culture within the previous three was defined as current infection. Also, for 
ten of these preschool children, CF care was delivered at one of the other centres 
participating in the London CF Collaboration, and sample collection and culture 
techniques may differ from those employed at Great Ormond Street Hospital.
Third, chest radiographs were not performed as part of this study. All children who 
attended Great Ormond Street Hospital for their clinical care had chest radiographs 
performed approximately once yearly for clinical indications. The radiograph 
closest in time to the lung function study (either before or after) was used for this 
secondary analysis.
6.6.4 Relationships between phase III slope parameters, LCI, and FEVi
Of the phase I I I  slope parameters studied here, the first breath S n I I I COrr is a measure 
of overall ventilation inhomogeneity, whilst S COnd,corr, and S acin,corr are measures of 
ventilation inhomogeneity generated by convective-dependent mechanisms, and by 
mechanisms dependent on diffusion-convection interaction, respectively. I t  can
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therefore be predicted that the LCI, which is a measure of overall ventilation 
inhomogeneity, will be closely related to first breath SnIIIcorr, and less closely 
related to S cond ,co m  and Sacin ,corr- The results presented here confirm this prediction. 
Figure 6.8 demonstrates that almost all children with CF who had abnormal first 
breath S n I I I COrr also had abnormal LCI, but that the converse was not true, 
indicating that LCI is the more sensitive of the two indices for detecting abnormal 
lung function in children with CF.
Figure 6.9 demonstrates that all but eight of the children with CF with a raised LCI, 
and all but two of those with a LCI greater than 9, also have raised SCOnd,corr- In 
contrast (Figure 6.10) the majority of children with raised LCI have normal Sacin,corr- 
This supports the conclusion that CF lung disease primarily results in ventilation 
inhomogeneity generated in the conducting airways, whilst only a minority of 
children with CF also have inhomogeneity generated more distally. It should be 
noted here that SCOnd,corr and Sacin,corr are calculated by different means, and it is not 
possible to estimate overall ventilation inhomogeneity by calculating the sum of the 
two. Further analysis of these relationships is therefore not possible.
There were only weak relationships between phase III slope parameters and FEVi 
z-score. The reasons for this have already been discussed in Chapter 5.
6.6.5 Relationship between phase III slope parameters and clinical information in 
children with CF
It has already been demonstrated that preschool children with CF who are infected 
with Pseudomonas aeruginosa have significantly higher LCI than those who are not 
infected. Data presented in this chapter demonstrate that both infected and non­
infected children have raised Scond, but only infected children have significantly 
raised Sacin- Results presented in Table 6.9 demonstrate that there are small but 
significant relationships between the presence of cough and raised first breath SnIII, 
raised SCOnd, and raised Sacin- Weak positive relationships between Chrispin-Norman 
score and first breath SnIII and Sacin were noted, whilst there was no relationship 
between Chrispin-Norman score and Scond- It is also noted that mean Chrispin- 
Norman score in preschool children with CF was only 6.8, suggesting that this score 
is not a sensitive marker of mild CF lung disease.
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These results are discussed further in the next chapter, but it should be noted again 
that these are all secondary analyses, for which this study is not powered, and 
results should be treated with caution.
6.6.6 Conclusion
In conclusion, this study has demonstrated that the S COnd and S a c in  analysis is 
possible in preschool children, and that volume correction facilitates comparison of 
children with and without lung disease. Most children with CF, even young 
preschool children, have raised S cond 5 though raised S ac in  is mainly seen in older 
school-age children.
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Chapter 7: Discussion
7.1 Summary of most important results
The hypotheses for this thesis were originally presented in Chapter 1, as primary 
and preliminary hypotheses:
Primary hypotheses:
1. More children with CF will have abnormal washout results than will have 
abnormal spirometry results.
2. Children with CF with abnormal washout curve results will also have 
abnormal phase III slope results. These children will have evidence of 
inhomogeneity arising both from convective flow {i.e. S COnd)> and from the 
interaction between diffusion and convection {i.e. S acin ) .  Both measures of 
inhomogeneity will be greater in older children.
Preliminary hypotheses:
A. Children aged two to five years are unable to meet some of the quality control 
criteria for spirometry, but alternative criteria may be feasible.
B. In healthy subjects, the LCI is independent of subject age, age group {i.e. 
preschool or school-age), sex, and body size. In all subjects, the LCI is 
independent of variations in respiratory rate, tidal volume, and functional 
residual capacity seen during spontaneous tidal breathing.
C. In healthy subjects, the phase III slope is negatively related to tidal volume, 
but otherwise independent of subject age, age group, sex, and body size. In all 
subjects, the phase III slope is negatively related to tidal volume, but is 
independent of variations in respiratory rate and functional residual capacity 
seen during spontaneous tidal breathing.
Results have been presented in four chapters.
In chapter 3, preliminary hypothesis A was tested. It was demonstrated that 75% of 
preschool children are able to perform spirometry, but that most cannot meet the 
quality control criteria recommended for adults, and that some modifications to
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these criteria may be appropriate. Related to this, FEVi is not an appropriate 
spirometry outcome measure for preschool children, and an alternative is required.
In chapter 4, preliminary hypotheses B and C were tested. It was demonstrated that 
almost 80% of preschool children can perform MBW at first attempt. It was also 
shown that LCI is largely independent of subject characteristics and breathing 
pattern during spontaneous breathing in healthy children; that there is a hyperbolic 
relationship between SnIII and the expired volume of that breath, and that SnIII as a 
product of expired volume is largely independent of subject characteristics. It was 
also demonstrated that exclusion of small breaths during quality control reduces the 
variability of the results without introducing bias, and that the plot of SnIII versus 
turnover is linear between 1.5 and 6.0 turnovers, even in preschool children.
In chapter 5, primary hypothesis 1 was tested. It was demonstrated that more 
children with CF have abnormal LCI than have abnormal spirometry; that there is a 
positive relationship between LCI and age; and a negative relationship between LCI 
and FEVj. In a secondary analysis, it was demonstrated that preschool children with 
CF who are infected with Pseudomonas aeruginosa have higher LCI than those 
who are not infected.
In chapter 6, primary hypothesis 2 was tested. It was demonstrated that the S cond and 
Sacin analysis is possible in preschool children, and that volume correction facilitates 
comparison of children of different ages. Most children with C F ,  even young 
preschool children, were noted to have raised S COnd, with no age relationship seen. In 
contrast, only a minority of children with C F  had raised S aCin > and nearly all of these 
children were aged 10 years or older.
Interpretation and discussion is presented within the results chapters. The aim of 
this final chapter is to draw the information from the four results chapters together, 
and to discuss the implications of these results with regard to our understanding of 
the development of lung disease in preschool children with CF.
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7.2 Strengths and weaknesses of study design
7.2.1 Overall study design
This study was performed in two stages. In the initial phase, the MBW technique 
was compared to spirometry in a population of children with CF and in a matched 
healthy population. In the second phase, a similar cross-sectional study was 
performed in matched populations of preschool children, with and without CF. The 
strengths and weaknesses of this design are discussed below.
7.2.2 Local control population
For well-established measures of lung function, reference equations for normal 
subjects are often available. These equations are derived from populations of 
healthy children, tested at one or more centres. A scatter of normal values is 
collated, and the values can be regressed against height, weight, sex, or sometimes a 
combination of predictor variables. The resultant regression equations can be 
applied to data obtained in subsequent children, with raw data converted into 
percent predicted, or z-scores.
It is possible to use these prediction equations as control data for observational 
studies. In other words, results obtained in children with disease are converted into 
z-scores, or percent predicted values, for interpretation. In effect, the researcher is 
using the healthy population from which the reference equations were derived as 
the control population for the study. The weakness of this method is that results 
may not be directly comparable, either because of differences in data collection 
methodology between centres, or because of differences in the test populations (e.g. 
different ethnic make-up, or differing body composition between countries or 
between eras). A strength of the current study is that a local, matched control 
population was employed. This allows direct comparison of lung function results 
between CF and control groups, and facilitates comparison of the relative sensitivity 
of different techniques. It is accepted that the original control group was not 
matched well for ethnicity, and further subjects had to be recruited. It is also true 
that the relatively small number of control subjects prevents detailed analyses of the 
effects of ethnicity, sex, maternal smoking history etc. upon lung function results in
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this age group. However, the use of a local control group is still preferable to the 
use of external controls.
Reference equations for spirometry parameters were available for both school-age 
and preschool children, but these were employed to ensure that data collected at 
ICH was similar to that previously reported from other centres. Encouragingly, 
healthy children tested at ICH had normal z-scores for most parameters tested 
(Chapters 3 and 5). Important exceptions were that healthy preschool children 
tested at ICH had higher FEVi and FVC results than children previously tested in 
Oslo 40 (Table 3.6), with a smaller scatter, and that children tested at ICH had a 
larger scatter in MMEF scores than children previously tested in Indianapolis24. 
One possible explanation for the discrepancy with the Oslo data is that some of the 
FEVi and FVC results from Oslo may have been reported from expiratory efforts 
that were terminated early. This would result in the Oslo group reporting results for 
these parameters that were erroneously low, and with an erroneously large scatter. 
An alternative explanation is that the Oslo group included some children with 
respiratory disease. The authors of the Oslo study identified a number of children 
with a history of respiratory symptoms, but claimed that this subpopulation had 
identical spirometry results to those children with no respiratory symptoms. The 
author has attempted to contact the Oslo group to discuss their data further, but has 
been unable to do so. It is more difficult to explain the discrepancy with the 
Indianapolis data. It may be that the high scatter seen at ICH is due to measurement 
error at this laboratory, but this is contradicted by the good concordance in FVC and 
FEVi results obtained in the two centres. On a related point, Table 5.6 presents an 
analysis of spirometry z-scores in healthy Swedish children, calculated by Swedish 
reference equations of Solymar et al and also by the equations of Rosenthal et 
al120 which were employed for the school-age children tested at ICH. It was 
demonstrated that results obtained from children tested in Sweden fit the equations 
of Rosenthal et al more closely than they fit the Swedish equations. One possible 
explanation for this discrepancy is that the Solymar reference equations are now 
out-of date (they were published in 1980). Dr Per Gustafsson has been informed of 
this finding, and will communicate it to Swedish paediatricians and researchers.
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7.2.3 Quality control
There have been few previous reports of spirometry or MBW in the preschool age- 
group. In common with other lung function tests, results from these two techniques 
were predicted to be dependent on consistent protocols for data collection and 
analysis. Although such protocols are available for spirometry in adult subjects34’35, 
one of the hypotheses of this study was that these quality control criteria would be 
inappropriate for the preschool age-group. Half of this thesis is therefore devoted to 
establishing quality control criteria for data collection in preschool children, and to 
examining the effects of subject and breath characteristics on the chosen outcome 
measures for both spirometry and MBW. Throughout the study, data collection 
methodology, data recording, and analysis and interpretation were regularly audited 
and cross-checked. Although the vast majority of the data were collected by the 
author with two co-researchers (Cara Oliver and Clare Saunders), other members of 
the Lung Function Research Team at the Institute of Child Health assisted with this 
quality control process. The experience and expertise of this team in performing 
similar quality control for infant lung function testing, and the availability of 
custom written software for data storage and retrieval, were major strengths of this 
study.
7.2.4 Selection of population
The primary aim of this study was to compare the relative sensitivity of two 
different lung function techniques for discriminating between children with CF and 
healthy children. It was therefore necessary to ensure that CF and healthy 
populations were well matched for age, sex, and ethnicity, but it was not essential to 
ensure that the CF sample was representative of the overall clinic population.
It is likely that selection bias operated for both the school-age and preschool CF 
populations. The school-age CF population was recruited opportunistically from 
out-patient and ward attenders, and it is likely that children who had more severe 
disease, and who were therefore attending hospital more frequently, were more 
likely to be approached to participate in this study. For the preschool population, the 
families of all children with CF aged 2 to 5 years who were attending the CF clinic 
at Great Ormond Street Hospital were approached to take part in this study. As this
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recruitment method did not yield an adequate number of subjects, the remaining 
subjects were recruited opportunistically from the other centres participating in the 
London CF collaboration. At commencement of this study, the primary aims were 
to determine whether preschool children could perform these lung function tests, 
and to compare the results obtained by different techniques. The study was more 
successful in meeting the original aims than expected, and in retrospect it could be 
argued that lack of rigour in subject recruitment has resulted in a lost opportunity to 
answer further questions. Were the study to be designed again, an attempt should 
have been made to recruit a representative sample of school age children with CF 
from the GOS clinic. This would have allowed the results to be extrapolated to the 
whole clinic population, and would also have allowed a comparison of outcomes 
between the GOS clinic and the CF clinic in Gothenburg, Sweden.
Healthy school-age children were recruited largely as friends of children with CF. 
Healthy preschool children were recruited largely from local schools and 
playgroups. In all cases children (or their parents) were asked a series of health 
questions to ensure that inclusion criteria were met. There is ongoing controversy as 
to how control populations should be defined. In this study, children who had been 
diagnosed with asthma or were on anti-asthma medication; children with cardiac, 
neuromuscular or skeletal disease; children who were bom small for gestational age 
or preterm; children who had previously been hospitalised for a respiratory 
condition; and children who had frequent respiratory symptoms over the previous 
12 months were excluded from the control group. Children who had previously had 
respiratory symptoms but had now outgrown these were not excluded. The rationale 
for this is that respiratory symptoms are very common in infancy and early 
preschool years, and that children with such a history but no ongoing symptoms 
should still be considered part of the healthy population.
On a related point, it would have been preferable to fully record how many healthy 
children were approached to participate in the study, how many responded, and how 
the children included in the study compared to those who did not respond or refused 
consent. This approach would have been consistent with recommendations for 
reporting randomised controlled trials125. Unfortunately, the hospital ethics 
committee would not allow recording of any data on children whose parents or
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guardians had not expressly consented to be included in the study. Instead, the 
recruitment method chosen for the study was to ask teachers to distribute 
recruitment letters and to await responses from parents. Although the number of 
recuitment letters sent to schools was recorded, there was no record of how many of 
these letters were actually distributed to families. In retrospect, this information 
should have been recorded and analysed.
7.2.5 Two studies rather than one
One clear weakness of this study design is that it is not possible to directly compare 
results between school-age and preschool children with CF. There are two reasons 
for this.
First, the data collection methodology for the two groups differs slightly, with the 
most important discrepancy being the subject-apparatus interface. In preschool 
children, a facemask apparatus with a putty seal was employed. School-age children 
wore nose-clips and breathed through a mouthpiece. The facemask system has a 
larger dead-space, and also allows the subject to breath nasally. The effect of 
subject-apparatus interface upon MBW parameters has never been studied (though 
such a study is planned for the near future). It is possible that the discrepancy in 
LCI between healthy preschool and school-age children (Figure 4.4, Table 4.8) is 
related to the interface, or to the method used to correct LCI for apparatus dead- 
space.
Second, the method of recruitment for the preschool and school-age subjects differs, 
with school-age children being drawn exclusively from the clinic at Great Ormond 
Street, and preschool children drawn from all five tertiary CF centres in London. 
The analysis of school-age children was initially intended as a pilot study, with the 
primary objective of establishing the MBW methodology (Section 1.10). 
Comparison of results between preschool and school-age children was not a 
primary objective of this study. When data collection in school-age children first 
commenced (September 2000), the findings of Gustafsson et al had not been fully 
analysed, let alone published. The finding that nearly all school-age children with 
CF have abnormal LCI, even when they have normal spirometry results, was 
unexpected. If this information had been available at the time the study was
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designed, then greater care would have been taken over recruitment methods for the 
school-age and preschool arms.
7.2.6 Inclusion of body plethysmography in the original protocol.
When this preschool study was first designed, the intention was to compare results 
obtained from MBW, body plethysmography, and spirometry. On interim analysis it 
became clear that sRaw results (from body plethysmography) obtained in healthy 
preschool children in the author’s laboratory were not identical to those reported 
from other centres. A number of potential methodological reasons for this 
discrepancy were identified, which require investigation. Results from body 
plethysmography were therefore excluded from this thesis. However, it should be 
noted that all preschool children in this study performed MBW, body 
plethysmography, and spirometry, in that order, and were not considered to have 
completed the study protocol unless results were obtained from all three tests. This 
complicates comparison of success rates for the two methods reported in this thesis.
7.2.7 Measures of inflammation and infection in preschool children with CF 
As described in Section 1.10, the ideal methodology for evaluating a lung function 
measure would be to compare it against a ‘gold standard’ method for the presence 
or absence of lung disease. For most lung diseases, and specifically for CF, no such 
gold standard exists.
Lung disease in CF is a progressive disease, caused by bacterial infection and an 
associated intense neutrophilic inflammatory response. This cycle of infection and 
inflammation results in excessive mucus production and airway narrowing.
19AProducts of neutrophils, such as neutrophil elastase account for much of the 
subsequent parenchymal destruction. It has been demonstrated that infants with CF 
have evidence of inflammation and infection in their lungs, even when they are
19 7asymptomatic, and that this inflammation is reduced by antibiotic treatment . 
Studies in infants, comparing presence of inflammation with lung function changes, 
have produced conflicting results. Dakin et a l8 demonstrated significant 
relationships between specific respiratory system compliance and pathogen load, 
and with the number of neutrophils in BAL fluid. Nixon et al 128 were unable to 
demonstrate a relationship between inflammation and reduced lung function (as
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measured by the raised volume rapid thoracoabdominal compression technique 
[RVRTC]).
The aim of this study was to compare the sensitivity of different lung function 
techniques. Ideally, measures of inflammation and infection should have been 
obtained at the same time as the lung function measures and used to inform this 
analysis. This was not possible for practical reasons. For all the infant studies 
described above, inflammatory markers were measured from BAL. This is an 
invasive technique, which requires general anaesthesia or heavy sedation in young 
children. None of the CF centres involved in this study perform routine BAL as part 
of the clinical care of young children with CF, and the author did not believe that 
this procedure could be justified for the current study. This decision may be 
reviewed for future studies of MBW in young children.
Alternatively, less invasive measures of lung inflammation have been described 
recently. The three techniques generating the most interest are analysis of induced 
sputum 129' 131, analysis of exhaled breath condensate (EBC)132' 134, and
1 1  ' Jfimeasurement of exhaled nitric oxide (eNO) ‘ . For all three of these techniques, 
methodology for data collection and interpretation have not yet been standardised 
for adults and older children. Modifications that allow EBC and eNO to be 
collected in infants have recently been described 139141 but this work is still in its 
infancy. It is not yet possible to employ these techniques in preschool children. 
Information on chronic bacterial infection was available from sputum and cough 
swab cultures taken at the child’s local hospital. These results suggested that 
preschool children infected with Pseudomonas aeruginosa had higher LCI than 
those who were not infected with this organism. However, culture from cough swab 
in young children may underestimate the presence of chronic infection when 
compared with culture from BAL142.
7.2.8 Measures of structural change in preschool children with CF
High resolution computed tomograph (HRCT) has been proposed as a method for 
detection of early lung disease in CF. HRCT scans can be scored for presence of 
bronchiectasis, airway plugging, and small airways disease (detected by differences 
in signal density between corresponding inspiratory and expiratory images). Studies
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using HRCT scoring have demonstrated that structural changes are already present 
in young children with CF 23;143 and that these structural changes may be present in 
children with normal plain chest radiographs and normal spirometry results . 
Ideally, the lung function results presented in this thesis should have been compared 
with scores obtained form inspiratory and expiratory HRCT scans. However, as for 
BAL, HRCT studies are not part of routine clinical care of children with CF 
attending the five CF centres in London, and the radiation exposure and expense of 
HRCT precluded these investigations being performed solely for comparison with 
lung function results.
Plain radiographs were performed regularly in the children studied here. 
Radiographs taken in children seen in the clinic at Great Ormond Street Hospital 
were scored according to the Chrispin-Norman scoring system, and these results 
were related to spirometry and MBW results. Weak correlations were seen.
7.2.9 Other measures of clinical status in preschool children with CF
Clinical assessments were made by the child’s consultant prior to lung function 
testing, and also by the author on the day of testing. Some of the questions asked 
were for the purpose of future analyses. Those data that were analysed here are 
discussed below:
• Mode o f presentation. There was no significant relationship between mode 
of presentation (i.e. with respiratory symptoms or gastrointestinal 
symptoms) and lung function results. This finding echoes that of 
Ranganathan144 in his previous study of infants with CF from the London 
Collaborative study.
• Maternal smoking. There was no significant difference in lung function 
results between children of mothers who smoked, and those who did not.
• Presence o f cough. Preschool children with cough had worse spirometry 
results, and tended to have worse LCI results.
• Investigator visual analogue score. There was no significant relationship 
between VASi and LCI, and only a weak negative relationship between 
VASi and spirometry parameters.
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The mode of presentation was obtained from consultant questionnaire, and was 
confirmed by direct questioning of the parents. No discrepancies were noted, and 
this information is likely to be accurate.
The remaining three measures can be criticised. First, all secondary analyses are 
underpowered, and type two error is possible. History of maternal smoking was 
derived solely from parental report. It has previously been demonstrated that the 
prevalence of maternal smoking may be underestimated by this method145, and this 
may apply to the data presented here. Ideally, salivary cotinine could have been 
measured from all preschool subjects participating in this study. This was not done 
because of a belief that the study protocol was already long and complicated, and 
that addition of a further investigation may have reduced success rates.
Presence of cough was defined by parental report. It has been demonstrated that 
parents do not describe wheeze in the same way as doctors146, and the definition of 
asthma from parental reported symptoms alone is discredited. Cough is a more 
straightforward symptom, and the author has assumed that parents of children with 
CF define cough in the same way (as each other, and as their doctors would). It is 
known that children with CF do not quantify cough well123, so for the current 
study, preschool children with CF were categorised simply by presence or absence 
of cough, rather than by cough frequency.
Investigator visual analogue scores are the most contentious of the clinical 
measures presented here. Visual analogue scores are not new, and are employed in 
a variety of research and clinical settings. However, they have not been validated 
in this setting, and intra- and inter-observer variability is unknown. All VASi 
scores were completed by the author, so inter-observer variability is not an issue, 
though within-observer, between occasion variability may still be a source of bias. 
Further, they were completed before lung function testing commenced, to minimise 
bias. However, it can still be argued that these scores are subjective.
In defence of this study, it is argued that there are no validated measures of clinical 
status for young children with CF. The most widely employed clinical scoring 
system in CF is the Shwachman-Kulczycki score. This scoring system can be 
heavily criticised, being complex and time consuming. More importantly, it dates 
from an earlier era of CF care, and has not been validated for the assessment of
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mild lung disease in young children. The only other scoring systems available for 
children with CF are designed for estimating prognosis of children with severe 
lung disease, so that timing of lung transplantation can be optimised. These scores 
would not have been appropriate for the current study.
7.3 Feasibility of spirometry and MBW in preschool children
Success rates for completion of spirometry and MBW in preschool children were 
presented in Chapters 3 and 5. These data are combined in Table 7.1.
Younger children (those aged less than 4 years) were significantly less likely to 
successfully produce FEVo.s results than older children. In comparison, there was 
no significant difference in success by age for LCI. These results compare 
favourably with success rates reported in other studies of lung function in preschool 
children 24;36^ 4W91.
Table 7.1 Number of preschool children successfully completing LCI 
or FEVo.s at first visit
All
children
(n=77)
Cystic
Fibrosis
(n=40)
Healthy
Controls
(n=37)
2-<3 
years 
(n=6)
3-<4 
years 
(n=32)
4-<5 
years 
(n=24)
5-<6 
years 
(n=15)
LCI 61 30 31 3 25 20 13
(79%) (75%) (84%) (50%) (78%) (83%) (87%)
FEVo.5 59 30 29 2 23 21 13
(77%) (75%) (78%) (33%) (72%) (88%) (87%)
Legend: Results are presented as number (%). Success rates fo r MMEF were 
identical to those for FEVo.s. Data are from Tables 3.2 and 4.3 (two subjects 
included in Table 3.2 did not attempt MBW and are excluded here).
i n
7.4 Quality control for spirometry in preschool children
7.4.1 Suggestions for spirometry quality control criteria in preschool subjects
There is now no doubt that spirometry in preschool children is feasible. Although 
some failure is inevitable, results can be obtained in 70 to 80% of these subjects. It 
remains to be proven whether measures obtained at this age are sensitive enough to 
influence clinical or research practice, but before these questions can be tested, it is 
essential that standards for quality control in the preschool age group are 
established. This process has recently been completed for infant lung function 
testing, and the European Respiratory Society and the American Thoracic Society 
have recently initiated a similar process for preschool lung function standardisation. 
Ideally, recommendations published by such working parties should be evidence 
based, but, as described in this thesis, such evidence is scarce in the preschool age 
group.
Data presented in Chapter 3 of this thesis may contribute to this standardisation 
effort for spirometry. At least, these data demonstrate that preschool children are 
unable to meet many of the quality control criteria stipulated for adult subjects. 
Based on the results presented in Chapter 3, the author is able to make the following 
suggestions:
a) All curves must be visually inspected, but this process could be facilitated 
by modifications to software
b) Start of test can be quantitatively assessed as in adults, but results greater 
than 80mL for VBE or 12.5% for VBE/FVC should be indications for visual 
re-inspection of the flow-volume trace, rather than automatic exclusion
c) FEV, should only be reported if FET for that expiration is greater than t
d) In all preschool children both FEV0.75 and FEVo.5 should be reported in 
addition to FEVi
e) Repeatability can be assessed as for adults, but criteria of lOOmL or 10% of 
best effort for AFVC and AFEV, may be more appropriate than the criteria 
applied to adults.
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In addition to these recommendations, users should be cautioned that current 
spirometry software may result in erroneous reporting of FET and timed expired 
volumes. The author and his supervisor have contacted manufacturers with requests 
to amend software to allow quantitative assessment of end of test, and to allow 
recording and re-analysis of multiple manoeuvres, including those initially assessed 
as inadequate or borderline. These software amendments should allow data to be 
excluded from reports or summaries, whilst still being retained on databases to 
allow future re-analysis.
Before incorporating such recommendations into guidelines it will be necessary for 
other groups to assess these criteria in their own populations. Given the portability 
of spirometry equipment, these criteria should ideally be tested in both specialised 
laboratories and in general clinics or health centres. Accurate application and 
interpretation of spirometric assessment in the preschool age group has considerable 
potential benefit, both for clinical practice and research. This potential benefit 
justifies the effort required for standardisation.
7.4.2 Which timed volume, and why?
One of the key points of the above recommendations is that FEVi may not be a 
suitable spirometry outcome measure in preschool age-group. Table 3.5 presents the 
median (IQR) FEVj/FVC ratio in the preschool population as 94% (91, 98%), with 
no difference between the CF and control populations. The FEV0.5/FVC ratio for the 
whole population was 81% (72, 87%), with a trend to lower results in children with 
CF compared with healthy children. The rationale for reporting FEVi in the adult 
population is that in healthy adults the FEVi/FVC ratio is about 70%. In adults, 
therefore, the FEV1 is completed relatively early in expiration, and is not affected 
by failure to maintain flow limitation at the end of expiration. Furthermore, 
moderate airway obstruction is predicted to cause prolongation of forced expiration, 
with reduced expiratory flow in mid-expiration. In adults, reduced mid-expiratory 
flow will reduce the FEVi/FVC ratio further, meaning that both the FEVi, and the 
FEVi/FVC ratio, are more sensitive markers of obstructive lung disease than FVC 
alone. In preschool children, FEVi is very similar to FVC. In addition, respiratory 
muscle strength, essential for maintaining flow limitation at low lung volumes, is
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less in young children than in adults. It can therefore be predicted that FEVi will be 
more variable than shorter timed expired volumes in this age group, and also that 
this index will be less able to discriminate subjects with airways disease than 
healthy subjects.
The observation that preschool children empty their lungs more rapidly than older 
children and adults is not unexpected 147' 149. it has long been known that infants 
undergoing the RVRTC manoeuvre complete maximal forced expiration in less 
than one second144. This phenomenon is attributed to large airway calibre relative to 
total lung volume in infants and younger children when compared to older children 
and adults. As a consequence, FEVo 4 or FEVo 5 are the preferred timed expired 
volumes reported from RVRTC in infants. On this point, a note of caution is 
appropriate. Many infant lung function laboratories in North America have adopted 
FEV0.5 as the preferred outcome measure from RVRTC. However, recent data by 
Ranganathan et al110 suggest that FEV0.4 is the more discriminatory of the two 
measures. Some infant lung function centres are still recording and reporting both 
these timed volumes. Those who are not may subsequently discover that they are 
not able to fully interpret their data. For preschool children it can be concluded from 
the data presented in this thesis that either FEV0.75 or FEV0.5 would be suitable 
spirometry outcome measures. If the experience from infant lung function testing is 
a precedent, then it would be prudent for all preschool laboratories to record and 
store both these variables from all manoeuvres, at least until international standards 
are published.
7.5 Quality control and variability for MBW indices
7.5.1 How many MBW runs are needed?
Results presented in Figure 4.2 and Table 4.6 demonstrate that LCI calculated as a 
mean of two runs is similar to that calculated as a mean of three runs, with no 
difference in population mean LCI, and 95% limits of agreement of -0.54, 0.49. In 
Figure 4.3 and Table 4.7 it is demonstrated that LCI obtained from the first run only 
is similar to that calculated as the mean of three runs, with a mean difference of 
only 0.1, and 95% limits of agreement of -1.22, 1.01. Mean differences between CF
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and control populations are far larger than these limits of agreement (being 5.08 in 
school-age children, and 2.72 in preschool children). It can be convincingly argued 
that calculating LCI from two, or even one MBW run will not reduce the ability of 
LCI to discriminate between CF and control populations. With such narrow limits 
of agreement, it is also likely that most children with CF who were identified as 
having abnormal LCI from the mean result of three runs, would have been labelled 
identically by LCI calculated as the mean of two runs. This analysis is beyond the 
scope of this thesis, but should be a priority for the future, as ability to report LCI 
from one or two MBW runs will reduce the duration and cost of the investigation.
Similar analyses could not be performed for Scond and Sacin, as these indices were 
calculated from an aggregated plot of SnIII versus TO, taken from all three MBW 
runs. This method of analysis was selected following preliminary work performed 
in our collaborating laboratory in Gothenburg124. It should be noted however that 
the best means of calculating Scond and Sadn in spontaneously breathing children has 
not yet been determined (see below), and it may in future be possible to establish a 
method that does not require data from three runs. Chapter 4 presents a detailed 
analysis of the effect of subject and breath characteristics upon MBW indices.
7.5.2 How should LC I be corrected fo r  dead-space?
The LCI, as presented in this thesis, is the simplest, and arguably the crudest 
method of describing the duration of a MBW run. Essentially, it describes how 
often the lungs have to recycle resident air in order to wash out a tracer gas. In 
Section 1.6.2 a number of other indices for describing washout curves were 
presented. The one that is most closely related to LCI is the mixing ratio (MR). The 
MR is presented as the ratio between the observed and the predicted number of
i L
breaths required to reduce the end tidal tracer concentration to 1/40 of starting 
value, where the predicted number of breaths is that which would be needed to 
complete the washout in ideal mixing conditions47.
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Calculation o f ideal number o f breaths for Mixing Ratio:
ln(end gas concentration • starting gas concentration1)
number o f  = ---------------------------------------------------------------
breaths
In (FRC ■ FRC+(Vr VDm)- ')
For this calculation it is necessary to include a measure of airway dead-space 
(Voaw), which is customarily estimated as 2mL • kg body weight.
The ideal number of breaths is calculated from the ratio between the logarithm for 
the end-tidal SF6 at end-washout and the logarithm for the FRC • (FRC + alveolar 
Vt)'1 ratio. The alveolar tidal volume (Vr) is calculated as average VT during the 
MBW minus the predicted airway dead space (Voaw = b.w. • 2 mL). In other words, 
there are only two differences between the MR and the LCI. First, the MR is 
presented as a ratio of observed versus predicted, whilst the LCI is presented as a 
raw number. Second, and more importantly, the MR includes a correction for 
airway dead-space, whilst the LCI does not.
Both LCI and MR are calculated in such a way that within-subject alterations in 
FRC and Vt are compensated. The LCI is calculated as the ratio of CEV to FRC. 
Any increase in FRC will increase the volume of tracer gas that needs to be washed 
out of the lung, and the CEV will also be increased. Any increase in Vt will reduce 
the number of breaths required for the subject to reach the end-point of the washout. 
However, as these breaths will be of larger volume, the CEV should not be affected. 
Apparatus dead-space is subtracted from any calculation of CEV, but airway dead- 
space is not. The mixing ratio (MR) is calculated as a ratio between the ‘actual’ and 
‘ideal’ number of breaths taken to reach the end of the washout. The ideal number 
of breaths is calculated at the end of the washout, using a formula that takes both 
the size of FRC and Vt measured during that washout into consideration. From the 
formula above, it can be seen that as Vt increases, and as the FRC decreases, the 
calculated ideal number of breaths will decrease48.
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Edelman47 has argued that in a uniformly ventilated lung, a decrease in FRC (with 
no change in V t)  will produce an increase in LCI. The explanation for this is related 
to the effect of airway dead-space, and mirrors the argument that a fall in V t will 
result in an increased LCI. Any subject who breathes at a very low tidal volume, 
such that the majority of ventilation is directed at airway dead-space may, 
theoretically, produce a high LCI. Likewise, at lower FRC the airway dead-space 
represents a larger proportion of the lung than at higher FRC. Edelman used these 
projections to justify the use of MR as an alternative index, as this index includes a 
correction for airway dead-space, and should therefore be less affected by changes 
in FRC and Vt- However, recent studies reporting both LCI and MR have noted 
little difference between the two indices27, and data presented in Chapter 4 of this 
thesis suggests that spontaneous changes in V t and FRC during tidal breathing in 
children do not affect LCI, presumably because these changes in FRC and V t were 
of insufficient magnitude. A preliminary analysis of data collected in school-age 
children (presented in the Appendix) demonstrated that the relationships between 
MR and V t and FRC were of similar magnitude to those seen with LCI. This 
suggests that these relationships result from subtle changes in the physiology of gas 
mixing, rather than just the effect of dead-space correction (see Section 4.7.4).
7.5.3 Correction o f  Sn III fo r  expired volume
Chapter 4 describes the relationships between MBW indices and subject and breath 
characteristics. In healthy children, LCI was noted to be largely independent of age, 
body size, and breath characteristics. In contrast, there was a negative relationship 
between first breath SnIII and age (Figure 4.16). Multivariate analyses suggest that 
this relationship is responsible for the apparent effect of subject characteristics upon 
SnIII. When subject characteristics were modelled against SnIII in healthy children, 
38% of the variability of SnIII was explained. However, the product of SnIII and 
expired volume was independent of subject characteristics in healthy children (r2 for 
multivariate model 2%, Figure 4.18).
The hyperbolic relationship between SnIII and expired volume could simply be 
explained mathematically. However, this requires two assumptions:
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• First, the tracer gas concentration at the beginning of the alveolar phase for 
the first breath of an MBW is always the same for any individual, 
regardless of expired volume
• Second, the tracer gas concentration at the end of the alveolar phase for the 
first breath of an MBW is always the same for any individual, regardless of 
expired volume.
SIII is calculated as the change in percentage gas concentration as a function of 
expired volume. The dimensions of SIII are therefore %' L"1. SIII is normalised by 
dividing by the mean gas concentration for the phase III interval, giving SnIII, the 
dimensions of which are L '1 (Figure 7.1). SnIII represents proportional change in 
gas concentration over the alveolar portion of the expired breath, expressed as a 
function of expired volume. If the volume of the expired breath is smaller, the 
volume of the alveolar phase will also be smaller. If it is assumed that the 
proportional change in gas concentration from beginning to end of the alveolar 
phase is the same, irrespective of the size of the expired breath, then a hyperbolic 
relationship between SnIII and expired volume is predicted. By the same logic the 
product of SnIII and expired volume (defined here as SnIIICOrr) should be 
independent of expired volume.
Interestingly, SnHICOrr is dimensionless (as is LCI) and, like LCI, SnIIICOrr is 
independent of age and body size in healthy children. This lends weight to the 
argument that the efficiency of gas mixing is constant throughout childhood, at least 
between the ages of two and 16 years.
The mathematical explanation presented is appealingly simple, but the two 
underlying assumptions are unlikely to be valid, as the tracer gas concentration at 
the first breath will be affected by the volume of the preceding inspiration, and by 
the FRC. For subsequent breaths the breathing pattern up to that point (including 
pauses and sighs) will affect gas concentrations at any given point in the MBW. It 
may be that the volume correction method proposed here does not hold for extremes 
of tidal volume, FRC or respiratory rate, and laboratory studies are necessary to 
investigate this.
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Figure 7.1 Calculation of SnlllCorr
Volume [L]
Legend: SIII is calculated as the change in gas concentration as a function o f  
expired volume. The dimensions o f  SIII are therefore % • L '1. SIII is normalised by 
dividing by the mean gas concentration fo r the phase III interval. The resultant 
normalised slope (SnIII) has dimensions L'1. It can be argued that i f  the size o f  the 
expired breath is smaller, the volume over which the alveolar phase develops will 
also be smaller, and the value o f SnIII will be greater. Volume correction creates a 
new index (SnIIIcorr), which is dimensionless, and which expresses the proportional 
change in gas concentration from the beginning to end o f  the alveolar phase, 
irrespective o f tracer gas concentration, and breath volume.
In Chapter 6, volume correction was applied to calculation of S aCin and S c o n d- S a c in>corr  
was calculated as the product of S aCm and first breath Vexp. S c o n d ,corr  was calculated as 
the product of S c o n d and mean Vexp. The resultant indices were age-independent in 
healthy subjects. The method of volume correction requires further investigation, as 
modifications could be proposed. In particular:
• Should breaths be corrected by the total expired volume (corrected for 
V DaPP)  or by the volume of the alveolar phase only?
286
• Should Scond be calculated by the established method, and then volume- 
corrected, or should all breaths of an MBW be volume-corrected 
individually, and Scond,corr calculated from the resultant plot of SnIIICOrr 
versus TO?
7.6 Clinical implication of results, and future research
7.6.1 Could MBW be used as a clinical tool in young children with CF?
At the beginning of this thesis, the starting aim was presented as “to investigate 
whether MBW could be employed as a measure o f  lung function in preschool 
children with CF” We know that this question cannot be fully answered by a cross- 
sectional observational study, but how much further have the data presented here 
taken us? What do we know now, and what remains to be answered? In this section 
we will discuss what MBW tells us about early lung disease that other lung function 
tests cannot, and also discuss priorities for future studies.
7.6.2 Why do some children with CF have normal spirometry and abnormal LCI?
An explanation for flow limitation during spirometry was presented in Section 
1.4.1, with a description of wave-speed theory. As forced expiration proceeds, 
choke points multiply and cascade peripherally. Flow measured at the mouth 
represents the integrated output of all the airways, and therefore demonstrates the 
stepwise limitation of global sites of flow-limitation as these sites move from one 
level to the next. As upstream parallel sets of choke points are completed, these 
choke points ‘jump’ to the next level150. McNamara et al151’152 demonstrated 
interdependence of regional expiratory flows in excised canine lungs, showing that 
within a region of lung whose emptying is controlled by a regional choke point, 
more peripheral upstream airways may become flow limited asynchronously. As 
some of these airways contribute less to regional flow, other non flow-limited 
airways compensate by increasing flow. By this mechanism, non-uniformities in 
flow are masked. It can therefore be predicted that spirometry will not be a sensitive 
tool for detecting mild, non-uniform airway disease.
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In contrast, LCI is predicted to be a sensitive marker o f  non-uniform airway disease, 
as it quantifies how quickly the resident gas o f  the lung is diluted by respiration. An 
increase in LCI can result from differences in specific ventilation between parallel 
lung units subtended at single branch points at any point within the conducting 
airways or within the diffusion-convection front o f  the lung. These differences in 
ventilation can be generated by more than one mechanism49. Within the conducting 
zone o f  the lung they can be generated by differences in airway calibre, either 
because o f  inflammation, remodelling, changes in airway tethering secondary to 
parenchymal damage, or simply secondary to luminal mucus obstruction. In 
addition, inhomogenous changes in compliance between parallel units can be 
predicted to increase LCI. Alternatively, increased LCI can result from diffusion- 
convection interactions between lung units subtended more peripherally. With this 
mechanism, inhomogeneous ventilation distribution can result sim ply from  
differences in size and com plexity o f  parallel units subtended at branch points 
within the diffusion-convection front. It is clear from the data presented in Chapter 
5 that LCI is a more sensitive marker o f  abnormal lung function in children with CF 
than parameters derived from spirometry. But what, exactly, is M BW  measuring? 
And do these abnormal results in very young children matter?
7.6.3 The origin and progression of CF lung disease
The relationship between inflammation and infection in young children with CF has 
been described in Section 7.2.6. The processes involved in the repair o f  airways 
affected by inflammation and infection are described as remodelling. The 
mechanisms involved are com plex, and are not w ell understood in children with  
CF. In adults, increase in height o f  the respiratory epithelium has been described in 
lung explants obtained from CF patients undergoing transplantation153. The same 
study demonstrated a reduction in the cartilaginous com ponent o f  the outer airway 
wall. Lobectomy and biopsy specimens have demonstrated subepithelial fibrosis, 
with smooth muscle thickening and inner airway wall thickening, particularly in the 
peripheral airways. One study in children, only published as an abstract so far, has 
demonstrated increased reticular basement membrane thickness which was 
independent o f  neutrophil and interleukin- 8  concentrations in B A L 154.
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A s inflammation and infection continue throughout childhood, increasingly 
abnormal lung function would be expected in later childhood, when compared with 
infancy. This does not appear to be the case. A  number o f  studies have investigated 
lung function in infants with CF. These studies have demonstrated that symptomatic 
infants with CF have reduced com pliance and conductance155’156, increased FRCho 
reduced V ’ m ax F R C , and a reduced m ixing index157. Ranganathan144 measured airway 
function using the RTC and the RVRTC in infants with CF recruited through the 
LCCFS. The incidence o f  lung function abnormalities detected in infants with CF 
was high, with 31% having abnormal FEV 0 .5 , and 12% having abnormal MMEF at 
first investigation. In contrast, in the current study, only 7% o f  preschool children 
have abnormal FEV0 .5 , whilst 27% o f  preschool children have abnormal MMEF 
(with the specificity o f  this parameter being only 80%) (Table 5.11). There are 
slight differences between the recruitment methods for Ranganathan’s study and the 
current study, but these differences are likely to result in children with more severe 
disease being over-represented in the preschool group, rather than the opposite.
The question o f  whether lung function in CF deteriorates or improves through early 
childhood is best answered by a longitudinal study, tracking changes in spirometric 
parameters from infancy to school-age. This is being undertaken for Ranganathan’s 
cohort, but the results are not yet available. In the meantime, Ranganathan noted the 
relatively poor lung function in infancy, compared with that seen in older children 
with CF, and proposed a number o f  possible explanations. In brief, these were:
a) Airways are more susceptible to closure or narrowing in infancy than later 
in childhood, and abnormalities are therefore more likely to be detected by 
spirometric techniques in infants
b) The RVRTC technique affects behaviour o f  airways (perhaps because o f  the 
deep inhalation required) so that it measures airway behaviour that 
conventional spirometry cannot detect
c) The volume parameters reported from infants and older children measure 
different things (although in the current thesis this problem has been 
addressed by reporting FEV0.5 and FEV0.75 as w ell as FEVi)
d) Treatment improves lung function during early childhood
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e) Data collected at school-age (or at preschool age) includes that o f  some 
subjects who were diagnosed late because they have a less severe CF 
phenotype
f) Diminished airway function in infancy reflects poor nutrition as w ell as 
inflammatory damage.
All these possible explanations are contentious, with limited data to support them. 
Some could be tested by longitudinal studies, though the limitations o f  comparisons 
or RVRTC parameters with parameters obtained from standard spirometry remain. 
Data presented in the current thesis suggest an alternative approach.
7.6.4 Progression of CFlung disease, measured by MBW 
It has already been described how LCI is more sensitive than spirometry for 
detecting abnormal lung function in children with CF. In addition, the volum e 
correction o f  S cond and S a c in  allows us to compute these indices in children, and 
compare results in children o f  differing ages. The results presented in Chapter 6  are 
dramatic, and not entirely expected. Nearly all children with CF, including the 
youngest, have raised S COnd,corr, with no age relationship seen (Figure 6.5). In 
contrast, most children under the age o f  10 years have normal S ac in ,co rr (Figure 6 .6 ), 
whilst this index is elevated in the majority o f  older school-age children. There are 
a number o f  possible explanations for these findings:
a) In children aged less than 10 years, CF affects airways within the 
conducting zone (by any o f  the mechanisms described in Section 7.7.1) but 
does not yet affect airways within the area o f  the diffusion-convection front, 
or cause structural damage to the acini. In children aged greater than 10 
years, more peripheral airways are also involved, and/or parenchymal 
destruction results in altered relationships between peripheral lung units 
subtended at branch points within the diffusion-convection front.
b) The nature and location o f  CF airway disease at different ages is similar, but 
the location o f  the diffusion-convection front is more proximal in older 
children.
c) The ventilation inhomogeneity is the result o f  differences in compliance 
between parallel lung units, which are subtended at branch points within the
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conducting airways in younger children, but also at branch points within the 
diffusion-convection front in older children.
These explanations are not mutually exclusive, but it is suggested that the first o f  
them is the most consistent with our current understanding o f  CF lung disease.
In Section 1.7, previous studies o f  M BW  in children with CF were presented. These 
studies described how indices o f  ventilation inhomogeneity are raised in CF 
subjects compared with healthy subjects26’28’29’72'75, and how ventilation  
inhomogeneity is correlated to airway resistance28 and F E V i75 in CF subjects. All 
o f  these studies were cross-sectional, and provided little information regarding the 
progression o f  CF lung disease. One month before this thesis was completed, the 
first longitudinal study o f  LCI in children with CF was published. This study, from 
the University o f  Berne, Switzerland, described longitudinal measurements o f  LCI 
(from nitrogen MBW ), FRCpieth, SReff, and spirometry. Unfortunately the study 
duration and the number o f  investigations undertaken by each child are not clearly 
presented, but at least some o f  the subjects appear to have undergone repeated 
measurement from the ages o f  6  to 20 years. The most important results from this 
study are: that LCI increases with age; that progressive rise in LCI is mirrored by 
progressive fall in FEVi and MEF50; and that consistently abnormal lung function  
(defined as a result 2 SD from the mean, in two consecutive years) w as seen earlier 
by LCI than by any other measure.
7.6.5 What about children with more severe lung disease?
The aim o f  this thesis was to investigate M BW  in young children, m ost o f  who have 
relatively mild lung disease. Leading on from this, could M BW  replace spirometry 
as an outcome measure in children (or adults) with more severe disease? The 
answer to this question is probably no. First, from a practical point, a M BW  run in a 
teenager with CF will take far longer than in a younger subject, partly because o f  
the low  respiratory rate in older subjects, and partly because o f  poor gas mixing in 
subjects with more severe disease. By comparison, spirometry is a quicker and 
cheaper test. Second, FEVi is known to predict survival in subjects with severe 
disease, not perfectly, but at least better than other objective measures. Extended 
longitudinal studies are necessary before M BW  parameters could be demonstrated
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to provide the same prognostic information. Third, it can be predicted that some 
children with more severe lung disease may have an artificially low  LCI, as some 
areas o f  lung that are severely diseased w ill be com pletely non-ventilating during 
tidal breathing, as airways leading to these regions are collapsed or completely 
obstructed by mucus. In this scenario LCI w ill only inform upon relatively healthy 
lung that is ventilated at rest, whilst severely damaged lung w ill be ‘invisible’. In 
these children spirometry manoeuvres w ill be a better reflection o f  overall lung 
disease. The presence o f  non-ventilating regions could be investigated by 
comparing FRC measured from M BW  (which w ill not include non-ventilating 
regions) with FRC measured plethysmographically (which w ill include such 
regions). Discrepancy between the two results w ill quantify the volum e that is not 
ventilated during tidal breathing. O f course, this information is still useful, both to 
the physiologist, and to the clinician. However, it may mean that M BW  is better 
suited to be an occasional tool in subjects with severe disease, rather than a primary 
monitoring tool.
7.6.6 What next?
Although it has now been demonstrated that many young children with CF have 
abnormal ventilation distribution, this does not necessarily mean that these children 
have clinically important lung disease, or that those with normal ventilation  
distribution do not. Comparison with a ‘gold standard’ is not possible, as there is no 
non-invasive gold standard for detecting CF lung disease. This question can only be 
answered by longitudinal studies, intervention studies, and studies relating lung 
function findings to other measures o f  lung disease.
a) Longitudinal studies: M BW  studies in infants, em ploying basic washout 
curve indices, have already been described15. In addition, it is possible that the Sacin 
and Scond analysis outlined in this thesis could be em ployed to interpret data from 
infant MBW. This provides an unprecedented opportunity to track the early changes 
o f  CF lung diseases, avoiding som e o f  the pitfalls o f  interpretation o f  spirometry at 
different ages. It is noted that other lung conditions could be investigated by similar 
methods. In order to determine whether M BW  is a potential marker for early CF
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lung disease, it w ill be necessary to perform M BW  in a cohort o f  infants with CF, 
ideally recruited from a screened population, and to fo llow  these children up at 
regular intervals. Ideally, this population should be follow ed into adulthood, so that 
survival can be used as the ultimate outcome measure. This would require very long 
study duration, and analysis w ill need to consider many confounding factors. In 
practice therefore this study could be continued into early school-age, with other 
measures o f  lung disease (e.g. spirometry results, or HRCT findings) as the 
outcome measure.
b) Intervention studies: Treatment o f  CF lung disease with anti-infective or 
anti-inflammatory agents is known to improve spirometry results and exercise test 
results in older subjects. At present there are no data on the effect o f  CF therapy 
upon MBW  indices. The most straightforward intervention study would be to 
perform MBW  before and after intravenous antibiotic therapy in children with acute 
infective pulmonary exacerbations. Interpreting data from such a study w ill not be 
straightforward. First, it w ill be necessary to quantify between occasion  
repeatability for MBW  indices in this population. Second, it can be predicted that 
some children with more severe lung disease may have an increase in LCI 
follow ing treatment, as areas o f  lung that are com pletely non-ventilating at the time 
o f  an exacerbation may ‘open up’ following treatment. I f  these areas o f  lung are 
more diseased than the rest o f  the lung, the result w ill be an increase in LCI. This 
pitfall can be overcome by restricting the study to subjects with mild disease, or by 
simultaneously measuring MBW  and plethysmographic FRC before and after 
intervention. Following such a study, the effect o f  other interventions (e.g. long 
term anti-inflammatory therapy) could also be tested, with M BW  measured 
alongside other outcomes.
c) Other measures of disease severity: Objective measurements o f  
inflammation and structural lung damage have been discussed above. The majority 
o f  CF centres in the UK do not perform either routine BAL or routine HRCT in 
young children with CF. The cost o f  these procedures (both financial, and potential 
adverse effects) is considered to outweigh the potential benefit. However, with
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increasing emphasis on detection o f  mild disease and early infection, this risk- 
benefit balance is changing, and a number o f  centres are considering these 
investigations for routine monitoring. The paediatric CF centre at the Royal 
Brompton Hospital now  perform BAL upon diagnosis for all children with CF, 
though they do not perform regular repeat BAL, or HRCT, in children who are 
doing well (personal communication, A  Bush, Royal Brompton Hospital, London). 
The CF clinic in Gothenburg performs HRCT on alternate years in all subjects 
(personal communication A  Lindblad, Gothenburg). CF centres in Australasia have 
long performed regular surveillance BAL in all young children with CF158, but the 
centres in Perth and Melbourne are now considering com bining this investigation 
with limited slice HRCT, performed under the same anaesthetic i f  necessary, as part 
o f  a research protocol (personal communication S Ranganathan, Melbourne). The 
author is communicating with the Perth-Melboume group about the possibility o f  
introducing M BW  into this research protocol.
7.7 Conclusion
The starting aim for this thesis was presented as: “to investigate whether the 
efficiency o f gas mixing, measured by the inert gas multiple-breath washout 
technique, could be employed as a measure o f  lung function in preschool children 
with CF. ” This broad aim led to multiple unanswered questions, w hich were clearly 
beyond the scope o f  a single thesis. A  small number o f  specific hypotheses were 
therefore generated, and these have now been tested. It can now  be concluded that 
preschool children are able to reliably perform both spirometry and M BW , provided 
that methodology for data collection and interpretation is modified. Furthermore, 
MBW  is able to detect abnormal lung function in children with CF more frequently 
than spirometry, and modifications to M BW  analysis may provide detailed 
information on the location and distribution o f  early CF lung disease. A ll o f  these 
findings support the hypothesis that M BW  w ill have value as a clinical measure in 
this patient group, and suggest that further investigation is justified.
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